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1 Introduction
Human spaceflight is a challenging field of research, as space travel has fascinated
mankind for more than 50 years and space programs are heading towards further
orbital and interplanetary exploration. 
In 1961, Yuri Gagarin started manned space flight as the first human to travel into Earth
orbit. Since then, human beings have been essential for the exploration of space. Not
only ongoing projects like the habitable International Space Station (ISS; Fig. 1), but
also future projects like a manned mission to Mars show the advantage of humans in
space over robotic processes. Even though robotic space missions are necessary to
prepare for manned operations, humans enable versatility and can react quickly when
problems arise. Communication lags between Earth and a spacecraft travelling to Mars
as it can take ~ 20 minutes to send commands between the two, and another 20 min-
utes before a response is received (Nimon, 2013). 
Main problems of manned space flight are several increased health risks, which
humans face during long-term missions. This is due to several harmful environmental
factors, including microgravity and radiation, which can cause major hazards to an
astronaut (Thirsk et al., 2009). Spending a long time in microgravity environment leads
to severe bone and muscle mass loss, changes in cardiac performance and a fluid shift.
Additionally, astronauts are exposed to a radiation environment that differs extremely
from the radiation field on Earth. Humans in space are exposed to different kinds of
radiation, as there is less or no protection from the Earth!s atmosphere and magnetic
field. They are constantly exposed to space radiation at a low dose rate over a long
period of time. An increase in cancer risk is the main concern for astronaut exposure
to space radiation, as it persists after landing (Durante and Cucinotta, 2008).
Fig. 1: The International Space Station (ISS)
from above. The ISS is the largest human-
made object ever to orbit the Earth and
marked its 10th anniversary of continous
human occupation on November 2nd, 2010.
Since the first expedition, which was launched
October 31st, 2000, the space station has been
visited by 204 individuals up until November
2nd, 2012 (www.nasa.gov). It is located at an
altitude of ~ 400 km in low Earth orbit (LEO)
(Credit: STS-114 Crew, NASA).
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These risks have to be understood, for short-term trips into space but especially for
long-term journeys. As radiation is one of the limiting factors, it has to be investigated,
in which way the different radiation qualities influence future manned space missions,
to alleviate given risks with appropriate countermeasures. In this work, the effect of
space-relevant radiation on a molecular level is investigated.
1.1 Radiation
1.1.1 Radiation biology basics
Radiation biology is defined as the study of the biological effects of ionizing radiation
on living systems. Ionizing radiation is radiation with enough energy so that during an
interaction with an atom, it can remove tightly bound electrons from the orbit of an atom,
causing the atom to become charged or ionized. In contrast, non-ionizing radiation, like
electric and magnetic fields, radio waves or ultraviolet light is the part of the electro-
magnetic spectrum where there is insufficient energy to cause ionization.
The term ionizing radiation can be subdivided into the types of directly and indirectly
ionizing radiation. Charged particles like electrons, protons, !-particles and heavy ions
are directly ionizing. The likelihood of the effect hereby decreases with increasing velo-
city of the particle and increases with charge. With decreasing velocity, the chance of
interaction between particle and matter increases, while the electric field gets stronger
with increasing charge.
X-rays, "-rays and neutrons are indirectly ionizing. They do not carry electrical charge
and can transfer energy to charged particles during interactions with matter.
For a better understanding of radiation effects, a few basic terms are defined here.
Linear Energy Transfer (LET) is the average energy (#E) imparted to a medium by a
charged particle per unit track length (#S). The corresponding unit is keV/$m. Low LET
results in sparsely ionizing radiation, whereas high LET is densely ionizing (Pouget and
Mather, 2001), resulting in different interactions with the target molecule. The diameter
of a densely ionizing particle track ranges around several $m. During traversal of the
cell, high atomic number and high-energy (HZE) particles loose energy which results
in ionization of molecules. Particles with high LET cause a dense ionization along their
track.
LET = #E/#S (Equation 1)
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Relative biological effectiveness (RBE) describes the effect size of a certain radiation
quality in biological systems. It compares the effectiveness of a test ionizing radiation
(Dtest) to that of a reference radiation, e.g. X- or !-rays (Dref). RBE is dependent on dose,
dose rate, biological endpoint of interest, LET, particle velocity and charge (Hall and
Giaccia, 2012a).
RBE = Dref/Dtest (Equation 2)
The Bragg peak describes the maximum of ionization density which a charged particle
produces along its track. The number of ions that are created per unit of path length
increases as the particle slows down. It reaches the Bragg peak close to the end of its
trajectory. Here, residual energy is lost over a very short distance. The peak is followed
by a rapid decrease of energy loss (Fig. 2).
1.1.2 Radiation environment in space
Radiation exposure in space severely differs from the natural radiation field humans
are exposed to on Earth. Terrestrial radiation is largely characterized by low LET radi-
ation (X-, "- or !-rays) and partly high LET radiation in form of #-particles, e.g. from
radon decay. Astronauts face a broad spectrum of radiation qualities, ranging from X-
rays to high-energy particles such as electrons, neutrons, protons and heavy ions with
high charges. 
Most harmful factors which influence manned space missions are not only the cosmic
ionizing radiation but also secondary radiation produced by interactions of cosmic radi-
Fig. 2: Bragg curves of all accelerated ions
used in this work. The Bragg curves show the
energy loss while traversing through water of
the following ions: 13C (71 MeV/n, LET 34
keV/$m), 22Ne (75 MeV/n, LET 92 keV/$m), 36Ar
(84 MeV/n, LET 272 keV/$m), 58Ni (54 MeV/n,
LET 906 keV/$m), 16O (91 MeV/n, LET 51
keV/$m), and 48Ti (997 MeV/n, LET 108
keV/$m). The energy on target and the average
LET over the shaded area, which indicates the
average thickness of a human cell, are given in
brackets for each ion. Cells were irradiated in
the consistent LET range before the Bragg peak
(adapted from Hellweg, 2012).
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ation with matter of the walls of the space ship. Protection from radiation by the Earth!s
magnetic field decreases as the distance from Earth increases. 
The first indication of an effect of space radiation on the human body were events
described by Apollo and Skylab astronauts as "light flashes!. Nowadays it is known that
these "light flashes! are visual phenomena, caused by cosmic ray particles passing
through the eye and directly interacting with the retina (Narici et al., 2004).
On Earth, the average radiation dose reaches 2.4 mSv1 per year. On the ISS, which is
located at a height of ~ 400 km, radiation doses of 0.5 mSv per day can be measured
(Beaujean et al., 2002; Reitz et al., 2005). During extravehicular activities (EVAs), doses
reach three times this amount (Berger and Reitz, 2006). During an interplanetary Mars
mission, which is estimated to take up to three years (Grigoriev et al., 1998), dependent
on shielding and solar activity, equivalent doses of up to 1000 mSv at the blood-forming
organs can be received (Horneck et al., 2006). These values currently make space radi-
ation a limiting factor for long-term missions in space (Durante and Cucinotta, 2008).
1 Sievert (Sv) is the corresponding unit for the dose equivalent (H). H is the energy dose weighted by
the biological effectiveness of a given radiation quality or radiation quality factor (Q). Q is a dimensionless
radiation weighting factor and was derived from the measured RBE#values. Q ranges from 1 at low LET
(<10 keV/$m) to 30 at high LET (~ 100 keV/$m). With very high LET Q decreases due to so-called over-
kill or wasted energy (Durante and Cucinotta, 2008). 1 Sv = 1 J/kg.
H = radiation quality factor (Q) % absorbed dose (D) (Equation 3)
Fig. 3: Radiation sources in space. The space
radiation environment in our Solar System is com-
posed of different radiation qualities and sources.
Primary components of the radiation field are
galactic cosmic rays (GCR), which originate from
outside our Solar System, and solar cosmic radia-
tion (SCR), which constantly flows from the Sun.
The radiation field is composed of a variety of radi-
ation species, like electrons, protons, &-particles,
X-rays, heavy ions, '-rays and neutrons. Highly
energetic ions are of main interest for long-term
space missions, as these particles pose the most
hazardous radiation risk for humans in space.
(taken from Hellweg and Baumstark-Khan, 2007).
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Primary components of the radiation field in space are galactic cosmic rays (GCR) and
solar cosmic radiation (SCR, Fig. 3). GCR originate from outside our solar system. Main
components are protons (87 %), !-particles (12 %) and heavy ions (1 %) covering the
full range of elements, with some of them, like iron and carbon nuclei, being more abun-
dant (George et al., 2009). 
In this work, heavy ions are of main interest, as they have a high RBE (Barendsen et
al., 1960; 1963; Skarsgard, 1998). For radiation effects on a molecular level, these high-
energetic particles are several times more effective than X-rays. GCR fluxes vary with
the solar cycle (Badhwar, 1997;"Wilson et al., 1989). During minimum solar activity, the
GCR"flux peaks, while it decreases during solar maximum. GCR can reach energies
up to 1012 MeV.
Solar cosmic rays consist of 95 % protons and originate from the surface of the Sun.
Further components are !-particles and heavy ions. During solar particle events (SPE),
which originate from magnetically disturbed regions of the Sun, highly energetic
charged particles are burst.
On a three-year mission to Mars, as described above, the exposure to GCR can accu-
mulate to doses up to 1.0 Sv and thereby cause late effects to the astronauts# health.
During solar flares, doses up to 4.2 Gy2 can be reached (Horneck et al., 2006), leading
to severe acute effects in the human body. These values depend on the solar cycle and
shielding condition.
Radiation protection is a complex issue as for high energy GCR passive shields are
too massive to be practical and high-energy particles can penetrate thick shielding. Fur-
thermore, they will likely produce showers of secondary radiation inside the spacecraft
upon impact with the shielding material, which may be more harmful than the GCR
themself (National Council on Radiation Protection and Measurements [NCRP], 2006).
1.1.3 Artificial radiation sources
To investigate its effects on human cells, space radiation has to be simulated as effec-
tively as possible. Therefore, heavy ion accelerators are used to expose cells to highly
energetic heavy particles, an important component of the space radiation field. About
26000 accelerators exist worldwide, with most of them used for medical applications
like radiotherapy. Major research machines are only a tiny fraction of the total
(Maciszewski and Scharf, 2004).
2 Gray (Gy) is the corresponding unit for the absorbed dose (D), which is the energy deposited per mass
unit. 1 Gy = 1 J/kg.
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Beamtimes at two accelerators were available during this work, the Grand Accélérateur
National d!Ions Lourds (GANIL) in Caen (France) and the heavy ion synchotron
(Schwer ionen-Synchotron, SIS) at the Gesellschaft für Schwerionenforschung (GSI) in
Darmstadt (Germany).
The accelerator forms a beam of subatomic particles which are ionized, collected and
directed into the particle accelerating facility. When an experiment is conducted, differ-
ent beam variables like species and energy with its consequential LET are offered. As
an example for a particle accelerator, Fig. 4 presents an overview of the GSI accelerator
facility in Darmstadt, Germany.
Fig. 4: The GSI heavy-ion accelerator facility in Darmstadt, Germany. The GSI was founded in 1969 as
the Society for Heavy Ion Research (Gesellschaft für Schwerionenforschung). The accelerator allows to
prepare ion beams of all the elements up to uranium in any state of electric charge. It accelerates these
beams to nearly the speed of light. The linear accelerator (UNILAC) accelerates ions to 20 percent of
the speed of light. In the heavy ion synchrotron (SIS) the ion beam is further accelerated up to 90 percent
of the speed of light in the course of several hundred thousand revolutions. Previously accelerated ions
can be stored in the experimental storage ring (ESR; Credit: GSI).
1.1.4 Effects of whole body radiation exposure in humans
Effects of ionizing radiation can be acute or delayed, depending on the time frame of
radiation exposure as well as dose and dose rate. Furthermore, the quality of radiation
is of importance, as the major hazard in manned spaceflight results from highly ener-
getic particles. Acute effects, which are mostly due to exposure to high proton fluxes
during solar flares, appear soon after irradiation (from minutes to a few days),!while
delayed effects like cancer can only occur after several years.
UNILAC
SIS
ESR
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While the current estimates of cancer risks for adults aged 40 are between 0.001 and
0.01 for a chest X-ray, this increases up to more than 1 % for an ISS!mission and
reaches more than 10 % for a planned Mars mission (Durante and Cucinotta, 2008). 
The radiosensitivity of cells, tissues, organs or organisms depends on different circum-
stances. Cells are least sensitive in S phase, the part of the cell cycle in which DNA!is
replicated. They are most sensitive in G2/M phase, in which dublicated chromosomes
are "checked# for errors for subsequent cell divison. Furthermore, undifferentiated,
quickly dividing and highly metabolically active cells are more sensitive compared to
resting cells. Bone marrow, lymphoid organs and gastrointestinal stem cells for example
are highly sensitive, whereas muscle, kidney and liver are fairly low radiosensitive
(Bergonié and Tribondeau, 1906). 
Table 1: Radiation effects in humans after whole body irradiation (adapted from Hellweg and Baumstark-
Khan, 2007).
Chronic dose Risk
~ 0.4 Sv/year First evidence of increased cancer risk as late effect from protracted 
radiation
2-4 Sv/year Chronic radiation syndrome with complex clinical symptoms
Acute!single
dose Effect Outcome
0.1-0.03 Sv First evidence of increased cancer risk 
as late effect (Pierce and Preston, 2000; 
Pierce et al., 2012)
< 0.25 Sv No obvious direct clinical effect
< 0.5 Sv Nausea, vomiting No early death anticipated
(> 0.7 Sv) 3-5 Sv Bone marrow syndrome:!Symptoms include Death rate for this syndrome
internal bleeding, fatigue, bacterial peaks at 30 days, but con- 
infections and fever. tinues out to 60 days. Death 
occurs from sepsis
5-12 Sv Gastrointestinal tract syndrome:!Symptoms Deaths from this syndrome
include nausea, vomiting, diarrhea, dehy- occur between 3 and 10 days
dration, electrolytic imbalance, loss of post exposure. Death occurs
digestion ability, bleeding ulcers. from sepsis
> 20 Sv Central nervous system syndrome:! No survivors expected
Symptoms include loss of coordination,
confusion, coma, convulsion, shock, and the
symptoms of the blood forming organ and 
gastrointestinal tract syndromes
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Table 1 lists radiation effects in humans after a whole body irradiation (Hellweg and
Baumstark-Khan, 2007). The syndromes listed in this table depend on the sensitivity
of the respective tissue and cells.
While the biological effects of protons are well investigated, the underlying mechanisms
for damage caused by highly energetic particles are still largely unknown. One of the
major uncertainties in risk prediction for space radiation are the poorly understood
effects of extraordinary radiation qualities on cells, tissue and whole organisms. Also,
the effect of dose rates in space on the biology of DNA repair, cell regulation and tissue
response are of main interest (Durante and Cucinotta, 2008).
1.1.5 Biological consequences of radiation exposure on the cellular level
To understand the impact of radiation exposure on the human body, the radiation
response processes on the molecular level have to be investigated. The most critical
target within a cell is the cell nucleus, since it contains the genetic information in form
of DNA and instructions required for the cell to perform its function. 
DNA!damage and repair. DNA can be damaged by ionizing radiation in a direct or in
an indirect manner. Concerning indirect action, radiation interacts with other molecules
within the cell, which might not be critical targets but may cause damage by producing
free radicals. Due to the high amount of water in living matter, hydroxyl radicals gener-
ated by water radiolysis, are responsible for most damages to biomolecules, including
DNA, causing single strand breaks (SSB), double strand breaks (DSB), oxidative base
damages or base loss. In the direct action, radiation is directly interacting with the DNA
molecule.
In case of a SSB, the undamaged second strand provides the template for DNA!repair.
DSB in mammalian cells can be repaired by non-homologous end-joining (NHEJ), sin-
gle-strand annealing (SSA) and homologous recombination (HR)!(Bennardo et al.,
2008). 
DNA!damage can be repaired in an error-free or in an error-prone way, which may lead
to hazardous changes like genome rearrangement. Depending on the type and severity
of the DNA damage, the cellular radiation response can have different outcomes. The
progression of the cell cycle can be arrested so that the cell has the ability to repair its
DNA and replace other damages biomolecules. Repair can either be error-free or error-
prone, but in both cases the cell has the ability to survive in the end. While undergoing
an error-prone repair, a mutation can occur, leading to a transformation with severe out-
comes like tumor growth. The mutation can as well be too hazardous for the cell to
Introduction
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survive. Additionally, crosslinks in DNA can occur, either in the same strand or in the
opposite strands of the DNA, leading to a block in DNA replication. The radiation!dam-
age can be so severe, that DNA repair is impossible. If that is the case, immediate or
delayed cell death can occur (Dalinka and Mazzeo, 1985). Alternatively, the cell under-
goes a permanent growth arrest, which can lead to premature differentiation or
senescence.
Amount and type of damage are determined by the type and dose of radiation (Kraft,
1987;!Baumstark-Khan et al., 1993; Hada and Sutherland, 2006). Radiation with a low
LET is sparsely ionizing, resulting in damages that are diffusely distributed (Fig. 5 A).
High LET radiation thus causes clustered DNA!damage with a high percentage of DSB
(Fig. 5 B). Clusters caused by HZE particles are complex as they contain mixtures of
various types of damages within a restricted DNA segment. These clusters are more
difficult or even impossible to repair, compared to the diffuse and less severe DNA!dam-
age caused by sparsely ionizing radiation. Lesions caused by irradiation with densely
ionizing radiation might be responsible for their high RBE for major biological endpoints
(Fakir et al., 2006; Hada and Sutherland, 2006). It was shown that HZE!particles induce
larger foci compared to X-rays (Costes et al., 2006) with streaks of foci indicating the
path of the particle track. Further, HZE!nuclei produce lesions that persist longer (Desai
et al., 2005). 
The predominant cellular response to radiation is a DNA!damage response (DDR)
which starts with detection of DNA damage. It activates a cascade to signal the pres-
A B
Fig. 5: Different patterns of DNA
damage depending on linear
energy transfer (LET). Low LET
radiation produces diffuse DNA
lesions that are easily repairable
(A). "-particles with high!LET are
densely ionizing and produce clus-
tered DNA!damage along a linear
track. These multiply damaged
sites are poorly repairable (B)
(modified from Pouget et al., 2011).
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ence of lesions and to promote their repair (Jackson and Bartek, 2009). The signal
transduction pathways activated by the DDR can lead to cell-protective and cell-altering
but also destructive responses (Khanna et al., 2001; Ohnishi et al., 2002). One key fac-
tor to regulate cellular cascades initiated by genotoxic stress is Ataxia
telangiectasia-mutated (ATM). ATM!is a kinase that is activated upon DNA!DSB and
will be described in more detail in chapter 1.2.3. Depending on cell type, ATM!can acti-
vate pathways that can either protect from or trigger apoptosis (Khanna et al., 2001;
Jackson and Bartek, 2009), including the Nuclear Factor "B (NF-"B) pathway.
Cell cycle arrest. As a consequence of DNA damage, DDR mechanisms regulate cell
cycle progression (van Gent et al., 2001; Jackson and Bartek, 2009). Cell cycle check-
points are initiated to coordinate DNA repair processes (Krempler et al., 2007;!Pawlik
and Keyomarsi, 2004). Checkpoints halt the cell cycle temporarily to avoid replication
and segregation of damaged DNA, to provide time for the repair of DSBs or function to
permanently remove damaged cells from the actively proliferating population. Upon
DNA!damage, the G1/S checkpoint can prevent replication of DNA, the S-phase check-
point delays replicative DNA synthesis and the G2/M checkpoint is able to block entry
into mitosis. Cell cycle checkpoints target Cyclin and Cyclin-dependent kinase (Cdk)
complexes, that normally promote cell cycle progression.
Several studies investigate the interplay of DSB repair and cell cycle control mecha-
nisms to reveal how cell cycle progression is regulated in the presence of DSBs,
induced by ionizing radiation (Linke et al., 1997; Cann and Hicks, 2006; Deckbar et al.,
2010). DNA!damage initiates a chain of events, with ATM playing a critical role, as it
targets downstream effectors like checkpoint kinases (ChK) and inhibits cell cycle pro-
gression in different phases of the cell cycle (Hall and Giaccia, 2012b).
Still, the underlying mechanism of the response to damage cluster caused by heavy
ions is not well understood so far and has to be studied on a cellular and molecular
level. 
1.2 The transcription factor Nuclear Factor !B (NF-!B)
1.2.1 The NF-!B proteins
The Nuclear Factor "B (NF-"B)/Rel family is composed of inducible dimeric transcrip-
tion factors which are involved in the regulation of more than 200 genes. Its members
are DNA-binding proteins that recognize "B or "B-like DNA!motifs (NF-"B-responsive
elements, NREs). 
Introduction
17
NF-!B was originally identified as a protein that interacts with an 11-base pair sequence
in the ! immunoglobulin light-chain enhancer in B-cells (Sen and Baltimore, 1986). This
factor is involved in the cellular response to several stimuli and is essential for regulat-
ing immune response, inflammation, cell proliferation and cell death (Baldwin, 1996;
Gómez et al., 1997; Ghosh et al., 1998; Li and Verma 2002; Karin and Lin, 2002;
Bonizzi and Karin, 2004). Defects in the NF-!B pathway are related to tumor develop-
ment as it gives the cells additional growth advantages. 
The NF-!B/Rel family is composed of related proteins consisting of NF-!B1 (p50/p105),
NF-!B2 (p52/p100), RelA (p65), c-rel and RelB (Moynagh, 2005;"Hoffmann et al.,
2006). Fig. 6 gives an overview of all NF-!B/Rel and I!B proteins. 
Fig. 6: The family of mammalian NF-!B/Rel and I!B proteins. (A) All NF-!B/Rel proteins with their
respective number of amino acids indicated on the right. S276, S311, S529 an S536 indicate serine phos-
phorylation sites; lysines K122, K123, K218, K221 and K310 are sites of acetylation of RelA; (NLS)
nuclear localization signal; (RHD) Rel-homology domain; (TAD) carboxy-terminal transactivation domain;
(purple circles) ankyrin repeats; (GRR) glycine-rich region; (LZ) leucine zipper; (B) NF-!B regulating I!B
inhibitory proteins; (SS) two serine residues, indicating sites of phosphorylation (taken from Chen and
Greene, 2004).
A
B
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All proteins share a ~ 300 amino acid N-terminal domain called the Rel homology
domain (RHD) which contains sequences necessary for DNA binding, dimerization and
nuclear localization. The RHD allows the formation of homo- and heterodimers, that
bind to the !B-sites. These sites are located in the promoters and enhancer regions of
genes. The c-rel, RelB and RelA proteins have a transactivation domain, which strongly
activates transcription after binding to !B sites. p50 and p52 proteins lack this domain
and therefore act as transcriptional repressors (May and Gosh, 1997).
Members of the NF-!B family, except for RelB, can form hetero- and homodimers with
one another. The most common form is the p65 subunit associated with p50 or p52.
In most cells, the cytosolic molecules I!B", I!B# or I!B$ inhibit the release of NF-!B
and thereby its activation. Additionally, the precursor proteins p100 and p105, which
are processed to p52 and p50 respectively, are able to function as I!B-like proteins.
They are characterized by I!B-typical ankyrin repeats, a 33-amino-acid motif that
mediates protein-protein interaction (Hayden and Gosh, 2004). I!B proteins mask the
nuclear-localization sequences (NLS) on the NF-!B subunits and retain them in the
cytosol. 
1.2.2 The classical and non-canonical NF-!B pathway
Three major types of signaling to activate NF-!B have been identified; the classical
(canonical), the alternative (non-canonical) and the genotoxic stress-induced (s. 1.2.3)
pathway. In the classical and the non-canonical pathway the signal is transmitted via
receptors into the cell (Fig. 7). In the classical pathway, NF-!B is activated by a variety
of different stimuli like pro-inflammatory cytokines, e.g. tumor necrosis factor " (TNF-
") or Interleukin 1 (IL-1), growth factors like c-Myc, Ras and p53 or by microbial and
viral infections via Toll-like receptors (TLR). Activation of NF-!B involves phosphoryla-
tion of two serine residues in I!B proteins. This modification triggers their ubiquitination
and degradation by the proteasome. The classical pathway is defined as being media-
ted by a NF-!B essential modulator (NEMO)-dependent I!B kinase (IKK). Ubiquitination
of I!B depends on activation of the upstream IKK%complex, formed by the homologous
kinases IKK" and IKK#, the non-enzymatic proteins IKK! or NEMO and the protein
ELKS, rich in glutamine (E), leucine (L), lysine (K) and serine (S) (Madonna et al.,
2012). After degradation of I!B, free NF-!B translocates into the nucleus and activates
its target genes involved in innate immune and inflammatory responses, developmental
processes, cellular growth and inhibition of apoptosis (Karin and Ben-Neriah, 2000,
Karin and Delhase, 2000). This classical pathway mostly involves p50/RelA or p50/c-
Rel dimers. 
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The non-canonical pathway does not involve NEMO (Shih et al., 2011) and depends on
the specific activation of a homodimer of IKK!, which is activated via the NF-"B inducing
kinase (NIK). The pathway starts at membrane receptors of the tumor necrosis factor
receptor (TNF-R) superfamily. Factors binding to these receptors are e.g. B-cell activa-
tion factor (BAFF), lymphotoxin # (LT#) or CD40 ligand (CD40L). The mechanism of the
non-canonical pathway relies on the inducible processing of p100 instead of degradation
of I"B. Finally, a heterodimer with$RelB$is formed and translocated into the nucleus to
activate genes involved in cell survival (Senftleben et al., 2001). The non-canonical path-
way regulates biological functions such as lymphoid organogenesis, B-cell survival and
maturation, dendritic cell activation and bone metabolism (Dejardin, 2006).
1.2.3 The genotoxic stress-induced NF-!B pathway
The third pathway which activates NF-"B is induced by genotoxic stress, especially by
DSB (Fig. 8). Several pathways have been environmentally developed by the cell to
detect and repair DNA damage (Wood, 1996; Karagiannis and El-Osta, 2004; Reddy
and Vasquez, 2005). As a response to genotoxic stress, the kinase ATM is one key fac-
tor to regulate cellular cascades, activated when DSB are present in the cell nucleus.
In resting conditions, ATM$is kept inactive in a dimeric form in the nucleus. Its$activation
is regulated by the heterotrimer Mre11/Rad50/NBS (Falck et al., 2005; Uziel et al.,
2003) which binds to DSB extremities and leads to ATM$autophosphorylation. Upon
Fig. 7: Activation of the classical and the
non-canonical NF-!B pathway. The clas-
sical NF-"B pathway is triggered by
various signals, including those medi-
ated by innate and adaptive immune
receptors. It involves activation of the
IKK$complex (IKK1, also known as IKK!,
and IKK2, also known as IKK#), I"B!
phosphorylation and subsequent degra-
dation. In the non-canonical pathway,
phosphorylated p100 is processed to
p52, depending on NIK$and IKK! (IKK1),
but not on the trimeric IKK complex
(taken from Chen and Greene, 2004).
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DSB induction, the ATM dimers dissociate and one molecule phosphorylates the adja-
cent one. ATM!can respond to alterations in chromatin formation (Bakkenist and
Kastan, 2003) and!is known to initiate the nuclear cascade which leads to NF-"B acti-
vation. It was shown that the response to the genotoxic agent camptothecin (CPT) (He
et al., 2007) and to low LET!ionizing radiation (Lee et al., 1998) are ATM-dependent.
The activated NF-"B is a p50/p65 heterodimer.
DNA!damage further results in an increased nuclear translocation of the proteins p53-
inducible death domain-containing protein (PIDD) (Lin et al., 2000) and NEMO (IKK!).
Upon genotoxic stress, PIDD, together with receptor-interacting protein 1 (RIP1) and
NEMO, forms a complex, which accumulates in the nucleus (Janssens et al., 2005).
The PIDD/RIP/NEMO complex enhances sumoylation of NEMO.
The two distinct cascades, involving ATM and PIDD respectively, converge, when ATM
binds to and phosphorylates NEMO. Subsequently, NEMO is further mono-ubiquitini-
ted. The NEMO/ATM complex leaves the nucleus and associates with IKK# and IKK$.
Together with!ELKS, IKK!phosphorylates I"B and allows its poly-ubiquitination, leading
to proteasomal degradation. Here, the pathway triggered by DNA!damage merges with
the canonical pathway, involving p65/p50 heterodimers and I"B.
1.2.4 Activation of NF-!B in response to ionizing radiation 
The molecular mechanisms, leading to different cellular outcomes after irradiation with
heavy ions are still under investigation. Though, it has been shown, that NF-"B is not
only involved in regulating gene expression after treatment with inflammatory stimuli,
Fig. 8: Activation of the genotoxic stress-
induced NF-!B pathway. NF-"B
activation triggered by DSB results in
two independent cascades. ATM is acti-
vated and additionally PIDD translocates
into the nucleus. Both cascades con-
verge when ATM phosphorylates NEMO.
Modified NEMO leaves the nucleus and
associates with IKK# and IKK$. The
activated IKK complex phosphorylates
I"B#. From here, signalling resembles
the classical NF-"B pathway (adapted
from Habraken and Piette, 2006).
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carcinogens, stress and growth factors but also ionizing radiation, which promotes bind-
ing of NF-!B to DNA (Brach et al., 1991; Sahijdak et al., 1994; Ahn et al., 2007). Further,
different radiation qualities such as heavy ions with a medium LET"(~ 270 keV/#m)
were shown to activate NF-!B in human embryonic kidney cells (Baumstark-Khan et
al., 2005; Hellweg et al., 2007).
NF-!B is involved in pro-survival signalling (Rashi-Elkeles et al., 2006) and regulates
apoptosis by inducing the expression of anti-apoptotic proteins in many cell types
(Baichwal and Baeuerle, 1997;"Chen and Greene, 2003;"Kucharczak et al., 2003). NF-
!B gives cells a growth and survival advantage and its activation therefore contributes
to the radioresistance of tumor cells (Li and Sethi, 2010;"Baldwin, 2001). At the same
time, defects in this pathway are related to tumor development as NF-!B activation can
result in survival of mutation-prone cells. Further, the NF-!B pathway is involved in
inflammation processes (Chastel et al., 2004) as its activation results in production of
pro-inflammatory cytokines. 
Heavy ion experiments have revealed a strong dependency of RBE for different bio-
logical endpoints on LET, ion species, energy and charge (Bird and Burki, 1975;"Stoll
et al., 1995; Wulf et al., 1985; Yatagai, 2004). Exposure to accelerated heavy ions
results in stronger activation of NF-!B in human cells than X-rays (Baumstark-Khan et
al., 2005). It was shown that activation of NF-!B differs depending on the heavy ion
species and its LET in human embryonic kidney cells (HEK; Hellweg et al., 2011a).
Additionally, the potential to activate NF-!B by energetic carbon ions with an LET below
80 keV/#m was comparable to the effect induced by X-rays (Hellweg et al., 2011b). The
maximal NF-!B activation was observed in a LET range of 80-300 keV/#m (Hellweg et
al., 2011a).
As previously described, the LET"also influences the type of DNA"damage, as densely
ionizing radiation causes DSB containing and non-DSB clustered DNA"damage. So far,
the role of NF-!B in DNA"repair is not fully understood.
The central role of NF-!B in cellular survival and inflammatory responses of the tissue
after exposure to ionizing radiation makes it an important pharmacological target for
modulating the cellular radiation response. In cancer therapy using heavy ions such as
carbon ions, understanding the role of NF-!B will be of importance for revealing the
underlying mechanisms of the cellular radiation response. Inhibiting NF-!B might pro-
mote the killing effect of radiation therapy by suppressing survival signals. Radiation
therapy acts through the induction of DSBs resulting in elimination of cancerous cells
via different death mechanisms including apoptosis (Li et al., 2001). Further, investigat-
ing the role of NF-!B in the cellular radiation response will not only be of interest for
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astronauts, who are exposed to a potentially life-threatening radiation environment dur-
ing long-term space missions, but also relevant for cancer therapy. For risk
assessment, more detailed knowledge concerning NF-!B and the involvment in cellular
outcomes after irradiation with different radiation qualities is needed.
1.2.5 Biological endpoints in NF-!B investigation
To investigate NF-!B  and its involvement in the cellular outcome after irradiation, dif-
ferent biological endpoints are of interest. In this work, growth, cell cycle progression,
survival and expression of its target genes were investigated. 
1.2.5.1 NF-!B in growth and survival
The importance of NF-!B in survival was revealed by mice lacking the RelA gene,
which had embryonic lethal consequences, due to an increased sensitivity of hepato-
cytes to the apoptotic action of TNF-" (Beg et al., 1995). Further evidence for these
findings was shown by different cellular models, in which inactivation of NF-!B lead to
increased apoptotic sensitivity of cells after exposure to various stimuli or stress con-
ditions (Bottero et al., 2001; Busuttil et al., 2002; Van Antwerp et al., 1996; Wang et al.,
1996). 
Active NF-!B induces transcription of a set of genes, coding for anti-apoptotic proteins.
Defects in NF-!B result in increased susceptibility to apoptosis leading to increased cell
death. A number of anti-apoptotic genes like TNF receptor-associated factors 1 and 2
(TRAF1 and TRAF2; Sheikh and Huang, 2003), cellular inhibitor of apoptosis proteins
1 and 2 (c-IAP1 and c-IAP2; Deveraux and Reed, 1998) or caspase 8-FAS-associated
death domain (FADD)-like IL-1#-converting enzyme inhibitory protein (c-FLIP; Kreuz et
al., 2001) are induced by NF-!B. NF-!B further regulates activities of the caspase fam-
ily, which is central to most apoptotic processes (Sheikh and Huang, 2003).
One major signalling pathway involving anti-apoptotic functions of NF-!B is the TNF
receptor 1 (TNF-R1) signalling pathway, which is induced after irradiation (Luce et al.,
2009). Further common genes known to be involved in regulation of apoptosis are X
chromosome-linked inhibitor of apoptosis protein (XIAP), B-cell lymphoma 2 (BCL-2)
and B-cell lymphoma-extra large (BCL-XL). 
Under certain circumstances, NF-!B has pro-apoptotic functions and amplifies cell
death. This is due to the induction of genes coding for the death receptor Fas or its lig-
and FasL (Ravi et al., 1998a).
Introduction
23
Defects in the NF-!B pathway are related to tumor growth and proliferation and over-
expression of NF-!B target genes gives cells additional growth advantages (Baichwal
and Baeuerle, 1997; Sonenshein, 1997). Therefore, anti-tumor therapies seek to block
NF-!B activity to inhibit proliferation or to sensitize tumor cells to conventional thera-
pies, such as chemotherapy.
1.2.5.2 NF-!B and cell cycle regulation
NF-!B might be involved in cell cycle arrest in order to allow DNA repair (Li et al., 1994;
Russell et al., 2002; Zhou et al., 1999). It was shown to be involved in the induction of
cyclin D1, which is an essential element of the transition of G1 to S phase (Guttridge
et al., 1999). Additionally, NF-!B was shown to regulate the cell cycle through actions
on the cyclin-dependent kinase (CDK)/cyclin-dependent kinase inhibitor (CKI) system
(Joyce et al., 2001). Activators of CDKs are, amongst others, the cell cycle regulating
growth arrest and DNA"damage-inducible gene 45 (GADD45) genes. GADD45 genes
are activated by ionizing radiation, with GADD45# being regulated by NF-!B (Lieber-
mann and Hoffmann, 2008). Ataxia-telangiectasia-patients lacking ATM, which induces
NF-!B activation via the genotoxic stress-induced pathway, suffer from extreme
radiosensitivity and cell cycle anomalies (Lavin and Shiloh, 1996). Further, it was found
that NF-!B is involved in the regulation of different cell cycle phases following treatment
with DNA-damaging agents and TNF-$. Besides, cells, which were unable to activate
NF-!B, underwent transient G2-M arrest and extensive cell death (Wuerzberger-Davis
et al., 2005). 
In response to radiation, the progression of the cell cycle is arrested to allow more time
for DNA repair. Depending on the severity of DNA"damage, the cell can repair the
damage or is not able to repair and undergoes cell death.
The outcome of the cell depends on radiation quality, dose, cell type, dose rate and the
cell cycle phase at the time of radiation exposure. The role of NF-!B in cell cycle reg-
ulation after irradiation with HZE particles is not fully understood.
1.2.5.3 NF-!B and its target genes
To obtain an overview on NF-!B-dependent gene expression after irradiation with dif-
ferent radiation qualities, a variety of genes was analysed in this work. Common genes,
which are expected to be involved in the radiation response were investigated, as gene
expression after radiation exposure and the role of NF-!B within is not completely
understood. To obtain a primary overview, genes involved in cell cycle, p53 signalling,
stress response, apoptosis, DNA damage, the NF-!B pathway and oxidative stress
were investigated initially. 
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As this work focusses on NF-!B as a central element in the cellular radiation response,
the expression of NF-!B target genes was of special interest. Table 2, taken from Nis-
hikori (2005), shows only a small selection of the various processes in which NF-!B
target genes are involved. 
Table 2: Selection of NF-!B target genes (taken from Nishikori, 2005). All of the genes shown are related
to tumor progression. (VEGF) vascular endothelial growth factor; (IL-8) Interleukin 8; (IL-6) Interleukin
6; (COX2) cyclooxygenase 2; (iNOS) inducible nitric oxide synthase;"(MMP-9) metalloproteinase-9; (uPA)
urokinase plasminogen activator;"(ICAM-1) intracellular adhesion molecule-1;"(VCAM-1) vascular cell
adhesion molecule-1; (ELAM-1) endothelial-leukocyte adhesion molecule-1.
Activity Genes
Inflammation TNF, IL-1, chemokines
Cellular immortality Telomerase
Cell survival BCL-XL, c-IAP, XIAP, c-FLIP
Angiogenesis VEGF, TNF, IL-1, IL-8
Proliferation TNF, IL-1, IL-6, cyclin D1, c-MYC
Tumor progression COX2, iNOS, MMP-9, uPA
Metastasis ICAM-1, VCAM-1, ELAM-1
Amongst the large number of genes regulated by NF-!B, gene expression analysis
focussed on genes involved in the regulation of the inflammatory response, tumorige-
nesis and apoptosis. Expression of NF-!B-dependent genes coding for cytokines,
ligands and receptors, inflammatory response genes etc. was analysed to get an insight
into the underlying mechanism of different cellular outcomes after exposure to space-
relevant radiation.
1.2.6 Inhibiting the NF-!B pathway by chemicals and by RNAi
Targeted inhibition of the NF-!B pathway helps to reveal molecular mechanisms and
its role in the cellular radiation response. Further, it might induce and increase the killing
effect in cancer therapy, when combined with chemo- or radiotherapy.
In this work, the chemical inhibitors MG-132 and KU-55933 were used to suppress the
NF-!B pathway and to investigate its impact on the radiation response. MG-132 inhibits
the proteasome, which is essential for degradation of the ubiquitinated I!B-inhibitor.
Zanotto-Filho et al. (2009) showed, that MG-132 presented an increased apoptotic
effect compared to other inhibitors in leukemia cells. Further, MG-132 arrested cells in
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G2/M phase of the cell cycle and blocked doxorubicin-induced NF-!B activation. MG-
132 was shown to be an effective inducer of apoptosis in tumor cells and may be a
potent anticancer agent (Banerjee and Liefshitz, 2001).
KU-55933 interferes with the DNA damage induced pathway by inhibiting ATM and
showed that it acts as a radiosensitizing agent in preclinical studies (Kuroda et al.,
2012). Cell cycle arrest in the G2 phase after irradiation with ionizing radiation could be
effectively abrogated by inhibiting ATM with KU-55933 (Landsverk et al., 2011).
Fig. 9 shows the targets of MG-132 and KU-55933 in a schematic view of the classical
and the genotoxic induced NF-!B pathway.
In addition to chemically inhibiting elements of the NF-!B pathway, a stable transfection
using RNA interference (RNAi) to knockdown RelA expression was performed. The
mechanism of RNAi was discovered in the nematode worm Caenorhabditis elegans as
a response to double-stranded RNA"(dsRNA) which resulted in sequence-specific gene
silencing (Fire et al., 1998). RNAi was discovered as a system within living cells that
helps to control which genes are active and how active they are. As a consequence,
antisense RNA"was used as an approach to inhibit gene expression (Hannon, 2002).
The RNAi pathway results in degradation of targeted mRNA"by the RNAi induced
silencing complex (RISC; Fig. 10). Different methods can be chosen to achieve mRNA
cleavage. DsRNA can be introduced into the cell, which is subsequently cleaved by
dicer into small interfering RNAs"(siRNA). SiRNAs are 21-23 nucleotides in length and
can also directly be introduced into the cell. They associate with RISC"and are directed
to the target mRNA. SiRNA"does not allow stable transfection and only works under
transient transfection conditions. 
Fig. 9: Chemical inhibition of
the NF-!B pathway. KU-55933
targets ATM, which is activated
by DNA"DSB in the genotoxic
stress-induced NF-!B path-
way. In the classical and the
genotoxic stress-induced path-
way, MG-132 inhibits the
proteasome from degrading
I!B#.
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Alternatively, vectors expressing short hairpin RNA!(shRNA) can be stably transfected
into the cell. The vector is transported into the nucleus, where shRNA!is expressed by
RNA polymerase III!(Pol III). ShRNA is translocated into the cytoplasm where is is
cleaved into siRNAs, which associate with RISC. Here, the different pathways con-
verge. In order to stably transfect cells, a DNA!vector expressing shRNA was used in
this work.
1.3 Aim of this thesis
Amongst all space environmental factors, microgravity and cosmic radiation are two of
the main limiting factors for long-term orbital and interplanetary space missions, causing
severe health risks for the astronaut. In order to provide a better basis for risk assess-
ment and countermeasure development, the effects of space-relevant radiation on the
cellular level have to be investigated.
It was shown that the transcription factor NF-"B is strongly activated by fluences and
ion species with high LET that are of relevance in space radiation environment. It is
hypothesised that the NF-"B pathway is a potential pharmacological target for mitiga-
tion of the radiation response as it might enhance survival of cells exposed to heavy
ions. Even though the NF-"B pathway has been investigated extensively throughout
Fig. 10: The RNAi pathway. Three distinct
approaches lead to cleavage of the target
mRNA by the RNA-induced silencing com-
plex (RISC). In non-mammalian cells,
dsRNA is introduced into the cell and fur-
ther cleaved into siRNA by cytoplasmatic
nucleases (Dicer)!(1). In mammalian cells,
RNAi can be triggered by transiently trans-
fecting siRNA!(2) or stably transfecting
cells with DNA vectors expressing shRNA
(3). In all cases, shRNA is further
processed into siRNA. All three pathways
converge at the association of siRNA with
RISC (Credit: Invitrogen).
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the last years, not much is known about its role in the cellular response to space-rele-
vant radiation. More detailed knowledge in this field is necessary to improve risk
estimation and assess the questions of how to prevent acute effects like cell death after
high dose irradiation as well as late effects like cell transformation during chronic low-
dose exposure. 
Specifically, the following tasks were accomplished:
1. Investigate NF-!B activation after exposure to different radiation qualities and 
quantities.
2. Chemical inhibition of key elements of different NF-!B subpathways to analyze 
their role in NF-!B activation induced by low and high LET ionizing radiation.
3. Knockdown of an important NF-!B subunit to assess its role in the cellular 
response to space-relevant radiation.
3.1 Characterization of the stably transfected knockdown cell line concerning 
cellular proliferation, cell cycle progression and gene expression.
3.2 Effects of NF-!B subunit knockdown on cell cycle progression, cellular 
survival and gene expression after exposure to low and high LET radiation.
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2 Material and Methods
2.1 Material
2.1.1 Chemicals
Chemicals were purchased at Sigma Aldrich (Steinheim, Germany), if not otherwise
stated.
2.1.2 Vectors
SureSilencing™ shRNA Plasmids (SABiosciences, Frederick, MD, USA) were desig-
ned to specifically knockdown the expression of RelA using the pGene Clip™
Hygromycin Vecor (Promega, Mannheim, Germany) as the backbone. Pre-designed
shRNA plasmids were delivered in a set of four individual vectors specific for the same
gene (Clone ID 1 to 4) plus one negative control (NC) shRNA vector. All vectors contain
the Hygromycin-resistance marker (Fig. 11). 
Fig. 11: pGene Clip! Hygromycin Vector circle map (Promega, Mannheim, Germany).!The vector con-
tains amongst others a transcription site for the T7 bacteriophage RNA!polymerase, a human U1 pro-
moter and termination site, a promoter for the SP6 RNA!polymerase, an Simian virus 40 (SV40) enhancer
and early promoter as well as coding regions for Hygromycin phosphotransferase and "-lactamase
(Ampr).
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Representative sequences used to design the enclosed shRNA refer to the RefSeq
Accession # NM_021975 and are listed below:
Clone!ID Insert sequence
1 CCTGAGCACCATCAACTATGA
2 GACCTTCAAGAGCATCATGAA
3 GCTCAAGATCTGCCGAGTGAA
4 GCGCATCCAGACCAACAACAA
NC ggaatctcattcgatgcatac
2.1.3 Oligonucleotides
Restriction enzymes and PCR primers were purchased from Promega, New England
Biolabs (Beverly, MA, USA) or SABiosciences.
2.1.4 Antibodies
Immunofluorescence was conducted using an anti-NF-kappaB p65 rabbit monoclonal
antibody (Epitomics, Burlingame, CA, USA; Catalog# 1546-1) with a working dilution
of 1:250. For detection of the primary antibody, a TRITC-coupled swine anti-rabbit anti-
body (Dako; Agilent Technologies, Karlsbrunn, Germany; Catalog# R0156), diluted
1:250, was used. 
2.1.5 Cell lines
The starting cell line for further stable transfection was HEK-pNF-!B-d2EGFP/Neo L2.
For generating this cell line, HEK-293 cells, generated from human embryonic kidney
cells (Graham et al., 1977), were stably transfected with the plasmid pNF-!B-
d2EGFP/Neo (Fig. 12), a reporter system to monitor NF-!B activation. The subclone
L2 was selected (Hellweg et al., 2003). In this cell line, d2EGFP, the destabilized variant
of EGFP, is used to report NF-!B activity in human cells. Therefore d2EGFP is under
the control of a synthetic promoter, which consists of four NF-!B binding sites (5"-
GGGAATTTCC-3") and the RNA#polymerase binding site from the thymidin kinase
promoter. For selection purposes the vector further contains a kanamycin/neomycin
resistance gene under the control of a bacterial promoter and the SV40 enhancer.
HEK-pNF-!B-d2EGFP/Neo L2 cells were transfected with a SureSilencing™ shRNA
Plasmid (Fig. 11) targeting RelA. The selected clone was named $HEK shRNA RelA"
and is characterized by a RelA knockdown (KD) level of 83.1 % and a resistance
against Hygromycin.
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Fig. 12: pNF-!B-d2EGFP/Neo vector circle map. The pNF-!B-d2EGFP/Neo plasmid was used for stable
transfection of HEK-293 cells (Hellweg et al., 2003). Here, the d2EGFP gene is under control of an NF-
!B-dependent promoter to report NF-!B activation. (f1 ori) f1 single strand DNA origin; (HSV TK poly A)
Herpes simplex virusthymidine kinase polyadenylation signal; (KanR/NeoR) kanamycin/neomycin resis-
tance gene; (KB4) 4x NF-!B response element; (5´MCS) 5´ multiple cloning site; (P) bacterial promoter
for expression of KanR/NeoR gene; (pSV40e) SV40 early enhancer; (pUC ori) pUC plasmid replication
origin; (SV40 ori) SV40 origin of replication; (SV40 poly A) SV40 late mRNA polyadenylation signal, (pTK)
thymidine kinase minimal promoter. 
2.2 Molecular biological methods
2.2.1 Plasmid ampification and verification
The shRNA"plasmid was propagated by bacterial transformation and extraction of DNA,
and its identity was checked by restriction analysis.
2.2.1.1 Transformation
100 #l of competent E. coli DH5$-cells (Stratagene; Agilent Technologies, Karlsbrunn,
Germany) were thawed on ice for 5-10 min. 2 #l of each SureSilencing™ shRNA Plas-
mid (30 - 50 ng/#l) was added to the cells and mixed well before incubating for 10-15
min on ice. Cells were heat-shocked at 42 ˚C for 45 s and placed back on ice for addi-
tional 2-3 min. 1 ml of antibiotic free Luria Bertani (LB)-medium (20 g/l, in ddH2O,
autoclaved) was added and cells were shaken for 30-45 min at 37 ˚C. Cells were cen-
trifuged for 3 min at 2500 x g. The supernatant was removed, leaving ~ 100 #l liquid
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including the pellet in the tube. The pellet was resuspended and plated on selective LB-
agar (35 g/l, in ddH2O, autoclaved) plates containing ampicillin (Biochrom GmbH, Berlin,
Germany) with a final concentration of 50 !g/ml for selection and incubated at 37 °C
over night (o/n).
2.2.1.2 Preparation of plasmid DNA 
One colony from an agar plate was added to 100 ml of LB-medium containing 50 !g/ml
ampicillin and cultured o/n under permanent shaking. For preparation of plasmid DNA
the Plasmid Maxi Kit (Qiagen, Hilden, Germany) was used. Bacteria were harvested
by centrifugation at 4 °C for 15 min at 4000 x g. The supernatant was discarded and
the cell pellet was resuspended in 10 ml P1 resuspension buffer. 10 ml P2 lysis buffer
were added, the solution was gently mixed and cells were lysed for 5 min at room tem-
perature. 10 ml of P3 neutralisation buffer were added and the solution was mixed. After
incubating the solution for 20 min on ice, it was centrifuged at 4 °C for 30 min at 13000
x g. Columns were equilibrated by applying 10 ml of QBT equilibration buffer. The
supernatant was applied to the column, which was then washed twice with 30 ml of
washing buffer QC. The DNA was eluted with 15 ml of elution buffer QF and collected
in a 50 ml falcon tube. It was precipitated by adding 0.7 volumes of 100 % isopropanol
and centrifugation at 4 °C for 30 min at 4000 x g. The supernatant was removed and
the pellet was washed with 10 ml 70 % EtOH. After centrifuging again at 4 °C for 10
min at 4000 x g, the supernatant was removed and the DNA pellet was dried at room
temperature. Afterwards, the pellet was resuspended in 100 !l TE storage buffer (10
mM Tris, 1 mM EDTA, pH 8.0).
2.2.1.3 Analytical cleavage of DNA 
To verify the correct size of all plasmids, an analytical cleavage with the restriction
enzyme ScaI was performed. Digestion of the shRNA plasmid with ScaI resulted in frag-
ments sized 3346 and 1643 bp indicating the presence of shRNA insert of 20 bp. For
the reaction mix, 2 !l RE 10x buffer, 2 !l template DNA (10 ng), 1 !l ScaI (10 u/!l) and
15 !l ddH2O were mixed in a 0.5 ml tube. Restriction digestion was run at 37 °C for 1
h in the thermoblock TRIO (Biometra, Göttingen, Germany).
2.2.1.4 Electrophoretic separation of DNA fragments 
Separation of DNA"fragments was performed by agarose gel electrophoresis. Agarose
(Serva Electrophoresis, Heidelberg, Germany) was added to 1x TAE buffer (50x TAE
buffer: 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5 mol/l EDTA pH 8.0, ad 1 l
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ddH2O) to the final concentration of 1 % and solubilized by boiling. DNA was visualised
by adding 1:10000 diluted SYBR® Safe DNA Gel Stain (Invitrogen, Karlsruhe, Germany)
to the DNA!samples. After cooling to less than 65 °C DNA samples were mixed with 6x
DNA Loading Dye (Fermentas; Thermo Scientific, Schwerte, Germany) and loaded
onto the gel. In order to define the size of the separated fragments, a DNA size maker
(GeneRuler™ 1kb DNA Ladder; Fermentas) was also loaded onto the gel.
2.2.2 Gene expression analysis
mRNA expression levels were determined by reverse transcriptase quantitative real-
time polymerase chain reaction (real-time RT-qPCR). Therefore, RNA was isolated
according to 2.2.2.1 and reverse transcribed into cDNA (s. 2.2.2.3). Gene expression
analysis, as described hereafter, was conducted to determine knockdown levels of RelA
with the RT2 qPCR Primer Assay (s. 2.2.2.4), to investigate the kinetics of expression
levels of selected NF-"B target genes by real-time qPCR (s. 2.2.2.5) and to finally exa-
mine whole sets of target genes with the RT2 Profiler™ PCR Array (s. 2.2.2.6). 
2.2.2.1 RNA isolation
RNA!was isolated for subsequent determination of mRNA!levels by real-time RT-qPCR.
For statistically significant results in the knockdown verification, each sample was pre-
pared in triplicates. At a density of ~ 50 % cells were lysed with RLT buffer containing
10 % 14.3 mol/l #-Mercaptoethanol and transferred into an RNase-free Eppendorf tube
with an iced syringe. RNA was isolated using the RNeasy® Mini Kit (Qiagen) according
to the manufacturers protocol. To avoid overloading of the columns, not more than 700
$l of buffer containing lysed cells were used for RNA!isolation. As RNA!was used for
cDNA!synthesis and subsequent RT-qPCR, the additional DNase treatment step was
included to eliminate residual genomic DNA. For preparing the DNase I stock solution,
DNase I (1500 Kunitz units;!Qiagen) was diluted in 550 $l RNase-free H2O. The DNase
I stock solution was further diluted 1:8 in RDD!buffer (Qiagen). Subsequently, 80 $l of
the DNase I incubation mix were added to the columns and incubated for 15 min at
room temperature. RNA was eluted in 50 $l RNase-free H2O.
2.2.2.2 Integrity of RNA
RNA concentration and purity were measured photometrically (A260/280) with the Nano-
Drop 2000c Spectrometer (Thermo Scientific). Additionally, RNA concentration, RNA
integrity (RNA Integrity Number; RIN) and rRNA ratio (28S/18S) were measured by
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micro-electrophoresis using the RNA 6000 Nano Assay in the Agilent 2100 Bioanalyzer
(Agilent Technologies).
For gene expression analysis with the RT2 Profiler™ PCR Arrays (SABiosciences), furt-
her RNA quality control with RT2 RNA QC PCR!array (SABiosciences) was performed,
as described in 2.2.2.6.
2.2.2.3 cDNA synthesis
Quality, integrity and quantity of isolated RNA were analyzed according to 2.2.2.2. Sub-
sequently, RNA was reverse transcribed into cDNA using the RT2 First Strand Kit
(SABiosciences). A preliminary genomic DNA (gDNA) elimination step was conducted,
as recommended in the protocol:
Reaction Mix:
Total RNA 1000 ng 
5X gDNA Eimination Buffer (GE) 2 "l
ddH2O ad 10 "l
To detect genomic DNA!contamination in isolated RNA!samples, one sample lacking
reverse transcriptase was used as a negative control. The reaction mix was incubated
at 42 °C for 5 min.
The RT reaction mix for one sample contained 
5X RT Buffer (BC 3) 4 "l 
Primer & External Control Mix 3 (PC2) 1 "l
RT!Enzyme Mix 3 (RE3) 2 "l
ddH2O 3 "l
The RT!reaction mix was added to the gDNA Elimination Mixture and incubated at 42
°C for 15 min. The reaction was stopped by heating at 95 °C for 5 min. CDNA concen-
tration at this stage was 50 ng/"l. Finally 91 "l of H2O were added to each 20 "l cDNA
synthesis reaction to obtain a final cDNA concentration of 9 ng/"l. CDNA samples were
stored at -20 °C.
For real-time qPCR experiments as described in 2.2.2.5, cDNA synthesis was perfor-
med using the iScript cDNA Synthesis Kit (BioRad). Therefore, 1000 ng RNA was
transcribed in 4 "l iScript reaction mix with 1 "l iScript reverse transcriptase. CDNA was
diluted to 5 ng/"l with DNase-free water.
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2.2.2.4 Determination of knockdown-level by real-time qPCR
Knockdown levels of RelA mRNA were determined using the RT2 qPCR Primer Assay
(SABiosciences). The primer pairs SYBR® Green Human RELA and SYBR® Green
Human HPRT 1 were used for targeting the gene of interest (GOI) V-rel reticuloendo-
theliosis viral oncogene homolog A (RELA) and the housekeeping gene (HKG)
Hypoxanthine phosphoribosyltransferase (HPRT; Tab. 3). 
Table 3: qPCR primer pairs as described in the RT2 qPCR Primer Assay (SABiosciences). All genes
listed are human genes. (HPRT) Hypoxanthine phosphoribosyltransferase 1; (RELA) V-rel reticuloen-
dotheliosis viral oncogene homolog A.
Gene symbol RefSeq Accession # Amplicon size Melting temperature
RELA NM_021975.3 65 bp 80 °C
HPRT1 NM_000194.2 89 bp 76.5 °C
Every single sample of the seeded triplicates was analysed by three real-time qPCR
reactions to characterize the expression levels of the GOI and the HKG. The HKG was
used to normalize the results. The qPCR!experiment was set up in a 96-well PCR!plate
(4titude, Surrey, UK) as depicted in Fig. 13.
Fig. 13: Setting up real-time PCR validation of knockdown. The figure represents a 96-well plate. The
reactions in the first set of six numbered columns characterizes the knockdown-level of RELA in the in-
dicated RNA!samples, while columns 7 to 12 depict the expression of HPRT in the corresponding RNA
samples. (NTC) no template control; (P1)-(P3) triplicate PCR reaction.
1         2         3 4         5         6 7         8         9 10        11        12
A
Clone #1 Seeding #1
P1        P2        P3
Clone #3 Seeding #3
P1        P2        P3
Clone #1 Seeding #1
P1        P2        P3
Clone #3 Seeding #3
P1        P2        P3
B Clone #1 Seeding #2P1        P2        P3
Clone #4 Seeding #1
P1        P2        P3
Clone #1 Seeding #2
P1        P2        P3
Clone #4 Seeding #1
P1        P2        P3
C
Clone #1 Seeding #3
P1        P2        P3
Clone #4 Seeding #2
P1        P2        P3
Clone #1 Seeding #3
P1        P2        P3
Clone #4 Seeding #2
P1        P2        P3
D
Clone #2 Seeding #1
P1        P2        P3
Clone #4 Seeding #3
P1        P2        P3
Clone #2 Seeding #1
P1        P2        P3
Clone #4 Seeding #3
P1        P2        P3
E Clone #2 Seeding #2P1        P2        P3
Clone #5 Seeding #1
P1        P2        P3
Clone #2 Seeding #2
P1        P2        P3
Clone #5 Seeding #1
P1        P2        P3
F
Clone #2 Seeding #3
P1        P2        P3
Clone #5 Seeding #2
P1        P2        P3
Clone #2 Seeding #3
P1        P2        P3
Clone #5 Seeding #2
P1        P2        P3
G
Clone #3 Seeding #1
P1        P2        P3
Clone #5 Seeding #3
P1        P2        P3
Clone #3 Seeding #1
P1        P2        P3
Clone #5 Seeding #3
P1        P2        P3
H Clone #3 Seeding #2P1        P2        P3 NTC
Clone #3 Seeding #2
P1        P2        P3 NTC
PCR primers specific for RELA PCR primers specific for HPRT
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The real-time qPCR reaction mix for one PCR tube was composed referring to the RT2
qPCR Primer Assays protocol as follows:
RT2 SYBR!Green qPCR Master Mix 12.5 "l 
ddH2O 8.5 "l
Template cDNA (27 ng) 3 "l
10 "M!PCR primer pair stock 1 "l
As a negative control DNA was replaced by H2O. 
Real-time qPCR analysis was performed in the Opticon2 thermocycler (BioRad,
Munich, Germany) according to the protocol in Table 4.
The quality of the qPCR was controlled (s. 2.2.2.5) and data were analysed as descri-
bed hereafter.
Table 4: Real-time qPCR protocol for validation of RELA knockdown levels. The cycling conditions are
taken from the RT2 qPCR Primer Assay protocol (SABiosciences).
Cycles Time Temperatures
Initial denaturation 1 10 min 95 °C
Denaturation 15 s 95 °C
Annealing 40 35 s 55 °C
Plate Read
Elongation 30 s 72 °C
Melting curve read every 0.2 °C 60-95 °C
Final 1 1 min 29 °C
To determine the percentage of knockdown measured by real-time qPCR, an Excel-
based data analysis template provided by SABiosciences was used. The detailed
algorithm, which is used in this sheet for calculations is described in detail in the Sure-
Silencing™shRNA Plasmids protocol (SABiosciences). It includes determination of the
arithmetrical average of the technical triplicate PCR Ct values and standard deviations
for both genes (RELA!and HPRT1) and individual #Ct values for each biological repli-
cate transfection of each design and the negative control. It calculates average #Ct and
its standard deviation across the biolological replicates and the average ##Ct and its
standard deviation for each design based on the ##Ct method:
#Ct = Ct (GOI) - Ct (HKG) (Equation 4)
##Ct = #Ct (KD) - #Ct (NC) (Equation 5)
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Finally, the average knockdown and its 95 % confidence interval (C.I.) is calculated.
The interpretation of the design is defined as follows: 
Successful design: Observed KD ! 70 % and an upper 95 % C.I. boundary ! 55.5 %
Failed design: Observed KD < 33.3 % and a lower 95 % C.I. boundary < 55.5 %
2.2.2.5 Real-time qPCR for selected NF-!B target genes
To investigate the dose-effect relationship and the kinetics of NF-"B-dependent gene
expression, the expression of two NF-"B target genes, NFKBIA and GADD45beta, was
analysed by real-time RT-qPCR. GAPDH was used as housekeeping gene. 
For real-time RT-qPCR experiments investigating NFKBIA and GADD45beta, reverse
transcription of purified RNA into cDNA was performed using the iScript cDNA Synthe-
sis Kit (s. 2.2.2.3). To investigate the qPCR efficiency for each gene of interest, a
dilution series of standards (25 - 0.008 ng/well cDNA) was prepared additionally. The-
refore, 3 #l cDNA of each sample were pooled. Standards were measured in triplicates
and samples and negative controls in duplicates.
Primers used for gene expression analysis have previously been established in the Cel-
lular Biodiagnostics working group and are listed below:
Gene Primer sequence Amplicon size
GAPDH fwd CAATGACCCCTTCATTGACC 146 bp
rev GATCTCGCTCCTGGAAGATG
GADD45beta fwd ACAGTGGGGGTGTACGAGTC 155 bp
rev TTGATGTCGTTGTCACAGCA
NFKBIA fwd AACCTGCAGCAGACTCCAC 137 bp
rev TGCTCACAGGCAAGGTGTAG
The reaction mix was composed as follows:
SYBR$Green Mix (Invitrogen) 12.5 #l 
forward (fwd) primer (0.2 #mol/l) 0.5 #l 
reverse (rev) primer (0.2 #mol/l) 0.5 #l 
Template cDNA (5 ng/#l) 2 #l
ddH2O ad 25 #l
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For NFKBIA, betaine (N,N,N-trimethylglycine, Sigma) was added to the reaction mixture
to a final concentration of 1 mol/l to facililate amplification due to the high GC content
of the target sequences. Quantitative real-time analysis was performed in the Opticon2
thermocycler in 96-well plates according to Table 5:
Table 5: qPCR protocol for investigations of the dose-effect relationship and the kinetics of NF-!B-
dependent gene expression. NFKBIA and GADD45beta were NF-!B target genes of interest. GAPDH
was used as housekeeping gene. 
Cycles Time Temperatures
Initial denaturation 1 2 min 50 °C
1 2 min 95 °C
Denaturation 15 s 95 °C
Annealing 44 30 s 61 °C (NFKBIA)
61.9 °C (GADD45beta)
60 °C (GAPDH)
Elongation 30 s 72 °C
Plate Read
20 s 78 °C
Plate Read
Melting curve read every 0.2 °C 60-95 °C
Final 1 1 min 29 °C
Quality of RT-qPCR was controlled as described hereafter. Subsequently, the PCR effi-
ciency (E) was determined by means of the dilution series of cDNA standards.
Therefore, a linear regression analysis was applied, resulting in a slope, which enables
calculation of the PCR"efficiency according to the equation
E = 10(-1/slope) (Equation 6)
An optimal PCR results in an efficiency (E) of 2, which indicates the exact doubling of
the PCR product in each cycle. The threshold for determining the threshold cycle (Ct)
was set manually in the exponential part of the amplification plots in the logarithmic dia-
gram of the standard curve (Fig. 14). For comparison of all samples and genes, the
threshold was kept constant throughout all PCR"runs. Gene expression results of the
housekeeping gene were used to measure background variation in gene expression. 
The software REST© (Relative Expression Software Tool; W. Pfaffl & G.P. Horgan, TU
Munich, Germany) was used for statistical evaluation of the expression of target genes
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relative to the reference gene GAPDH. Expression levels were related to each other
according the following equation:
Relative gene expression = (Equation 7)
Fig. 14: Real-time qPCR amplification plots and standard curve. (A) The amplification plot shows the in-
creasing fluorescence with increasing cycle number. The dotted line indicated the manually set threshold,
which is located in the exponential part of the curve. (B)!The respective standards curve is shown on the
right, indicating a slope resulting in a PCR efficiency of ~ 2.
To control the quality of the qPCR, a dissociation (melting) curve was run immediately
after each cycling program. The settings for the melting curve are listed in the above-
mentioned real-time qPCR!protocol. Additionally, the quality of selected PCR products
was further tested by loading the PCR product on an agarose gel as described in
2.2.1.4. 
2.2.2.6 Real-time qPCR array
To assess RNA!quality and to rule out genomic DNA!contamination for subsequent
gene expression analysis with RT2 Profiler™ PCR Arrays, the RT2 RNA QC PCR!array
(SABiosciences) was used. The detailed setup of the quality control plate and its functi-
ons is described in the RT2 RNA QC PCR Array protocol. The array detects inhibition
of reverse transcription or of PCR!amplification, genomic DNA!contamination, false po-
sitive signals and multi-peak dissociation curves. In detail, it includes analysis of high
(HK1, ACTB) and low (HK2, HPRT1) housekeeping gene expression levels as well as
(ETarget gene)"Ct Target gene (control - sample) 
(EReference gene)"Ct Reference gene (control - sample)
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reverse transcription (RTC), positive PCR (PPC), genomic DNA (GDC), no reverse tran-
scription (NRT) and no template (NTC) controls (s. 3.4.2, Table 11). Data analysis of
this array is based on a Excel-based template provided by SABiosciences. After ente-
ring Ct values, interpretations are performed according to the algorithm which is des-
cribed in detail in the RT2 RNA QC PCR Array protocol. For genomic DNA
contamination, e.g., Ct values must be greater than 35 in order to interpret the results
as genomic DNA contamination not affecting the gene expression profiling results. If Ct
values are less than 35, genomic DNA contamination is evident.
Human RT2 Profiler™ PCR Arrays (SABiosciences) were used for expression profiling
of 89 genes per sample. Two different arrays were available, with one being customized,
individually composed of genes of interest of several singalling pathways and one array
focussing on genes targeted by NF-!B. An overview of all genes included in these ar-
rays is listed in Table 17 (s. Appendix). Each well of these arrays contains primers for
the respective gene. Only cDNA samples, which had been approved by the RT2 RNA
QC PCR Array to prevent false positive signals by genomic DNA"contamination, were
used for further analysis. The RT-qPCR master mix for one 96-well plate was was set
up according to the RT2 Profiler™ PCR Array protocol:
RT2 SYBR"Green qPCR Master Mix 1350 #l 
ddH2O 1248 #l
Template cDNA (9 ng/#l) 102 #l
Quantitative real-time analysis was performed in the Opticon2 thermocycler according
to Table 6. Results were analysed according to the algorithm decribed in the RT2 RNA
QC PCR Array protocol. It is based on the $$Ct method:
$Ct = Ct (target gene) - Ct (reference gene) (Equation 8)
$$Ct = $Ct (sample) - $Ct (control) (Equation 9)
The relative expression of treated sample versus control was calculated by means of
equation 10. As efficiency curves for the 89 genes were not available, a PCR efficiency
of 2 was assumed:
Relative gene expression ="2-$$C (Equation 10)t
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Table 6: Cycling conditions for real-time PCR according to the RT2 Profiler™ PCR array protocol. 
Cycles Time Temperatures
Initial denaturation 1 10 min 95 °C
Denaturation 15 s 95 °C
Annealing 40 35 s 55 °C
Elongation 30 s 72 °C
Plate Read
Elongation 20 s 78 °C
Plate Read
Final 1 1 min 95 °C
2 min 65 °C
Melting curve read every 0.2 °C 65-95 °C
2.3 Cell culture
2.3.1 Culture conditions 
Cell culture work was conducted using a sterile tissue culture hood (Hera safe, Kendro,
Berlin, Deutschland). HEK-pNF-!B-d2EGFP/Neo L2 cells were grown under standard
conditions in 75 cm2 flasks (Nunc, Wiesbaden, Germany) in selection-medium (S-
medium), consisting of "-medium (ALPHA MEM-medium; Biochrom) with addition of
the following agents:
Fetal bovine serum (FBS) 10 % 
L-glutamine 2 mmol/l
Glucose 0.34 %
Penicillin/Streptomycin 10,000 IE / 10,000 #g/ml
Neomycin/Bacitracin 1 mg / 50 U/ml
Amphotericin B 250 #g/ml
G418 0.6 mg/ml
For culturing HEK shRNA RelA cells, 200 #g/ml Hygromycin (US Biological, Massachu-
setts, USA) was added to the S-medium. For some experiments, cells were grown in
"-medium, which does not contain G418 and Hygromycin.
Cells were grown at 37 °C, saturated humidity and in a 5 % CO2 / 95 % air atmosphere. 
To ensure that the newly established cell line HEK$shRNA RelA is free from Myco-
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plasma contamination, it was screened at the Leibnitz-Institut DSMZ-Deutsche Samm-
lung von Mikroorganismen und Zellkulturen GmbH (Braunschweig, Germany) by Dr.
Uphoff (s. 7.5).
2.3.2 Coating of cell culture vessels with Poly-D-Lysine
For transporting cells or handling them for longer terms at room temperature, tissue
culture plates or wells were coated with Poly-D-Lysine (final concentration: 0.01 mg/ml)
to allow a stronger binding of cells to the substrate, as they would easily detach other-
wise. Therefore, the culture vessels were coated with Poly-D-Lysine for 15 min at room
temperature and subsequenty washed three times with PBS. 
2.3.3 Cultivation of cells
Passaging of cell lines was accomplished once a week by using standard detachment
procedures using phosphate buffered saline (137 mM NaCl, 2.3 mM KCl, 4.3 mM
Na2HPO4*7H2O, 1.4 mM KH2PO4, pH!set to 7.4, autoclaved)!and 0.05 % trypsin con-
taining 0.02 % EDTA (PAN-Biotech, Aidenbach, Germany) solution. For counting cells,
a Fuchs-Rosenthal counting chamber (W. Schreck, Hofheim, Germany) was used.
Cells were seeded to a density of 1.5 - 3 x 104 cells/cm2. Medium was changed as
required every few days.
2.3.4 Freezing and thawing of cells
For preservation in liquid nitrogen, confluent cells were trypsinized and centrifuged for
5 min at 80 x g at room temperature. The pellet was resuspended in the required
volume (2 x 106 cells/ml) of freezing medium (10 % Dimethylsulfoxid in "-medium) and
pipetted into cryotubes (Nunc). Tubes were stored at -80 °C for at least 24 hours and
subsequently transferred to liquid nitrogen for long-term storage.
Cryotubes were thawed in a 37 °C water bath (Lauda, Königshofen, Germany). Cells
were added to 20 ml of prewarmed "-medium and plated in 75 cm2 cell culture flasks.
After 24 hours medium was exchanged to remove residual DMSO.
2.3.5 Cytotoxicity of chemical inhibitors
Cytotoxicity of the chemical inhibitors KU-55933 and MG-132 was measured by means
of the MTT assay. Here, reduction of MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide) to formazan can be correlated to the activity of cellular
enzymes and measured colorimetrically. HEK-pNF-#B-d2EGFP/Neo L2 cells were see-
ded in 96-well plates (BD Biosciences, Heidelberg, Germany; area per well: 0.3 cm2)
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and preincubated with each inhibitor for 20 and 72 hours. NF-!B was activated by
adding tumor necrosis factor " (TNF-"). After removing medium, cells were incubated
for 1 h at 37 °C with serumfree "-medium containing 0.1 mg/ml MTT. Subsequently,
cells were lysed with DMSO/SDS solution (99.4 % (v/v) DMSO, 0.6 % (v/v) acetic acid,
10 % (w/v) SDS) while shaking them for 20 min with 30 rpm.
100 % DMSO was used to measure the background signal of a dead cell layer. As a
negative control, cells were not treated with TNF-". Finally, absorbance of formazan
was measured with the fluorescence/luminescence/absorption microplate reader
LAMBDA Fluoro 320 (MWG Biotech AG, Penzberg, Deutschland) at 562 nm. Cell sur-
vival was calculated as a ratio of formazan-absorbance of treated vs. untreated
samples.
2.3.6 RNA interference (RNAi)
2.3.6.1 Determination of cytotoxic Hygromycin B concentration
For selection of cells which were successfully stably transfected with the SureSilen-
cing™ shRNA plasmid, the appropriate concentration of the antibiotic Hygromycin B
had to be determined. HEK-pNF-!B-d2EGFP/Neo L2 cells were seeded in S-medium
in a 96-well plate. At a cell density of ~ 80 %, Hygromycin B (50 mg/ml) was added to
the medium to final concentrations ranging from 0 to 400 #g/ml. As a positive control
of the cytotoxic effect, 10 % EtOH$was added to the medium. One well served as a
blank-control and was therefore left empty.
After 10 days, medium was removed, cells were washed with PBS$and finally stained
with 200 #l of formaldehyde/cristal violet solution per well. After 30 min, the staining
solution was removed and cells were washed with PBS. Cell growth was determined
by measuring absorbtion at a wavelength of 410 and 592 nm in the LAMBDA Fluoro
320 and calculated as a ratio of absorbance values of treated vs. untreated sample.
Formaldehyde/crystal violet solution:
Crystal violet (Merck, Darmstadt, Germany) 0.1 g 
Formaldehyde 3.7 %
H2O ad 100 ml 
2.3.6.2 Stable transfection
HEK-pNF-!B-d2EGFP/Neo L2 cells were seeded in Poly-D-Lysine-coated 6-well-plates
(Nunc). Each single one of the 6 wells was allocated for transfection with one of the five
SureSilencing™ shRNA Plasmids. Four of these plasmids were coding for different tar-
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geting sequences of RelA mRNA, while the fifth plasmid was a negative control vector
containing a scrambeled artificial sequence which did not match any human, mouse or
rat gene. Cells in the sixth well served as a negative control and were mock transfected.  
Each transfection was performed three times.
Transfection was conducted at a cell density of ~ 50 %. Therefore, DNA!concentration
of each vector was measured and DNA was mixed with serumfree "-medium as well
as 6 #l of transfection reagent according to the FuGENE 6® (Roche, Mannheim, Ger-
many) protocol. Cells in each well were transfected with 2 #g of DNA.
After three days of incubation, cells were transfered into ∅ 6 cm cell culture dishes
(Nunc) containing selective medium containing 400 #g/ml Hygromycin. Medium was
changed regularly. After approximately 10 days, cells were seeded for RNA isolation
(s. 2.2.2.1) to measure the knockdown level of RelA in the mixed population of Hygro-
mycin-resistant cells.
2.3.6.3 Clone selection
Two cell lines showing the highest knockdown level were chosen for further clone
selection. Therefore, cells had to be singularized by seeding 50 cells in a 96-well-plate
containing Hygromycin-medium. Cells were incubated for 2-3 weeks until they grew
colonies. Single colonies were washed with PBS, trypsinised and transfered to a 25
cm2 cell culture flask (Nunc) containing 5 ml of Hygromycin-medium. When cells had
reached a density of 80-100 %, their knockdown level was determined by seeding them
in triplicates and proceeding according to 2.2.2.1- 2.2.2.4.
2.3.7 Growth kinetics
To characterize differences in growth behaviour between HEK-pNF-$B-d2EGFP/Neo
L2 and HEK shRNA RelA, both cell lines were seeded with the same cell number (1 x
104 cells/cm2) in Poly-D-Lysine-coated 6-well plates. To ensure identical growth condi-
tions, both cell lines were seeded in S-medium. Twice a day the cell number of one well
was determined until cells have reached the stationary growth phase.
The doubling times for the cell lines were calculated based on the slope of the growth
curve (m) during exponential growth:
Doubling time =!ln 2/m (Equation 11)
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2.3.8 Colony forming ability test (CFA test)
A cell survival curve describes the relationship between the radiation dose and the pro-
portion of cells that survive (Fig. 15). The fraction of cells surviving is plotted on a
logarithmic scale against a dose on a linear scale. A cell which is apparently intact as
it is synthesizing protein and DNA, but has lost the capacity to divide indefinitely is by
the definition of the colony forming ability test dead. A survivor that has retained its
reproductive integrity and is able to proliferate indefinitely to produce a colony is said
to be clonogenic. The colony forming assay (Puck and Marcus, 1956) determines the
ability of one cell to form a colony after exposure to ionizing radiation. One colony is
defined to consist of at least 50 cells, resulting from six doublings. A dose of 100 Gy is
necessary to destroy cell function in nonproliferating systems. By contrast, the mean
lethal dose for loss of proliferative capacity is usually less than 2 Gy (Hall and Giaccia,
2012c).
The multitarget model describes the survival curve in terms of its initial slope (D1) result-
ing from single-event killing; the final slope (D0) resulting from multiple-event killing; and
either n or Dq to represent the size or width of the shoulder of the curve. The parameters
are correlated according to equation 12:
Dq = D0 + ln n (Equation 12)
D1 is the dose required to reduce the fraction of surviving cells to 0.37. D0 is reciprocal
of the slope in the exponential part of the curve. The extrapolation number n and the
quasi-threshold dose Dq measure the width of the shoulder. The larger the value n, the
larger is the shoulder of the survival curve.
Fig. 15: Clonogenic survival of mammalian cells
exposed to radiation. The graph illustrates the mul-
titarget model. The curve is described by the initial
slope (D1), the final slope (D0), and a parameter
that represents the width of the shoulder, either n
or Dq. Densely ionizing radiation results in a dose-
response curve which is a straight line from the
origin. For sparsely ionizing radiation, the curve
displays a shoulder, while at higher doses it beco-
mes straight again (taken from Hall and Giaccia,
2012c).
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Cells were seeded in ∅ 6 cm cell culture dishes or 25 cm2 cell culture flasks and irra-
diatied with different doses of either X-rays or heavy ions according to 2.4.
Subsequently, each irradiated sample was trypsinized, counted and seeded in ∅ 6 cm
cell culture dishes or 25 cm2 cell culture flasks with a defined cell number. The cell num-
ber was determined according to the plating efficiency (PE) and the anticipated lethal
effect of irradiation. Six experiments were performed with six dishes/flasks per dose.
After irradiation cells grew for 14 to 21 days without medium change and were fixed
afterwards with formaldehyde/crystal violet solution (s. 2.3.6.1). Colonies were counted
and data were analysed according to 2.3.8.1. Only colonies containing more than 50
cells were scored as survivors.
2.3.8.1 Data analysis of CFA
To analyse clonogenic survival, plating efficiency (PE) and surviving fraction (SF) were
calculated as follows using the software tool DOSE (by Dr. Christa Baumstark-Khan,
DLR, Germany):
PE = colonies observed / number of cells plated (Equation 13)
SF = colonies counted / cells seeded x (PE/100) (Equation 14)
The probability that all targets will not be hit is defined as survival S. DOSE calculates S
by dividing the PE of irradiated samples (PED) by the PE of unirradiated control (PED=0):
S = PED / PED=0 (Equation 15)
The relative survival of non-irradiated cells equals 1. DOSE!calculates S and its natural
logarithm (ln S) from the PE for each colony count, resulting in a semilogarithmic sur-
vival curve. The underlying algorithm, derived from the multitarget model (Kellerer and
Hug, 1968), is defined as follows:
S = 1" (1" eD/D )n (Equation 16)
For higher doses, the equation can be simplified to the following regression line equation:
ln S = constant of proportionality (v) # dose (D) + ln n (Equation 17)
ln S is defined by a regression line with the slope $ and the axis intercept ln n.
$ = -1 / D0 (Equation 18)
0
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2.3.9 Detection of NF-!B-dependent d2EGFP expression by flow cytometry
NF-!B can be induced by a variety of stimuli, including irradiation with X-rays or heavy
ions (s. 2.4) and the cytokine TNF-". TNF-" was used as a positive control in irradiation
experiments. Therefore, TNF-" (stock solution:#10 ng/$l) was added to the growth
medium to a final concentration of 10 ng/ml at a cell density of ~ 50 %. At several time-
points cells were washed with PBS, trypsinized and fixed with cold 3.5 % formaldehyde
in PBS. After storing the samples at 4 °C for 30 min, PBS#was added to dilute formal-
dehyde to less than 1#%. NF-!B activation was determined by measuring GFP
expression in a flow cytometer.
The Fluorescent Activated Cell Scanner (FACScan, BD Biosciences) is equipped with
an argon laser (488 nm) for excitation and three fluorescent emission detection chan-
nels (FL1 515-545 nm, FL2 564-606 nm, FL3 > 670 nm). EGFP#is characterized by an
emission maximum (%max) of 509 nm and an excitation spectrum peaking at 470 nm and
was therefore measured in the FL1 channel. Data were collected by the CellQuest soft-
ware. For each sample, the forward (FSC)#and side scatter (SSC) as well as the
fluorescence of 20,000 cells were detected and afterwards displayed in WinMDI V2.8
(Windows Multiple Document Interface for Flow Cytometry; J. Trotter, Scripps Institute,
La Jolla, CA, USA).
2.3.9.1 Evaluation of flow cytometry data from d2GFP"analysis
The cell population was displayed in a dot plot using the WinMDI V2.8 software. FSC
and SSC were used to define a region of intact cells which were further evaluated. From
the gated population, a histogram showing the frequency of cells with a defined fluo-
rescence intensity was plotted. Markers for d2EGFP(-) and d2EGFP(+) cells were set by
means of untreated and TNF-" treated cells (Fig. 16). 
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Fig. 16: Flow cytometry data analysis of NF-!B activation. The dot plot (A) of a cell population allows to
manually define a region in respect to cell size (forward scatter) and granularity (side scatter). Events
outside this region are not taken into acount for further analysis. A threshold for the forward scatter was
set in order to eliminate the debris. The histogram (B) shows the d2EGFP fluorescence of the gated cell
population. In the control sample, markers for d2EGFP(-) and d2EGFP(+) cells are set. The percentage of
d2EGFP(+)  cells was used as a value for measuring NF-!B activation. The green graph represents a ty-
pical histogram of HEK-pNF-!B-d2EGFP/Neo L2 cells 18 hours after treatment with 10 ng/ml TNF-".
2.3.10 Cell cycle!analysis by flow cytometry
To analyse distribution of cells in the cell cycle after irradiation, DNA#was stained with
propidium iodide (PI). Cells were seeded in ∅ 3 cm culture dishes and irradiated with
different doses. After several timepoints, cells were detached with 1.5 ml trypsin which
was subsequently added into a 15 ml falcon containing 4.5 ml of iced 100 % EtOH.
Samples were stored at -20 °C for at least 24 hours. 
For analysis, 12 ml of PBS#was added, and cells were centrifuged for 5 min at 1000 x
g at room temperature. The supernatant was discarded and 1 ml of PI#staining solution,
containing RNase A to digest residual RNA, was added. Samples were incubated at 37
°C for 1 hour. Afterwards, red fluorescence was measured by flow cytometry.
PI"staining solution:
RNase#A (1 mg/ml) 50 $l (50 $g/ml)
100 % Triton X-100 1 $l (0.1 %)
PI (2.5 mg/ml) 8 $l (20 $g/ml)
PBS ad 1000 $l 
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2.3.10.1 Evaluation of flow cytometry data from cell cycle analysis
PI!produces a fluorescent DNA adduct that can be excited at 488 nm with a broad emis-
sion centred around 600 nm. It was detected with the FL2 channel of the FACScan.
Fluorescence of 20,000 stained cells was measured and histograms were set up using
the CellQuest software. Analysis was accomplished with WinMDI V2.8, Cylchred (Car-
diff University, UK) and Flowing Software 2. As already described for evaluation of flow
cytometry data from EGFP!analysis, intact cells were selected by defining a region in
the SSC!versus FSC dot plot. Additionally, a FL2-width (FL2-W)/FL2-area (FL2-A) den-
sity plot was displayed to exclude doublets and cell debris from analysis. The PI
fluorescence of gated cells was shown in a histogram, quantifying cells throughout the
scale of fluorescence intensity, which is directly proportional to the amount of the DNA
content (Fig. 17).
Cylchred or Flowing Software 2 were used to determine the relative distribution of the
cell cycle phases by automatically or manually defining G1, S or G2 phase. In G2, the
DNA!content was the double of that observed in G1, and the DNA!content during S-
phase ranges between the ones of G1 and G2.
Fig. 17: Flow cytometry data of cell cycle analysis. The dot plot (A) of a cell population allows to manually
define a region in respect to width (FL2-W) and area (FL2-A) of the fluorescence signal and thereby ex-
cluding cell doublets. Events outside this region are not taken into acount for further analysis. The his-
togram (B) shows the PI fluorescence of the gated cell population. PI!fluorescence intensity is directly
proportional to the DNA content and can therefore be used to draw conclusions regarding the cell cycle
phases.
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2.3.11 Visualisation of RelA by immunofluorescence
Cells were plated on Poly-D-Lysine coated 16-well (8.6 cm2/well) glass chamber slides
(Lab-Tec®; Thermo!Scientific). At a density of ~ 50 %, cells were irradiated. At time-
points between 0 to 2 hrs cells were fixed with 3.5 % formaldehyde in PBS for 30 min
and washed with PBS afterwards. Cell membranes were permeabilized on ice by
adding 0.5 % Triton X-100/1 %!bovine serum albumin (BSA) in PBS for 15 min and sub-
sequently washed again with 1 %!BSA in PBS. Unspecific binding of the antibodies was
prevented by blocking with 50 % FCS in PBS for 1 h at room temperature. Cells were
incubated with the primary anti-RelA antibody (Epitomics) diluted in PBS at room tem-
perature for 1 h in a humidified chamber. Before adding the secondary antibody (Dako),
cells were washed with 1 % BSA in PBS. Cells were incubated light-protected for 1 hour
with the red-fluorescent secondary antibody, diluted in PBS. After washing with PBS,
the nucleus was visualized by incubation with blue-fluorescent DAPI solution (4´,6-Dia-
midino-2-phenylindole; Sigma Aldrich; 0.1 "g/ml in PBS) for 15 min. Subsequently cells
were washed again with PBS. Finally, the wells were removed from the slide and cover
slips were fixed with mounting medium (ProLong® Gold; Invitrogen). Pictures were
taken using a laser scanning microscope (Nikon Eclipse 80i) with the scanning system
#Nikon D-Eclipse D1$, analysing cells with laser wavelengths 405 and 543 nm.
2.4 Irradiation of cells
2.4.1 Irradiation with X-rays
X-irradiation was performed at DLR in Cologne using a Gulmay RS225 X-ray source
(Xstrahl, Surrey, United Kingdom). Cells were irradiated at room temperature with 200
kV!and 15 mA at a dose rate of ~ 1 Gy/min at room temperature. To eliminate soft X-
rays, a copper (0.5 mm) filter was used. Cells were irradiated in petri dishes (∅ 3 or 6
cm). Doses up to 16 Gy were used, with an LET of 0.3 to 3 keV/"m. Control flasks were
sham-irradiated.
2.4.2 Irradiation with heavy ions
Irradiation with heavy ions was performed at the heavy ion accelerator Grand Accéléra-
teur National d!Ions Lourds (GANIL) in Caen, France, or at the Gesellschaft für
Schwerionenforschung (GSI) in Darmstadt, Germany. Cells were incubated for at least
two days before heavy ion exposure. They were irradiated at room temperature!in Poly-
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D-Lysine coated 25 cm2 cell culture flasks. Prior to irradiation, flasks were completely
filled with serum-free !-medium to avoid desiccation during irradiation, closed and fixed
in an upright position in front of the ion beam (Fig. 18). Control flasks were sham-irra-
diated. Dosimetry was performed by determining the fluence3 (F) in particles/cm2
(P/cm2) by Isabelle Testard (GANIL) or Michael Scholz (GSI). To convert fluence"to
energy dose, the following formula (Wulf et al., 1985) was applied:
Dose (Gy) = 1.6 x 10-9 x LET (keV/#m) x F (P/cm2) (Equation 19)
Table 7 shows the characteristics of the accelerated ions that were used for heavy ion
beam experiments in this work. After irradiation, serum-free !-medium was discarded
and cells were either directly fixed for analysis or further cultivated under standard con-
ditions.
Fig. 18: Heavy ion experiment at the Gesellschaft für Schwerionenforschung (GSI) in Darmstadt. (A)
Beam exit window at the heavy ion synchrotron SIS. (B) For ion exposure, cells were grown in 25 cm2
cell culture flasks. Flasks were placed in an upright position in front of the ion beam exit (Pictures were
taken during beam time in August 2012). 
3 Fluence (F) is the number of particles ($N) per unit area ($A).
F = $N/$A (Equation 20)
A B
Material and Methods
51
Table 7: Characteristics of heavy ions used in this work.
Ion Energy Energy on target 4 LET in H2O Penetration depth Accelerator
(MeV/n) (MeV/n) (keV/!m) in H2O (!m)
13C 75 71.4 34.2 15120 GANIL
22Ne 80 74.5 91.8 10000 GANIL
36Ar 95 83.8 271.5 6336 GANIL
58Ni 75 54.1 905.9 2092 GANIL
64Ni 1000 996.9 174.5 263600 GSI
16O 95 90.8 50.5 16149 GANIL
48Ti 1000 996.9 107.7 319900 GSI
4 Effective irradiation energy at the cell monolayer after the energy losses in detectors, exit window, air
and bottom of the cell culture vessel (1200 !m polystyrene).
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3 Results
The aim of this project was to assess the role of NF-!B in the cellular response to dif-
ferent ionizing radiation qualities that are relevant for human spaceflight in order to
contribute to risk assessment and to understand basic principles for the development
of appropriate countermeasures. Therefore, methods to inhibit the NF-!B pathway at
different levels were established. The classical and the genotoxic stress-induced NF-
!B pathways were investigated and inhibition was performed by chemicals as well as
by RNAi. Finally, this work demonstrates the outcome of cells with and without an intact
NF-!B pathway after exposure to space-relevant radiation qualities. Biological end-
points under investigation were cell growth and progression through the cell cycle,
cellular survival and expression of NF-!B target genes after radiation exposure.
The original cell line, which was used in this work, was HEK-pNF-!B-d2EGFP/Neo L2.
These cells were generated by stable transfection of human embryonic kidney cells
(Graham et al., 1977) with the plasmid pNF-!B-d2EGFP/Neo, a reporter vector to moni-
tor NF-!B activation (Hellweg et al., 2003). In these cells, activation of NF-!B leads to
the expression of the reporter destabilized enhanced green fluorescent protein
(d2EGFP) by binding to the synthetic promoter (!B4-TK) of the integrated plasmid. The
NF-!B pathway in this cell line was characterized by visualizing RelA translocation to
the cell nucleus, determining the kinetics of NF-!B activation after radiation exposure
as well as the extent of NF-!B activation and the cellular survival after exposure to
several energetic heavy ions.
3.1 Activation of NF-!B
NF-!B activation in HEK-pNF-!B-d2EGFP/Neo L2 cells by TNF-" and by different
radiation qualities was shown by immunofluorescence and by flow cytometry of NF-!B
dependent d2EGFP expression, respectively.
3.1.1 Translocation of NF-!B into the nucleus
The NF-!B subunits RelA (p65) and p50 (NFKB1) have been described to translocate
into the nucleus (Whiteside and Israel, 1997) after degradation of their inhibitor I!B"
(encoded by the NKBIA gene) as a result of exposure to different agents such as pro-
inflammatory cytokines, e.g. TNF-".
To show the intracellular location of NF-!B with and without activation of this pathway
by TNF-", HEK-pNF-!B-d2EGFP/Neo L2 cells were treated with 10 ng/ml TNF-" for
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30 min and fixed with 70 % Ethanol. Immunofluorescence staining was performed using
a RelA!antibody and a TRITC-coupled polyclonal swine anti-rabbit antibody was used
for its detection. Cells were counterstained with DAPI to visualize the nuclei. Without
TNF-" treatment, the red fluorescence signal indicating RelA is uniformly distributed in
the cytoplasm (Fig. 19 A, B). 15 and 30 min after treatment with the known NF-#B acti-
vator TNF-", the predominant part of RelA is localized in the nucleus, with no or only
very low fluorescence in the cytoplasm (Fig. 19 C, D).
Fig. 19: RelA is translocated into the nucleus after treatment with TNF-!. Immunofluorescence staining
of RelA in HEK-pNF-#B-d2EGFP/Neo L2 cells using a monoclonal rabbit anti-p65 antibody (Epitomics;
red). (A, B) mock treatment: medium change; (C) 15 min after treatment with 10 ng/ml TNF-"; (D) 30
min after treatment with 10 ng/ml TNF-". Nuclei were counterstained with DAPI (blue). The length of the
scale bars is 20 $m.
3.1.2 Kinetics of NF-!B activation by different agents
To investigate NF-#B activation after exposure to different radiation qualities by quan-
tifying d2EGFP(+) cells, the time point of maximum d2EGFP expression after induction
had to be determined. Kinetics of NF-#B activation was investigated after exposing
HEK-pNF-#B-d2EGFP/Neo L2 cells to different radiation qualities and doses or treating
them with TNF-". Cells were fixed at different time points and NF-#B activation was
analyzed by flow cytometry. 
w/o TNF-" w/o TNF-"
10 ng/ml TNF-" 10 ng/ml TNF-"
A
C
B
D
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Fig. 20 A shows the kinetics of NF-!B-dependent d2EGFP expression after irradiation
with X-rays and after treatment with 10 ng/ml TNF-". The percentage of d2EGFP(+)
cells, indicating NF-!B activation, reaches its maximum at 16 to 18 hours after treat-
ment and decreases thereafter. TNF-" induces NF-!B activation in more than 50 % of
the cells and is thereby a significantly stronger inducer of NF-!B activation in compari-
son to X-rays.
Fig. 20 B shows the resulting kinetics of NF-!B activation after exposure to 13C ions (75
MeV/n, LET 34 keV/#m). The percentage of d2EGFP expressing cells again reaches
its maximum after 16 to 18 hours and subsequently decreases. Further, the activation
of NF-!B by both X-rays and 13C ions increases with higher doses. 13C ions are a much
stronger inducer of NF-!B activation than X-rays.
Fig. 20: Kinetics of NF-!B-dependent d2EGFP expression in HEK-pNF-!B-d2EGFP/Neo L2 cells after
radiation exposure. Cells were irradiated with different doses of X-rays (A) and 13C ions (B). 10 ng/ml
TNF-" was used as a positive control (A). At different time points after induction cells were fixed with 3.7
% formaldehyde and d2EGFP expression was analysed by flow cytometry.
3.1.3 NF-!B activation and cellular survival depend on the level of Linear 
Energy Transfer (LET)
It has been shown that heavy ions of different Linear Energy Transfer (LET) have a
varyingly strong impact on the amount of NF-!B-dependent d2EGFP expression and
cellular survival (Hellweg, 2011). Here, the results for NF-!B activation (Fig. 21 A) and
colony forming ability (Fig. 21 B) in HEK-pNF-!B-d2EGFP/Neo L2 cells after irradiation
A BX-rays (200 kV, LET 2.5 keV/"m) 13C ions (75 MeV/n, LET 34 keV/"m)
Results
55
with four different energetic heavy ions are shown, mainly complementing the already
published results in the LET range below 100 keV/!m. Cells were irradiated with 13C
(75 MeV/n, LET 34 keV/!m), 16O (95 MeV/n, LET 51 keV/!m), 22Ne (80 MeV/n, LET 92
keV/!m) and 58Ni (75 MeV/n, LET 906 keV/!m) ions. After 18 hours, cells were fixed
and the percentage of d2EGFP(+) cells was analysed by flow cytometry. Additionally,
cells were seeded directly after irradiation to determine their clonogenic survival ability.
The potential to activate NF-"B increases with higher doses and is higher for ions with
an LET below 100 keV/!m compared to 58Ni ions with an extremely high LET of 906
keV/!m. For these ions, the ability to activate NF-"B decreases.
The colony forming ability decreases with increasing doses and further depends on the
LET. Heavy ions with an LET#of 34 to 92 keV/!m have the most severe killing effect. In
extremely high LET ranges, the killing potential is lower. The parameters describing the
survival curves are listed in Table 8.
Fig. 21: Activation of NF-!B-dependent d2EGFP expression and clonogenic survival after exposure to
different energetic heavy ions. HEK-pNF-"B-d2EGFP/Neo L2 cells were irradiated with ions of different
energy and LET (13C: 75 MeV/n, LET 34 keV/!m; 16O: 95 MeV/n, LET 51 keV/!m; 22Ne: 80 MeV/n, LET
92 keV/!m and 58Ni: 75 MeV/n, LET 906 keV/!m). 18 hours after irradiation, cells were fixed with 3.7 %
formaldehyde and d2EGFP expression was analysed by flow cytometry (A). For investigating clonogenic
survival, cells were seeded in Petri dishes immediately after irradiation and colonies were fixed and stai-
ned after 14 to 21 days (B). For the colony forming ability (CFA) test, standard error (SE) from six repli-
cates per dose is shown. Doses (Gy) were calculated from fluences (P/cm2) according to Equation 19
(s. 2.4.2). (MeV/n) MeV/nucleon; (LET) linear energy transfer.
A B
Table 8: Parameters of the survival curves (single-hit-multi-target model).
Ion Energy LET in H2O D0 n Dq r2
(MeV/n) (keV/!m) (Gy) (Gy)
13C 75 34 0.88 ± 0.04 0.51 ± 0.08 -0.59 ± 0.11 0.92
16O 95 51 1.44 ± 0.07 0.59 ± 0.01 -0.77 ± 0.20 0.93
22Ne 80 92 0.78 ± 0.02 0.90 ± 0.04 -0.08 ± 0.04 0.97
58Ni 75 906 2.96 ± 0.17 0.51 ± 0.09 -2.01 ± 0.38 0.91
3.2 Inhibition of the NF-!B pathway by chemical inhibitors
The classical and the genotoxic stress induced NF-"B pathway might contribute to the
cellular radiation response. To study its role in cell death, survival and other biological
endpoints, a system to inhibit NF-"B in HEK-pNF-"B-d2EGFP/Neo L2 cells had to be
developed. The first aim was to test chemical inhibitors for their ability to suppress NF-
"B activaton by targeting different elements of its pathway. The ATM inhibitor KU-55933
and the proteasome inhibitor MG-132 were both tested for their cytotoxicity and efficacy
to suppress NF-"B activation after treatment with different agents.
3.2.1 Cytotoxicity of ATM inhibitor KU-55933 and proteasome"inhibitor MG-132
To determine the appropriate concentration of inhibitors, first, the concentration at which
cytotoxic effects of KU-55933 and MG-132 appear had to be determined. Inhibitors
were added to the cells in increasing concentrations. After 100 hours, growth of the
cells was analysed by the MTT#test. 
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Fig. 22: Growth of HEK-pNF-!B-d2EGFP/Neo
L2 cells after treatment with increasing concen-
trations of the ATM inhibitor KU-55933 and the
proteasome inhibitor MG-132. 100 hours after
adding the inhibitor, the number of viable cells
was analysed by means of the MTT#test. Means
and standard error of two independent experi-
ments with three replicates each are shown. The
dotted reference line indicates 80 % relative via-
bility.
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Fig. 22 shows the relative viability of HEK-pNF-!B-d2EGFP/Neo L2 cells after adding
KU-55933 and MG-132. MG-132 is not cytotoxic within the tested range of concentration.
For KU-55933, viability of the cells decreases suddenly at a concentration of 30 "mol/l. 
3.2.2 Chemical inhibition of TNF-!-induced activation of the NF-"B pathway
The ability of KU-55933 and MG-132 to suppress NF-!B signaling was initially tested
by activating NF-!B with TNF-# in presence of each inhibitor, respectively. Thus, the
appropriate concentration for suppressing NF-!B signaling in the classical pathway
could be determined. The inhibitor concentration was added to cells in varying concen-
trations and NF-!B activation was measured by detecting the reporter protein d2EGFP
by flow cytometry. Fig. 23 A depicts NF-!B suppression by MG-132. It was shown that
a non-cytotoxic concentration of 2 "mol/l was sufficient to abolish NF-!B activation
almost completely. KU-55933 was not able to suppress classical NF-!B signaling within
its non-cytotoxic range (Fig. 23 B).
Fig. 23: Effect of the proteasome inhibitor MG-132 (A) and the ATM inhibitor KU-55933 (B) on TNF-!
induced activation of the NF-"B pathway. Cells were preincubated with the inhibitor for 1 hour. Subse-
quently, 10 ng/ml TNF-# was added. Cells were detached and fixed with 3.7 % formaldehyde after 18
hours. NF-!B-dependent d2EGFP$expression was measured by flow cytometry. Mean and SE of three
independent experiments are shown. p % 0.05 *, p % 0.01 **, showing a significant difference of TNF-#
treated cells versus TNF-# and MG-132 treated cells.
A B
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3.2.3 Chemical inhibition of radiation-induced activation of the NF-!B pathway
Both inhibitors were finally tested for their ability to suppress radiation induced NF-!B
activation. In presence of each of the inhibitors, cells were irradiated with different
doses of X-rays and 36Ar ions. Both, MG-132 and KU-55933 were able to completely
suppress radiation-induced NF-!B activation (Fig. 24). While a concentration of 2 "mol/l
of MG-132 was used, 10 "mol/l had been shown to be the appropriate, non-cytotoxic
concentration for KU-55933, as described in the literature (Hickson et al., 2004). 
Fig. 24: Suppression of radiation-induced activation of the NF-!B pathway by KU-55933 and MG-132.
Cells were preincubated with the inhibitor for 1 hour and subsequently irradiated with X-rays (200 kV,
LET 2.5 keV/"m, A) or 36Ar ions (95 MeV/n, LET 272 keV/"m, B). After 18 hours, NF-!B-dependent
d2EGFP#expression was measured by flow cytometry. The percentage of d2EGFP(+) cells was normalized
to the mock-irradiated control. For 36Ar ions, doses (Gy) were calculated from fluences (P/cm2) according
to Equation 19 (s. 2.4.2). Mean and SE of three independent experiments are shown.
3.3 Inhibition of the NF-!B pathway by RNA interference (RNAi)
As the tested chemicals are not NF-!B-specific, they are not adequate to investigate
the role of NF-!B in different biological endpoints, as observed cellular responses can-
not be ascribed to this pathway. Further, the tested chemicals Parthenolide, Capsaicin,
Isohelenin and caffeic acid phenethyl ester (CAPE) were either cytotoxic or insufficient
in suppressing NF-!B-dependent d2EGFP#expression and therefore, results are not
shown in this work.
To investigate NF-!B more specifically, RNA interference (RNAi) was chosen as an
additional method. The NF-!B subunit RelA (p65) was chosen as the target for mRNA
degradation and subsequent decrease of RelA protein levels.
A B
X-rays (200 kV, LET 2.5 keV/"m) 36Ar ions (95 MeV/n, LET 272 keV/"m)
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3.3.1 Stable transfection of HEK-pNF-!B-d2EGFP/Neo L2 cells with shRNA
vectors
To establish a cell line with a permanent RelA knockdown, a stable transfection was
performed using shRNA vectors, containing a Hygromycin resistance marker for
selection of transfected cells (s. 2.1.2). The shRNA plasmids were propagated in E.
coli. The quality of the plasmid preparation from transformed E. coli was controlled by
restriction digestion and visualized on an agarose gel (Fig. 25).
To determine the appropriate cytotoxic concentration of Hygromycin, it was added to
HEK-pNF-!B-d2EGFP/Neo L2 cells in varying concentrations. It was shown that the
minimum concentration needed to kill shRNA untransfected HEK-pNF-!B-d2EGFP/Neo
L2 cells was 400 "g/ml (Fig. 26). Once the stably transfected cell population was avai-
lable, a maintenance concentration of 200 "g/ml was chosen for continued cell growth.
HEK-pNF-!B-d2EGFP/Neo L2 cells were transfected with four individual shRNA#plas-
mids specific for RelA. A fifth transfection using a negative control shRNA plasmid was
performed. Hygromycin resistant cells were harvested 11 days after it had been added
Fig. 25: Control digestion of the
pGene Clip™ Hygromycin Vector. Di-
gestion with ScaI. Expected frag-
ments: 1643 bp, 3346 bp; (1-5)
RELA-1-RELA-5; (M) GeneRuler 1 kb
DNA ladder.
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Fig. 26: Viability of HEK-pNF-!B-d2EGFP/Neo L2
cells after being cultivated in culture medium contai-
ning varying concentrations of Hygromycin. Medium
was changed after 4 and 7 days. After 11 days, cells
were fixed and stained with a formaldehyde/crystal
violet solution. Cell growth was determined by measu-
ring crystal violet absorbance at a wavelength of 592
nm. The dotted reference line indicates 80 % relative
viability.
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to the medium and RNA of each of the five transfected cell populations was isolated (s.
2.2.5). RNA!was controlled according to the parameters RNA concentration, RNA inte-
grity (RIN), rRNA ratio (28S/18S) and purity (A260/280; s. 2.2.2.2). For an adequate
quality control and a subsequent cDNA synthesis, the samples had to exhibit a RIN of
at least 9. Samples showing a RIN!of less than 9 were not reliable. In most cases, the
RIN was 10, the highest possible value. Additionally, samples had to exhibit a rRNA
ratio and a A260/280-value of ~ 2. Due to the high number of RNA samples tested in
this work, Fig. 27 representatively depicts one example of an appropriate RNA!sample
that was used for further cDNA!synthesis.
Fig. 27: RNA quality control using the Eukaryote Total RNA Nano Assay (Thermo Scientific). Intact 18S
and 28S rRNA subunits are visualised on a gel-like image (A) and by electropherogram (B). This example
shows the electrophoresis results of RNA extracted from untreated HEK-pNF-"B-d2EGFP/Neo L2 cells,
displaying a RIN of 9.8, an rRNA ratio of 2.0 and a concentration of 154 ng/#l.
3.3.2 Verification of RelA-knockdown on mRNA level
After RNA quality control, cDNA!was synthesised by reverse transcription, with 1000
ng RNA being used for each sample, and analysed by qPCR (s. 2.2.2.4). To control the
quality of the qPCR, a melting curve program was run immediately after completion of
the PCR program. Results showed the expected melting temperatures of 80 °C for the
RELA PCR product and 76.5 °C for HPRT1 (Fig. 28 A). Controlling the PCR quality by
performing a dissociation curve was conducted with every real-time RT-qPCR in this
work. The quality of the PCR product and the primer was further tested by loading the
PCR product on an agarose gel. Bands were visible at the expected sizes of 65 bp
(RELA) and 89 bp (HPRT1; Fig. 28 B).
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Fig. 28: Quality control of real-time RT-qPCR. (A) dissociation curve showing the expected melting tem-
peratures of 80 °C for RELA and 76.5 °C for HPRT1; (B) agarose gel showing the PCR products of SA
Biosciences primer for RELA (65 bp) and HPRT1 (89 bp); (M1) low range DNA ladder (Fermentas); (M2)
20 bp low ladder (SIGMA).
To determine the efficiency of each shRNA!plasmid in down-regulating RelA expres-
sion, the percentage of RelA-knockdown of each stably transfected cell population had
to be assessed. The knockdown level of each shRNA plasmid after stable transfection
into HEK-pNF-"B-d2EGFP/Neo L2 cells was calculated from the Ct values of RelA
expression in transfected cells, using a validation sheet (SABiosciences; Table 9). This
Excel-based data analysis template performs the calculation as described in 2.2.2.4.
Calculations displayed the highest knockdown level in cells that had been stably trans-
fected with plasmids RELA-1, showing a knockdown level of 52.7 %, and RELA-4 with
a knockdown level of 47.6 % (Fig. 29). 
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Table 9: RelA knock-down 5 in Hygromycin-resistent cells after stable transfection with the shRNA plas-
mids RELA-1 to RELA-4.
5 Real-time RT-qPCR!results for shRNA plasmids RELA-1 to RELA-4. The table shows the validation
sheet (supplied by SABiosciences, formerly SuperArray) for determining the knockdown-level of RNAi
plasmids. This Excel-based data analysis template calculates the percentage of knockdown, interpreting
a successful design as an observed knockdown-level of " 70 % and an upper 95 % confidence interval
boundary of " 55.5 %. Each set of three columns represents a shRNA construct (RELA-1 to RELA-4)
and the negative control (NC). Each column within a set represents one replicate transfection. Each row
represents a technical replicate. For both, RelA and the reference gene HPRT1, the average and stan-
dard deviation (SD) of the Ct values of each transfection were calculated. The internal quality control
(QC) reports #OK$ if the SD of the replicates$ Ct is below 0.3, indicating sufficient reproducibility. For each
transfection, the %Ct is calculated by substraction of the Ct of HPRT from the Ct of RelA. For all replicates
of each plasmid (triplicate PCR reactions and biological replicates), the average and SD of %Ct were
determined. The expression difference between cells transfected with shRNA plasmid and the negative
control plasmid where then computed by subtracting the respective %Ct values (%%Ct). The SD of %%Ct
had to be smaller than 0.55 to pass QC. The relative expression was calculated according to equation
10 (s. 2.2.2.6) and expressed as percent of control. The percent knockdown was determined by sub-
tracting the relative expression from 100 %. The confidence interval for knockdown was determined using
the same formulas on +SD and -SD.
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By reason of their high knockdown-level, cell populations that were transfected with
plasmids RELA-1 or RELA-4 were chosen to further processing to achieve a greater
and more consistent level of knock-down. Colonies grown from single cells were isola-
ted from the polyclonal population. In each clone the plasmid was integrated randomly
into genomic DNA, resulting in possible position effects on shRNA expression. 
Fig. 30: RelA knockdown level of different HEK-pNF-!B-d2EGFP/Neo L2 clones isolated from polyclonal
populations transfected with the plasmids RELA-1 or RELA-4. The arrow depicts clone #9 (!HEK shRNA
RelA"), which had been transfected with the plasmid RELA-4 and shows the highest knockdown level of
more than 80 %. All knockdown-levels were calculated with the SABiosciences validation sheet (Table
9 and 10). Means and SD of triplicate PCR reactions and three biological replicates are shown. The dot-
ted line indicates the threshold of 70 %, from which the knockdown is defined as !successful". 
Fig. 29: Selection of the most effective shRNA
plasmid by comparing the knockdown level. Total
RNA of the Hygromycin-resistant polyclonal popu-
lations was isolated two weeks after transfection
with the five plasmids (RELA-1 to -4). RelA knock-
down was verified by RT-qPCR after transfection
of HEK-pNF-#B-d2EGFP/Neo L2 cells with shRNA.
Means and SD of three individual experiments with
three replicates each are shown.
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After RNA isolation and quality control of monoclonal cell populations according to
2.2.2.1 and 2.2.2.2, the RelA knockdown of each clone was determined by RT-qPCR,
similar to the procedure described to investigate the knockdown level of the polyclonal
populations. A selection of clones and their respective knock-down level is depicted in
Fig. 30. Table 10 shows the real-time RT-qPCR!results displayed in the SABiosciences"
validation sheet for the selected clone, which was named #HEK shRNA RelA" and is
characterized by a RelA knock-down level of 83.1 % (mean of three individual experi-
ments) and a resistance against Hygromycin.
Table 10: RelA knock-down 6 in clone #9 that resulted from stable transfection of HEK-pNF-!B-
d2EGFP/Neo L2 cells with the shRNA plasmid RELA-4.
6 Example of real-time RT-qPCR!result for clone #9 (#HEK shRNA RelA"), isolated from the polyclonal
population which had been stably transfected with plasmid RELA-4. The table shows the validation sheet
(supplied by SABiosciences) that was also used for determining the highest knockdown-level of the poly-
clonal cell populations after transfection with the four different shRNA plasmids (Table 9). A set of three
columns represents one clone. This validation sheet was modified so that only clone #9 and the negative
control (NC) are shown. Each column within a set represents one biological replicate with three technical
replicates during qPCR. Each row represents one technical replicate and three independent seedings. 
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3.3.3 Verification of RelA-knockdown on protein level
Knockdown efficiency was further determined by comparing the fluorescence intensity
of the untreated original and the knockdown-cell line after immunofluorescence staining
using the RelA antibody. Images of both cell lines were acquired using a laser scanning
microscope (Nikon Eclipse 80i) with the scanning system !Nikon D-Eclipse D1" set to
the same illumination time. Fig. 31 depicts RelA-staining of HEK-pNF-#B-d2EGFP/Neo
L2 (Fig.$31 A) and HEK$shRNA RelA (Fig.$31 B) cells. Comparing the fluorescence
signal of both cell lines, the observed intensity is strongly reduced in the knockdown
cell line. Still the tendency of the RelA signal to be restricted to the cytoplasm occurs
in both cell lines in the uninduced state.
Fig. 31: Visualisation of RelA after RelA knockdown. Immunofluorescence staining was performed with
fixed cells using a monoclonal rabbit anti-p65 antibody (Epitomics). Without activation of NF-#B, the RelA
signal is restricted to the cytoplasm. In the knockdown cell line the intensity of red fluorescence is reduced.
(A) HEK-pNF-#B-d2EGFP/Neo L2 cells; (B) HEK shRNA RelA cells. The length of the scale bar is 20 %m.
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3.3.4 Verification of RelA-knockdown on reporter protein level
To visualize the RelA-knockdown of the selected clone on reporter protein level, the ori-
ginal HEK-pNF-!B-d2EGFP/Neo L2 cell line, as well as the knockdown (HEK shRNA
RelA) and the control cell line, which was transfected with a negative control shRNA
vector, were treated with different radiation qualities or with TNF-". d2EGFP fluores-
cence was measured 18 hours after treatment by flow cytometry. Fig. 32 A-C depict
histograms obtained by flow cytometry. 
Fig. 32: Activation of NF-!B dependent d2EGFP expression in different cell lines by TNF-" and X-rays.
Cells were harvested and fixed for flow cytometry 18 hours after treatment. Histogram overlays of repre-
sentative flow cytometric analysis are shown in A, B and C. (A) HEK-pNF-!B-d2EGFP/Neo L2; (B) HEK
shRNA control; (C) HEK#shRNA RelA;#(D) summarizes the results of two individual experiments, showing
mean and standard error.
A B
C D
HEK-pNF-!B-d2EGFP/Neo L2
HEK shRNA RelA
HEK shRNA control
The original HEK-pNF-!B-d2EGFP/Neo L2 cell line as well as the control transfected
cell line exhibit a strong increase in d2EGFP(+) cells after treatment with X-rays and
TNF-". Fluorescence intensifies with increasing doses and reaches ~ 50-70 % after
TNF-"-treatment. HEK shRNA RelA cells show a very low increase in fluorescence
intensity after treatment with a maximum in d2EGFP(+) cells of only ~ 20 % (Fig. 32 C
and D). A similar effect was shown for 13C ions. After irradiation with increasing dose,
fluorescence intensity reaches up to 20 % in the original and the control cell line, whe-
reas d2EGFP was not inducible in the knockdown-cell line (Fig. 33).
Fig. 33: Activation of NF-!B dependent d2EGFP expression in different cell lines by 13C ions (75 MeV/n,
LET 34 keV/"m). Cells were harvested and fixed for flow cytometry 18 hours after irradiation. Doses (Gy)
were calculated from fluences (P/cm2) according to Equation 19 (s. 2.4.2). Histogram overlays of flow
cytometric analysis are shown in A, B and C. (A) HEK-pNF-!B-d2EGFP/Neo L2; (B) HEK shRNA control;
(C) HEK#shRNA RelA;#(D) dose effect curve with a combined regression curve for HEK-pNF-!B-
d2EGFP/Neo L2 and HEK shRNA control cells.
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3.4 Characterization of the RelA-knockdown cell line
3.4.1 HEK shRNA RelA cells exhibit a prolonged lag-phase in growth experiments
To investigate the effect of NF-!B on the growth rate, both cell lines were seeded with
the same starting cell number and counted twice a day up to a time point of ~ 260
hours, when cells had reached confluence. Compared to the original cell line, HEK
shRNA"RelA cells show a prolonged lag phase with an initial decrease in cell number
(Fig. 34). While HEK-pNF-!B-d2EGFP/Neo L2 cells transfer to the exponential growth
phase (logarithmic, log) after 24 to 48 hours, the knockdown cell line enters this phase
only after 48 to 72 hours. Once the cells have reached the log phase, there is no sig-
nificant difference in the growth velocity. During this phase, the doubling time is 28.2
hours for both cell lines. In the final plateau phase, the knockdown cells seem to grow
slightly less confluent than the original cell line, which was also observed during culti-
vation of the cells.
3.4.2 Changes in gene expression in absence of RelA
To compare gene expression in both cell lines, two different RT2 Profiler™ PCR Arrays
(SABioscience) were used. The first array was customized and contained a set of 89
genes, involved in the NF-!B signaling pathway, cell cycle, apoptosis, p53 signaling,
stress and toxicity pathways, DNA damage etc. This customized array was designed
to analyse the expression of selected genes which might be of relevance to the cellular
radiation response. The second array was commercially available and restricted to 89
NF-!B target genes (RT2 Profiler™ PCR Array: Human NF-!B Signaling Targets). 
Fig. 34: Growth kinetics of HEK!shRNA!RelA
cells compared to the original cell line. 1 x 104
cells/cm2 cells were seeded in 6-well plates
and cultivated in S-medium. Twice a day the
cell number of one well was counted after de-
taching cell by trypsination. The graph shows
a summary of four independent experiments.
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To assure a consistent RNA quality in advance, the concentration and purity of all RNA
samples was determined and all samples were tested for ribosomal RNA band integrity
as described in 2.2.2.2. After cDNA synthesis (s. 2.2.2.3), samples were additionally
investigated with an RT2 RNA QC PCR!array (SABiosciences) to assure proper RNA
and cDNA quality and to rule out genomic DNA!contamination. This array includes the
RNA!quality control parameters housekeeping gene expression levels, reverse tran-
scription and polymerase chain reaction efficiency as well as genomic and general DNA
contamination (s. 2.2.2.6). Table 11 shows an example of the cDNA!quality plate. The
results showed that no RNA!sample impurities were affecting reverse transcription or
PCR, no genomic DNA!contamination was detectable or affecting the results and that
the PCR!system was clean. Samples were only used for further analysis, when the
given quality control parameters were assessed as correct. 
Table 11: Quality control 7 of cDNA!for further gene expression analysis with the RT2 Profiler™ PCR array
(SABiosciences), using the analysis template of the RT2 RNA QC PCR!array.
7 This example displays the results of a real-time RT-qPCR plate investigating the quality of 12 cDNA
samples of both, the original and the knockdown cell line, after irradiation with different doses of X-rays.
For each sample, the validation sheet (supplied by SABiosciences) reports the average Ct value and furt-
her contains a number of PCR controls that test for RNA!integrity, the presence of inhibitors of reverse
transcription and PCR !amplification and genomic and general DNA!contamination.
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After assuring a proper quality of all!samples, the samples were further characterized
with the RT2 Profiler™ PCR Arrays. The results of both arrays were combined. In the
following results, the standard error (SE) is shown for only those genes which were pre-
sent in both arrays or in case that experiments had been repeated. A list of all genes is
shown in Table 17 (s. Appendix). Table 12 shows genes that are more than threefold
up- or downreglated in the knockdown cell line compared to the original cell line. All
investigated genes and their respective values of up- or downregulation are listed in
Table 18 (s. Appendix).
Table 12: Gene expression in HEK!shRNA!RelA cells compared to the original cell line HEK-pNF-"B-
d2EGFP/Neo L2 using the RT2 Profiler™ PCR array 8 (SABiosciences).
Gene symbol Description Relative gene expression
" ± SE
CCND1 Cycin D1 -3.69 ± 1.15
IL8 Interleukin 8 -8.12 ± 5.20
JUN Jun oncogene 4.25 ± 2.48
RELA V-rel reticuloendotheliosis viral oncogene -6.18 ± 1.47
homolog A 
TNF Tumor necrosis factor -3.37 ± 1.54
8 The table shows all genes from both, the customized and the NF-#B signaling array, that are more than
threefold up- or downregulated in HEK sRNA RelA cells compared to HEK-pNF-#B-d2EGFP/Neo L2
cells. 162 genes were investigated. Mean and standard error of the expression level were calculated
from up to five individual experiments with untreated cells. Prior to investigating gene expression with
the RT2 Profiler™ PCR arrays, a proper RNA!and cDNA quality was confirmed.
3.4.3 Differences in gene expression of both cell lines after TNF-!-treatment
TNF-$, which is known to be a strong NF-#B activator, was added to the cells for 6
hours, which was shown to be an appropriate time point to investigate NF-#B target
gene expression (Fig.!40). Subsequently RNA!was isolated and tested for its integrity
as described in 2.2.2.1 and 2.2.2.2. After cDNA!synthesis, the RT2 RNA!QC PCR!Array
was performed for quality control and gene expression was investigated using the RT2
Profiler™ PCR Arrays as described in 2.2.2.6. Table 13 shows the expression profile
for each cell line respectively. Ct values of TNF-$ treated cells were compared to the
Ct values of the untreated sample of the respective cell line. Only genes more than
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threefold up- or downregulated are shown. A list of all genes and the corresponding
amount of regulation is shown in Tables 19 and 20 (see Appendix). 
In the original cell line, a set of CXCL genes and TNF itself are strongly upregulated by
TNF-treatment. The NF-B inhibitor NFKBIA shows an 6.3-fold upregulation.
In the knockdown cell line, the gene expression profile reveals five downregulated NF-
B target genes. None of the genes activated by TNF- in HEK-pNF-B-d2EGFP/Neo
L2 cells is notably regulated in the knockdown cell line.
Table 13: Gene expression in HEK-pNF-B-d2EGFP/Neo L2 (green) and HEKshRNARelA (red) cells
6 hours after treatment with TNF- (10 ng/ml) using the RT2 Profiler™ PCR array 9 (SABiosciences). (L2)
HEK-pNF-B-d2EGFP/Neo L2; (SH) HEK shRNA RelA.
Gene Description Relative gene expression
symbol  ± SE
L2 SH
CXCL1 Chemokine (C-X-C motif) ligand 1 11.73
CXCL10 Chemokine (C-X-C motif) ligand 10 5.14
CXCL2 Chemokine (C-X-C motif) ligand 2 6.51
IL8 Interleukin 8 5.35 ± 0.31
NFKBIA Nuclear factor of kappa light poly peptide 6.31 ± 0.52
gene enhancer in B-cells inhibitor, alpha 
TNF Tumor necrosis factor 13.91 ± 0.53
CCR5 Chemokine (C-C motif) receptor 5 -4.59
EXO1 Exonuclease 1 -4.92
IL10 Interleukin 10 -3.11
MT3 Metallothionein 3 -3.11
SOD3 Superoxide dismutase 3, extra cellular -3.11
9 The table shows all genes from both, the customized and the NF-B signaling array that are more than
threefold up- or downregulated (bold). 162 genes were investigated. The standard error of the expression
level is shown for genes occurring in both arrays.
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3.4.4 The RelA-knockdown cell line does not show significant changes in cell
cycle progression
It was shown that NF-!B is involved in cell cycle regulation by inducing cyclin D1, which
is involved in the G1/S transition (Guttridge et al., 1999). Further, results of gene
expression studies (Table 12) showed a nearly four-fold downregulation of CCND1
(cyclin D1) in the knockdown cell line compared to the original cell line. Therefore, the
distribution of cells in the different phases of the cell cycle was investigated for both cell
lines during 48 hours (Fig. 35). In HEK shRNA RelA cells, there was a tendency towards
a decreased percentage of cells in S-phase, but the amount of cells in different cell
cycle phases did not differ significantly in both cell lines. 
Fig. 35: Comparison of cell cycle progression within 48 hours in the original (A) and the knockdown cell
line (B). Distribution of the cell cycle phases G1, S and G2 was investigated by fixing cells in 70 % ethanol
at different time points and analysing PI stained cells by flow cytometry. Data from up to four individual
experiments was combined. Percentages were calculated by the Flowing Software 2 (by Perttu Terho).
3.5 Effects of RelA-knockdown on the cellular radiation response
After characterising both cell lines regarding different biological endpoints, the effect of
the RelA knockdown on the radiation response was investigated. Cells were irradiated
with different radiation qualities to subsequently study differences in their survival ability,
cell cycle progression and gene expression.
A B
HEK-pNF-!B-d2EGFP/Neo L2 HEK shRNA RelA
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3.5.1 HEK cells are more sensitive to X-irradiation in absence of RelA 
The effect of the RelA-knockdown on radiosensitivity was investigated by irradiating
cells with X-rays and subsequently determining their clonogenic survival ability. Colo-
nies were counted after 14 to 21 days. HEK shRNA!RelA cells showed a significantly
heightened radiosensitivity with p-values " 0.001 for 2, 6 and 8 Gy and p-values " 0.01
for 4 Gy (Fig. 36). The parameters describing the survival curves of both cell lines are
listed in Table 14.
Table 14: Parameters describing the survival curves (single-hit-multi-target model) after X-irradiation.
Cell line D0 n Dq r2
HEK-pNF-#B-d2EGFP/Neo L2 1.13 ± 0.02 Gy 1.21 ± 0.12 0.22 ± 0.11 Gy 0.94
HEK!shRNA RelA 0.78 ± 0.02 Gy 1.69 ± 0.18 0.41 ± 0.09 Gy 0.95
3.5.2 The RelA-knockdown cell line does not show changes in colony forming
ability after exposure to heavy ions
As it was shown that the colony forming ability depends on the LET, survival curves
after irradiation with heavy ions were performed (Fig. 37). To investigate the effect of
the RelA knockdown on the cellular response to accelerated heavy ions, the colony for-
ming ability of both cell lines was investigated. Cells were irradiated with 64Ni ions (1000
Fig. 36: Clonogenic survival after ex-
posure of HEK shRNA RelA and HEK-
pNF-!B-d2EGFP/Neo L2 cells to 200
kV X-rays. Survival was determined by
the colony forming ability test. Colo-
nies were fixed and stained 14 to 21
days after irradiation. Data from four
individual experiments with each six
replicates were combined. p " 0.05 *,
p " 0.01 **, p " 0.001 ***.
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MeV/n, LET 175 keV/!m) and seeded 4 hours after irradiation. Colonies were counted
after 14 to 28 days. In comparison to X-rays, exposure to high-LET radiation revealed
a more efficient killing effect. However, no differences in radiosensitivity between both
cell lines could be observed. The parameters describing the survival curves of both cell
lines are listed in Table 15.
Table 15: Parameters descrining the survival curves (single-hit-multi-target model) after irradiation with
64Ni ions.
Cell line D0 n Dq r2
HEK-pNF-"B-d2EGFP/Neo L2 0.55 ± 0.05 Gy 0.72 ± 0.11 0.18 ± 0.07 Gy 0.87
HEK#shRNA RelA 0.57 ± 0.02 Gy 0.76 ± 0.10 0.16 ± 0.07 Gy 0.95
3.5.3 Cell cycle progression after irradiation with X-rays and heavy ions
The effect of radiation on cell cycle progression and changes in the knockdown cell line
were investigated by irradiating cells with different radiation qualities and doses and
determining cell cycle distribution at different time points after irradiation. Cell cycle dis-
tribution was analysed by flow cytometry as described in 2.3.10. 
After irradiating cells with 2 Gy of X-rays, a shifting of the amount of HEK-pNF-"B-
Fig. 37: Clonogenic survival after ex-
posure of HEK shRNA RelA and HEK-
pNF-!B-d2EGFP/Neo L2 cells to 64Ni
ions (1000 MeV/n, LET 175 keV/"m).
Survival was determined by the co-
lony-forming ability test (CFA). For in-
vestigating clonogenic survival, cells
were seeded in Petri dishes 4 hours
after irradiation. Colonies were fixed
and stained after 14 to 28 days. Mean
and SD from six replicates per dose is
shown. Doses (Gy) were calculated
from fluences (P/cm2) according to
Equation 19 (s. 2.4.2).
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d2EGFP/Neo L2 cells in each cell cycle phase can be observed. After 8 to 16 hours,
the number of cells being in G1 phase starts to decrease and to increase in the G2
phase (Fig.!38). From 16 to 24 hours after X-irradiation, cells in G2-phase significantly
increase compared to the untreated control. At ~ 40 hours after irradiation, the distri-
bution in the cell cycle is normalized. Comparing these results to the knockdown cell
line, no significant changes can be seen.
Fig. 38: Comparison of cell cycle progression within 48 hours in the original (A) and the knockdown cell
line (B) after X-irradiation. Cells were irradiated with 200 kV X-rays and fixed in 70 % Ethanol at different
time points after irradiation. Distribution of the cells in the cell cycle phases G1, S and G2 was investigated
by flow cytometric analysis of PI stained cells. Data from up to four individual experiments were combined.
Percentages were calculated by the Flowing Software 2 (by Perttu Terho). p " 0.05 *, p " 0.01 **, showing
a significant difference of irradiated versus non-irradiated cells (Fig. 35) for each time point.
HEK-pNF-!B-d2EGFP/Neo L2 HEK shRNA RelA
2
 G
y
4
 G
y
Results
76
Similar effects were shown for an X-ray dose of 4 Gy. After exposure to this dose, the
redistribution of cell cycle phases was more severe, with significant decreases in G1-
phase 16 and 24 hours after irradiation (Fig.!38). As already observed in the untreated
control (Fig. 35), the S-phase generally seemed to be less prominent compared to G1
and G2 phase in HEK!shRNA!RelA cells. However, these results are only a tendency
and differences between original and knockdown cell line are not significant.
It was then investigated, whether irradiation with heavy ions reveals clearer differences
in cell cycle progression between both cell lines, as heavy ions have an higher impact
on NF-"B activation. Therefore, cells were irradiated with 2 Gy of 48Ti ions (1000 MeV/n,
LET 108 keV/#m) and fixed at different time points after irradiation (Fig. 39). 
As already observed in the cell cycle experiment using X-rays, the distribution of cells
shifts towards the G2 phase 16 to 24 hours after irradiation. In contrast to X-rays, a lon-
ger time is required after irradiation with 48Ti ions for the return of the cell cycle
distribution to the initial situation. Even after 48 hours, both cell lines are arrested in the
G2 phase. The heavy ion experiment was conducted only once due to the limited avai-
lability of beam time, therefore the significance could not be determined. Cell cycle
progression was analysed by comparing histograms and calculating the amount of cells
in each cell cycle phase by the Flowing Software 2. From these results, no noticeable
differences of the HEK shRNA RelA cells compared to HEK-pNF-"B-d2EGFP/Neo L2
cells could be observed.
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Fig. 39: Cell cycle distribution at different time points after heavy ion exposure in the original and the
knockdown cell line. (0 Gy) Mock irradiated controls of HEK-pNF-!B-d2EGFP/Neo L2 and HEK shRNA
RelA cells; (2 Gy) irradiation with 48Ti ions (1000 MeV/n, LET 108 keV/"m) of HEK-pNF-!B-d2EGFP/Neo
L2 and HEK shRNA RelA cells. Cell cycle profiles after analysing PI-stained cells by flow cytometry are
indicated. In each histogram, the x-axis denotes the number of cells, while the y axis shows the emitted
fluorescent light and therefore the DNA#content. (TP) timepoint after irradiation. Percentages were cal-
culated by the Flowing Software 2 (by Perttu Terho).
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3.5.4 Time course of NF-!B-dependent gene expression after 48Ti irradiation
For the subsequent NF-!B target gene array, an appropriate time point for analysis of
NF-!B dependent gene expression as a response to radiation exposure had to be
determined (Fig. 40). 
Fig. 40: Relative gene expression of the NF-!B target genes GADD45beta and NFKBIA in HEK-pNF-
!B-d2EGFP/Neo L2 (A) and HEK shRNA RelA (B) cells after irradiation with different doses of 48Ti ions
(1000 MeV/n, LET 108 keV/"m). Gene expression was assessed by RT-qPCR, using GAPDH"as a re-
ference gene to normalize the results. The dotted line indicates the normal variation of expression. Mean
and standard deviation of relative gene expression are shown for three replicates.
A B
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Therefore, cells were irradiated with two different doses of 48Ti ions (1000 MeV/n, LET
108 keV/!m). GADD45beta and NFKBIA are known to be expressed NF-"B depen-
dently, thus these genes were used to investigate the time course of NF-"B dependent
gene expression by real-time RT-qPCR. GAPDH was used to normalize the results.
RNA was tested for all quality control parameters as described in 2.2.2.2. In the HEK-
pNF-"B-d2EGFP/Neo L2 cell line, expression of both genes peaks after 6 hours. The
extent of relative gene expression increases with rising doses. In the knockdown cell
line, NFKBIA regulation does not exceed the normal variation of the expression after
24 hours and GADD45beta is slightly downregulated 6 hours after irradiation. The
extent of gene regulation in HEK#shRNA RelA cells cannot be related to the radiation
dose.
3.5.5 Gene expression after X- and heavy ion irradiation in the original and in 
the RelA knockdown cell line
The aim of this experiment was to investigate the regulation of gene expression in HEK-
pNF-"B-d2EGFP/Neo L2 and in HEK shRNA RelA cells after irradiation with different
radiation qualities and doses. Therefore, cells were irradiated with X-rays and 48Ti ions
(1000 MeV/n, LET 108 keV/!m). After 6 hours, RNA was isolated and tested for inte-
grity, as described in 2.2.2.1 and 2.2.2.2. Additionally, a RT2 RNA#QC PCR Array was
run for quality control (s. 2.2.2.6). Gene expression was analysed, using the already
described target gene arrays. For samples being irradiated with X-rays, only the array
including genes from the NF-"B signaling pathway was used. For 48Ti ions, also the
customized array was applied. This was due to the fact that the X-ray experiment was
the last of all target gene array experiments. At that time it was already decided to focus
in detail on NF-"B regulated genes only.
Samples being irradiated with X-rays were exposed to the doses 0.5, 4 and 8 Gy. From
previous experiments and from results of other working groups, a higher biological
effectiveness for titanium ions was assumed, and therefore, lower doses were applied.
Doses for 48Ti ions were 0.5 and 4 Gy.
Expression profiles for both cell lines with genes more than threefold up- or downregu-
lated are shown in Table 16. A list of the results for all genes is shown in Tables 21 to
26 (s. Appendix).
In HEK-pNF-"B-d2EGFP/Neo L2 cells, the amount of upregulated genes as well as the
intensity of upregulation increases with increasing doses of X-rays. A similar effect can
be observed when regulated genes after irradiation with 4 Gy of both, X-rays and 48Ti
ions, are compared. After irradiation with 48Ti ions, the amount of upregulated genes
increases, as well as the intensity of regulation for genes that are regulated by both
radiation qualities. Highly upregulated are genes from the group of CXCL chemokines
and TNF. The same effect had already been observed after TNF--treatment.
In HEK shRNARelA cells, almost none of the genes from the expression profile of
HEK-pNF-B-d2EGFP/Neo L2 cells were regulated after exposure to low- and high
LET radiation. The only gene that appeared to be regulated in both cell lines after irra-
diation with 48Ti ions was JUN. JUN expression after exposure to X-rays and 48Ti ions
cannot be compared, as JUN was only present in the customised target gene array,
which had not been applied to X-irradiated samples. No correlation between the
amount of genes and the intensity of regulation to dose or radiation quality can be
observed in the knockdown cell line.
10 Cells were irradiated with X-rays (200 kV, 0.5, 4 and 8 Gy) and 48Ti ions (1000 MeV/n, LET 108
keV/m, 0.5 and 4 Gy). RNAwas isolated 6 hours after treatment. Differences in gene expression were
analysed using the RT2 Profiler™ PCR array (SABiosciences). The table shows all genes from both, the
customized and the NF-B signaling array, that are more than threefold up- or downregulated (bold). 162
genes were investigated. The standard error of the expression level is shown for genes occurring in both
arrays. 
Results
80
Results
81
Ta
bl
e 1
6:
Ge
ne
 ex
pr
es
sio
n i
n H
EK
-p
NF
-
B-
d2
EG
FP
/N
eo
 L2
 (g
re
en
) a
nd
 H
EK
sh
RN
A
Re
lA
 (r
ed
) c
ell
s a
fte
r t
re
at
m
en
t w
ith
 io
niz
ing
 ra
dia
tio
n1
0 . 
(L
2)
 H
EK
-
pN
F-
B
-d
2E
GF
P/
Ne
o 
L2
; (
SH
) H
EK
 sh
RN
A 
Re
lA
.
Re
la
tiv
e 
ge
ne
 e
xp
re
ss
io
n 
(
± 
SE
)
Ge
ne
X-
ra
ys
48
Ti
 io
ns
 
sy
m
bo
l
0.
5 
Gy
4 
Gy
8 
Gy
0.
5 
Gy
4 
Gy
L2
 
SH
L2
 
SH
L2
SH
L2
SH
L2
SH
BI
RC
3
3.
16
CD
83
3.
81
4.
26
CX
CL
1
4.
22
8.
94
9.
27
CX
CL
10
5.
53
21
.8
6
9.
72
CX
CL
2
4.
72
4.
41
IL
8
3.
27
7.
26
5.
71
 ±
 0
.6
4
JU
N
7.
93
3.
30
LT
A
3.
23
NF
KB
2
3.
94
NF
KB
IA
4.
23
3.
57
 ±
 0
.1
2
RE
LB
3.
05
TN
F
9.
32
8.
40
 ±
 0
.1
9
CC
L1
1
3.
22
3.
26
CD
80
4.
37
EG
R2
3.
17
JU
N
7.
93
3.
30
LT
B
4.
78
TN
FR
SF
1B
9.
69
5.
65
7.
09
TN
FS
F1
0
5.
37
3.
13
-3
.2
6
Discussion
82
4 Discussion
The aim of the project was to study the role of the NF-!B pathway in the cellular
response after exposure to high LET radiation as it occurs in space. For this purpose,
different approaches to inhibit or knockdown key components of this pathway were
taken. Motivation for this work was the hypothesis, that activation of NF-!B enhances
survival of cells exposed to space relevant radiation qualities as NF-!B is known to be
activated by fluences of accelerated heavy ions that can be reached during long-term
missions (Baumstark-Khan et al., 2005; Hellweg et al., 2011). Therefore, the NF-!B
pathway is a potential pharmacological target for mitigation of the radiation response.
Inhibition or knockdown of this pathway might reduce cellular survival after exposure
to different radiation qualities. These findings eventually facilitate risk estimation and
support the development of appropriate countermeasures.
The cell line HEK-pNF-!B-d2EGFP/Neo L2 was used as an essential tool for all expe-
riments conducted throughout this work. It enables quantification of NF-!B activation
by a reporter system measuring NF-!B-dependent d2EGFP expression (Hellweg et al.,
2003). It was shown by several research groups that the NF-!B pathway, including the
classical and the genotoxin-induced sub-pathway, is functional in HEK cells (Matsuda
et al., 2003; Hellweg et al., 2006; Muscat et al., 2007; Simon and Samuel, 2007). HEK
cells have a high NF-!B activating response to TNF-" (Aoudjit et al., 1997) which indu-
ces NF-!B-dependent gene expression in these cells (Li et al., 1998). Additionally, HEK
cells express neuronal markers similar to that of neuronal stem cells (Shaw et al., 2002;
Arnhold et al., 2008).
Few studies on high LET radiation with HEK cells exist (Ueda et al., 2001; Irarrazabal
et al., 2006; Tang et al., 2011, Sridharan et al., 2012). As HEK cells are quickly dividing
embryonic cells, they are rather radiosensitive.
4.1 Activation of NF-!B depends on LET
In order to compare activation of the NF-!B pathway via the classical and the geno-
toxin-induced sub-pathway, TNF-" was used in the irradiation experiments as activator
of the classical pathway. TNF-" is known to be a strong activator of NF-!B-dependent
gene expression. In HEK-pNF-!B-d2EGFP/Neo L2 cells, an increased binding of the
NF-!B subunit RelA to the !B binding site 15 minutes after incubation with TNF-" was
demonstrated, using an oligonucleotide-based NF-!B-ELISA (Hellweg et al., 2003).
Here, it was shown by immunofluorescence with the same cell line that translocation
of RelA into the nucleus occurs 15 to 30 minutes after treatment with TNF-".
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HEK-pNF-!B-d2EGFP/Neo L2 cells showed NF-!B-dependent d2EGFP expression
after incubation with TNF-" starting from 3 hours, and reaching its maximum after 6 to
24 hours (Hellweg et al., 2003, 2005;#Baumstark-Khan et al., 2005). Here, TNF-" and
ionizing radiation were used to activate NF-!B, resulting in a maximum d2EGFP
expression 16 to 18 hours after induction for both agents (Fig. 20). This time point was
determined to measure NF-!B activation by many different radiation qualities and doses
when maximal response can be expected. The kinetics of NF-!B activation in response
to X-rays and carbon ions additionally show that heavy ions induce a stronger NF-!B
activation than X-rays. NF-!B activation is activated by lower doses of carbon ions com-
pared to X-rays, and the maximal response is higher and observed at a lower dose
(10.9 Gy carbon ions versus 16 Gy X-rays). More data supporting these findings have
recently been published by the Cellular Biodiagnostics group (Hellweg et al., 2011).
Further, NF-!B activation is dose-dependent, due to the increasing DNA damage poten-
tial of increasing fluences.
Subsequently, the potential to activate NF-!B of several energetic heavy ions of differ-
ent LET was studied (Fig. 21 A). A first hint that heavy ions are stronger NF-!B
activators than low-LET radiation was published in 2005: high LET 36Ar ions (272
keV/$m) had a higher potency to activate NF-!B-dependent d2EGFP expression in
HEK cells than X-rays (Hellweg et al., 2005; Baumstark-Khan et al., 2005). A rapid and
persistent NF-!B activation after exposure to 56Fe ions was shown in human monocytes
already at low doses of 0.35-1.4 Gy (Natarajan et al., 2002), indicating a high RBE of
56Fe ions for this biological endpoint (Groesser et al., 2007). Further, exposure to accel-
erated 12C and 16O ions influences expression of NF-!B itself in Chinese Hamster V79
cells (Mitra et al., 2004, 2005), while it remains unclear which NF-!B subunit was ana-
lyzed in those studies. 
A maximum in biological efficiency in cell killing was determined in a LET range of 90-
200 keV/$m (Thacker et al., 1979; Ainsworth et al., 1983; Kraft et al., 1989). Concerning
NF-!B activation, the maximal activation was observed for heavy ions with an LET of
90-300 keV/$m, with a maximal RBE of ~ 9 for argon ions with an LET of 272 keV/$m
(Hellweg et al., 2011). Results in this work complement these data by showing that NF-
!B dependent d2EGFP expression rises quickly with increasing doses after irradiation
with heavy ions within an LET range of 34 to 92 keV/$m. For high doses of 16 to 20
Gy, up to 60 % of the irradiated cell population express the reporter d2EGFP(+), indicat-
ing NF-!B activation in the majority of the population. On the contrary, 58Ni ions with a
very high LET of 906 keV/$m activate NF-!B in only up to 25 % of the irradiated cells,
and much higher doses are required to induce a significant increase of d2EGFP(+) cells
Discussion
84
to the double of the background (ca. 8 Gy). This might be explained by the !overkill"
effect (Mehnati et al., 2005) that was observed also for other biological endpoints. This
overkill effect observed with ions with an LET above 500-1000 keV/#m is explained by
wasted energy which does not contribute to biologically significant damages. Such a
high LET increases the degree of ionization and DNA damage clustering without further
increasing e.g. cell death or mutations induction. According to the formula to convert
fluence to energy dose (equation 19), LET contributes to the energy dose, and a very
high LET results in higher energy doses, which energy is partly !wasted" in terms of bio-
logical effectiveness. At an LET resulting in maximal RBE, it is proposed that the
probability is highest that one single charged particle causes a DSB, which is the basis
for most biological effects. The degree of DNA lesion complexity correlates with increas-
ing LET (Tilly et al., 2002). This overkill effect is also present for NF-$B activation, as
shown for nickel ions in this work. For lead ions with very high LET (~ 9700 keV/#m)
(Hellweg et al., 2011), the RBE even drops below 1.
NF-$B can be anti-apoptotic and is involved in regulation of cellular survival and proli-
feration. Inhibition of NF-$B activation is associated with a tendency towards apoptosis
(Gao et al., 2004). In this work, NF-$B dependent d2EGFP expression was correlated
with survival (Fig. 21 B). NF-$B activation and the cell killing effect decrease with very
high LET (58Ni ions, 75 MeV/n), resulting in better survival compared to heavy ions with
an LET below 100 keV/#m. It is assumed that this effect is due to the decrease in the
lethal damage per unit dose, resulting in decreased RBE for cell killing (Mehnati et al.,
2005). Presence of non-hit cells among hit cells is one of the significant features for
exposure to very high-LET heavy ions. The relationship of NF-$B activation and survival
seems therefore quite complex in the very high LET range that results in overkill effects,
with the moderate extent of NF-$B activation giving no complete explanation for the
better survival of 58Ni ion exposed HEK cells compared to exposure with ions of a lower
LET. The extremely inhomogeneous dose distribution on the microscopic level, resul-
ting in very high doses at the sub-micrometer range with areas without any exposure
might explain the apparently better survival after 58Ni ions exposure.
The survival curves resulting from heavy ion exposure do not show the typical shoulder
formation, which is usually observed in response to exposure to low LET ionizing radia-
tion (Bird and Burki, 1975; Yang et al., 1977; Stoll et al., 1995; Durante et al., 1995). In
the experiments described here, the LET was high enough to abolish shoulder forma-
tion, which means that cells are not capable to repair potentially lethal DNA damages
adequately. This purely exponential course of the survival curves obtained after heavy
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ion exposure is in line with the results from other research groups (Barendsen et al.,
1963; Stoll et al., 1995; 1996).
4.2 Chemical inhibition of the NF-!B pathway
Several chemical inhibitors were tested for their cytotoxicity and ability to suppress NF-
!B activation by several agents in HEK-pNF-!B-d2EGFP/Neo L2 cells in order to
investigate the effect of an impaired NF-!B pathway on several biological endpoints.
The effects of the ATM"inhibitor KU-55933 and the proteasome inhibitor MG-132 are
shown and discussed in this work. Inhibition with Parthenolide, Capsaicin, Isohelenin
and caffeic acid phenethyl ester (CAPE), all targeting different elements of the NF-!B
pathway, was either insufficient or cytotoxic and results are not shown. 
Cytotoxicity of the inhibitors was tested by means of the MTT test to determine the
appropriate, non-cytotoxic concentration for further studies. The MTT"test indirectly
measures cell viability by quantification of mitochondrial enzymatic activity.
4.2.1 NF-!B activation by ionizing radiation is ATM dependent
TNF-# was used as a positive control to activate NF-!B and to determine the inhibitor
concentration needed to suppress NF-!B signaling. As the ATM"inhibitor KU-55933 was
not able to suppress NF-!B activation induced by TNF-# within its non-cytotoxic range,
a suitable concentration from literature (Hickson et al., 2004) was used in irradiation
experiments. KU-55933 is specific for ATM with respect to inhibition of other related
kinases such as DNA-dependent protein kinase (DNA-PK) or phosphatidylinositol 3$-
kinase (PI3K) which required a ~ 200 times higher concentration for their inhibition
(Hickson et al., 2004). Results showed that while it was not possible to suppress TNF-
# induced NF-!B activation, KU-55933 was able to suppress ionizing radiation induced
NF-!B activity completely. Increasing doses of X-rays and 36Ar ions were used to induce
NF-!B, showing its dose and LET dependency, as the percentage of d2EGFP(+) cells
increased with increasing doses and 36Ar ions had a higher impact on NF-!B dependent
d2EGFP expression than X-rays. 
Involvement of ATM in the induction of NF-!B-dependent gene expression after expo-
sure of human cells to X-rays (Ruscher, 2008) and to heavy ions had been shown in
previous projects of the Cellular Biodiagnostics working group. These results support
the assumption that ionizing radiation, including high-LET heavy ions, activates the
genotoxic stress induced NF-!B pathway and proofs that NF-!B activation induced by
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ionizing radiation is strictly ATM dependent. ATM foci form quickly in the nuclei of human
cells after exposure to carbon or iron ions and are believed to facilitate or initiate DNA
DSB repair by NHEJ and HR (Xue et al., 2009; Takahashi et al., 2008). ATM was
recently shown to be activated in human cells to a higher extent by carbon ions (LET
290 keV/!m) than by low-LET "-rays (Ghosh et al., 2011). This stronger ATM phospho-
rylation after heavy ion exposure might be important for the strong NF-#B activation
that was observed in the LET range of 90-300 keV/!m. 
In contrast, TNF-$ induced NF-#B activation was not impaired by KU-55933, as ATM
is not involved in the classical pathway, which is activated by TNF-$.
4.2.2 I!B degradation by the proteasome is essential for TNF-" and ionizing
radiation induced NF-!B activity
Incubation of HEK cells with the proteasome inhibitor MG-132 revealed that already at
low concentrations cells reduced the viability to 80-90 %. This viability level was still
well suitable for the irradiation experiments, but shows the involvement of the protea-
some not only in I#B degradation but in numerous processes, which are essential for
viability of the cell.
Within non-cytotoxic concentrations (viability above 80%), MG-132 was able to sup-
press TNF-$ and ionizing radiation induced NF-#B activity, showing that I#B
degradation by the proteasome is an essential step in both, the genotoxic stress and
the TNF-$ induced pathway.
However, it has to be considered, that disturbing proteasome functions with MG-132
leads to the loss of regulation of essential functions within the cell. MG-132 is effective
in inhibiting the NF-#B pathway and can thus be used for heavy ion experiments.
Nevertheless, as MG-132 not only inhibits I#B degradation but degradation of nume-
rous proteins, the observed biological outcomes cannot be ascribed to NF-#B inhibition
alone.
In conclusion, MG-132 and KU-55933 are useful to study the involvement of different
elements in the NF-#B pathway as it is activated in the cellular response to heavy ion
exposure. The results presented here show the relevance of ATM kinase and the pro-
teasome in the NF-#B activation that is induced during the cellular response to ionizing
radiation, including high-LET heavy ions. However, these chemical inhibitors are not
NF-#B specific.
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4.3 Knockdown of RelA by RNA interference (RNAi)
To inhibit the NF-!B pathway more specifically, RNAi was used to knockdown the RelA
subunit for subsequent studies with space-relevant radiation.
In this work, transfection with a shRNA"vector was chosen to develop a stable knock-
down cell line. This allows studying the effect of silencing gene expression without
transfecting cells prior to every experiment, which is of special importance when expe-
riments are conducted at heavy particle accelerators, where the procedure of
experiments is often unpredictable and experiments have to be adapted to the prevai-
ling circumstances. A stably transfected cell line provides a long-term knockdown,
permanently silencing the gene of interest, which cannot be achieved in repeated tran-
sient transfection assays. It eliminates experimental variation, especially when it is used
not only for one unique experiment but repetitively, due to investigations under varying
conditions. Additionally, transient transfection with siRNA does not allow transfected
cells to be identified due to a lack of selection markers. Therefore, siRNA transfected
cells cannot be enriched and transfection efficiency cannot be determined. In such
experiments, the knockdown level has to be verified for every transfection by RT-qPCR.
Stable transfection was performed with HEK-pNF-!B-d2EGFP/Neo L2 cells which were
developed by the Cellular Biodiagnostics working group several years ago and evalua-
ted extensively using different agents for activation of NF-!B (Hellweg et al., 2006),
including ionizing radiation (Hellweg et al., 2005; Baumstark-Khan et al., 2005). In this
cell line, NF-!B can be induced and the resulting reporter gene expression can be
quantified by flow cytometry. These cells allowed easy pre-screening of knockdown effi-
ciency by means of the NF-!B-dependent d2EGFP expression. The d2EGFP
fluorescence in response to TNF-# was expected to be reduced or completely abolis-
hed in case of successful knockdown. 
HEK-pNF-!B-d2EGFP/Neo L2 cells already contain a Neomycin-resistance marker,
therefore a SureSilencing™ shRNA Plasmid containing a Hygromycin-resistance mar-
ker for selection of stably transfected cells was chosen.
The NF-!B dimer that is activated by TNF-# and by ionizing radiation as X-rays and
accelerated carbon ions was previously shown to contain RelA, therefore, it was deci-
ded to knockdown this NF-!B subunit (Hellweg and Baumstark-Khan, 2007a; Hellweg
et al., 2009; 2011b).
Four individual shRNA plasmids were tested for their ability to suppress RelA expres-
sion. The knockdown level of each transfected cell population was measured
respectively. As each the initially transfected cell populations were polyclonal, including
cells with both, high and low knockdown levels depending on the integration site, the
Discussion
88
overall knockdown efficiency for each population only reached average knockdown
levels of ~ 40 to 50 %. This amount is defined as !mediocre" in the SABiosciences eva-
luation sheet. A knockdown level of # 70 % has to be achieved for gene suppression
to be defined as !successful".
Cells were sub-cloned to select for single integration events. This allows to achieve a
more consistent and higher knockdown level, as cells grown from a single clone are
assumed to have the same integration site of the plasmid. The greatest knockdown
(83.1 %) was reached for the cell line growing from clone 4-9, which was later named
!HEK$shRNA$RelA". 
The cell line !HEK$shRNA control", which had been stably transfected with a negative
control shRNA$vector, allows to create a baseline for measuring mRNA knockdown effi-
ciency. Further, it is needed to control for nonspecific side effects caused by stable
transfection.
The knockdown was verified on several levels. Measurement of steady state mRNA
levels by real-time RT-qPCR is very sensitive and the most direct way to proof the
decreasing amount of the RelA gene transcript. Still, it does not predict expected protein
levels, as mRNA can be translated several times and additionally modified post-tran-
scriptionally to enhance or reduce its stability. Residual mRNA might be sufficient to
compensate for the loss of the high percentage of mRNA, which has been degraded.
To show that RNAi also has an impact on translation rate, the knockdown has to be
shown on protein level and in the case of a transcription factor as NF-%B, on the level
of gene induction via the %B site. 
Knockdown verification on the protein level was performed by immunofluorescence.
This allowed visualization of RelA within the cell, confirming the substantial decrease
in RelA protein by the much lower fluorescence signal in HEK$shRNA$RelA cells com-
pared to the original cell line. Also, the cytoplasmic localization of RelA in unstimulated
cells was confirmed.
The loss of transcriptional activation by NF-%B in RelA knockdown cells was demons-
trated on reporter protein level by measuring d2EGFP expression in response to TNF-&
and ionizing radiation. Results show a minor residual ability of activating NF-%B, which
can be ascribed to the remaining ~ 17 % of RelA mRNA, which is not degraded.
HEK$shRNA control cells show that induction of d2EGFP dependent NF-%B expression
is still measurable and stable transfection does not affect the reporter system.
In HEK shRNA control cells the amount of d2EGFP(+) cells reaches ~ 70 % after TNF-
& treatment and thereby slightly exceeds the expression of green fluorescence
compared to the original HEK-pNF-%B-d2EGFP/Neo L2 cell line. This might be due to
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further selection of cells during incubation with hygromycin, which by chance are slightly
more responsive to NF-!B activating agents.
4.4 Characterization of HEK shRNA RelA cells
4.4.1 Changes in growth and cell cycle progression in absence of RelA
NF-!B is considered to be an important regulator of cellular proliferation (Li and Verma,
2002; Hayden and Ghosh, 2004). Therefore, to reveal possible differences in growth
behavior between the original and the cell line HEK shRNA RelA, growth curves of both
cell lines were compared. Both curves showed the typical division into lag phase, expo-
nential growth (log) phase and stationary phase. Though, the cell number of HEK
shRNA"RelA cells initially decreases in lag phase, and cells enter the log phase only
after 48 to 72 hours. There is no initial decrease in cell number in HEK-pNF-!B-
d2EGFP/Neo L2 cells, which enter log phase already after 24 to 48 hours. Further,
knockdown cells seem to grow less dense in the stationary phase compared to the ori-
ginal cell line. This supports the findings about the essential role of NF-!B in cell
proliferation. 
As it was shown in literature, defects in the NF-!B pathway are related to changes in
proliferation and growth behavior (Baichwal and Baeuerle, 1997; Sonenshein, 1997).
NF-!B inhibition by BAY11-7082 leads to decreased lymphocyte proliferation (Zhu et
al., 2008) and in a skeletal differentiation model, lack of NF-!B was related to"accele-
rated differentiation, assuming that NF-!B plays a role in proliferation while inhibiting
differentiation (Guttridge et al., 1999) which normally results in reduced or stopped cell
division. In line with this, it was shown that sustained myoblast proliferation and inhibi-
tion of myogenic differentiation is NF-!B-dependent and that inhibition of myogenesis
is specific to RelA (Langen et al., 2004; Dahlman et al., 2009).
In contrast, additional findings indicate that epidermal RelA deficiency leads to increa-
sed proliferation in the epidermis of mice (Zhang et al., 2003) and that NF-!B subunits,
including RelA, inhibit keratinocyte growth (Seitz et al., 1998; 2000). Though, it was
demonstrated, that RelA induces growth inhibitory genes in epidermal cells but not in
other cell types (Hinata et al., 2003).
Results in this work show that cell proliferation is delayed in absence of NF-!B. As it
will be discussed later, loss of NF-!B might lead to impaired cell-cell communication. A
prerequisite for this so-called bystander effect has been shown to be close proximity
between cells (Gerashchenko and Howell, 2003). Cells were seeded in low density at
the beginning of the growth curve experiments, which might explain the delay in proli-
feration in the RelA knockdown-cell line.
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According to literature, NF-!B transmits growth signals directly to key regulators of the
cell cycle (Hinz et al., 1999). Primary fibroblasts lacking NF-!B activity exhibit reduced
proliferation rates in conjunction with lower cyclin D1 levels, revealing the role of cyclin
D1, a key regulator of G1 checkpoint control and progression from G1 to S-phase, for
proper cell growth control. Loss of NF-!B affects cell cycle progression as NF-!B regu-
lates expression of cyclin D1 (Guttridge et al., 1999; Hinz et al., 1999). It was shown
that suppression of NF-!B leads to slowed cell cycle progression and that this reduction
can be recovered via transfection and expression of a cyclin D1 containing plasmid
(Guttridge et al., 1999; Hinz et al., 1999). From all NF-!B subunits, RelA has specifically
been associated to be a transcriptional activator of cyclin D1 gene expression (Dahlman
et al., 2009). 
In this work, a comparison of the distribution of cells within the cell cycle phases for
both cell lines revealed no differences in the untreated state (without activation of the
NF-!B pathway), suggesting a comparable regulation of cell cycle progression with and
without RelA. As it was shown that the NF-!B subunit p52 (NF-!B2) can also regulate
cyclin D1 (Westerheide et al., 2001; Rocha et al., 2003; Schumm et al., 2006), it might
substitute for the lack of RelA.
4.4.2 Changes in NF-!B target gene expression in RelA knockdown cells
To reveal changes in gene expression between HEK shRNA RelA and HEK-pNF-!B-
d2EGFP/Neo L2 cells, gene expression under different conditions was investigated with
the help of two different RT2 Profiler™ PCR Arrays. Overall, 162 genes, involved in cell
cycle control, apoptosis, DNA damage, stress and toxicity and NF-!B signaling were
investigated. In the course of these studies, a down- or upregulation specifically of NF-
!B target genes emerged, therefore, expression studies finally focused on this pathway.
Ct values indicating the amount of a specific mRNA were compared for the RelA knock-
down cells and the HEK-pNF-!B-d2EGFP/Neo L2 cells. In a cautious data
interpretation, the threshold for significant up- or downregulation was set to -3 or +3,
respectively, to avoid misinterpretation of physiological fluctuation of mRNA levels. First,
genes that are regulated more than threefold in the untreated knockdown cell line com-
pared to the untreated original cell line are discussed here.
CCND1 (Cyclin D1) is downregulated (-3.7) in absence of RelA, confirming it being tar-
geted by RelA, as discussed previously. Cyclins are positive regulators of cell cycle
entry, regulating progression from G1 to S phase. Overexpression of cyclin shortens
the duration of G1 phase, as a high level of cyclin D1 is needed for transition to S
phase. Increased proliferation in fibroblasts, regulated by NF-!B mediated cyclin D1,
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leads to delayed differentiation (Guttridge et al., 1999). Downregulation of cyclin D1
accelerates exit from the cell cycle and inhibits proliferation. Decreased cyclin D1 levels
are important for proper initiation of keratinocyte differentiation and cyclin D1 knock-
down in SCC9 cells enhanced loss of colony-forming ability (Nishi et al., 2009), which
was also shown in this work by survival experiments. Downregulation of cyclin D1 by
knocking down RelA therefore gives a possible explanation why proliferation of HEK
shRNA!RelA cells is delayed in growth experiments.
IL8 (Interleukin 8, CXCL8) is severely downregulated (-8.1) in HEK!shRNA RelA cells.
This cytokine is part of the CXC chemokine family and acts as proinflammatory medi-
ator, further activating proinflammatory cytokines in a positive feedback loop. It attracts
and activates neutrophils (Baggiolini et al., 1989), causing them to migrate towards the
site of infection. It was shown for several cell types, that the NF-"B binding site is
essential for transcription of IL8 (Stein and Baldwin, 1993; Wu et al., 1997; Elliot et al.,
2001). Kunsch et al. (1994) showed this especially for the subunit RelA. IL8 secretion
is increased in response to oxidative stress, mediated by TNF-#, which further induces
RelA-binding to the binding site of the IL8 promoter (Vlahopoulos et al., 1999).
JUN (JUN!oncogene; c-Jun) is the only gene that is more than threefold (4.3) upregu-
lated in RelA knockdown cells. It is one of the main members of the AP-1 family,
activating oncogenes. c-Jun affects cell proliferation, migration and invasion and, like
NF-"B, actively participates in tumorigenesis (Galardi et al., 2011). It was shown that
both, NF-"B and c-JUN activity are required for activating macrophage inflammatory
protein (MIP-2, CXCL2), a CXC chemokine in mice (Kim et al., 2003). It directly inter-
acts with RelA, which results in synergistic transcriptional activity via the "B binding
sites (Yang et al., 1999). Upregulation of the JUN!oncogene might be a regulatory
mechanism to compensate for the loss of RelA.
RELA (V-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa
light polypeptide gene enhancer in B-cells 3, p65) was expected to be downregulated,
as it was chosen as the target gene for RNAi. Its downregulation was shown to be -6.2,
meaning that there was six times less RelA mRNA in the HEK!shRNA RelA cells com-
pared to the HEK-pNF-"B-d2EGFP/Neo L2 cells, resulting in a reduction of the
expression level of 100 % to 17 % with a downregulation of 83%. This knockdown level
is in line with the 83.1 % observed using the RelA primer assays before.
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TNF (Tumor necrosis factor; TNF-!) is a cytokine and key mediator of inflammation that
can contribute to carcinogenesis through the activation of NF-"B (Pikarsky et al., 2004;
Balkwill, 2009). It binds to the receptors TNF-R1 and TNF-R2. TNF-R1 is expressed in
most tissues, while TNF-R2 is found only in cells of the immune system. In addition to
NF-"B, TNF-! can activate the MAPK pathway, which involves activation of the pro-
apoptotic transcription factor c-Jun. A third, death signaling, pathway is induced by
binding of TNF-! to TNF-R1 (Gaur and Aggarwal, 2003). Though TNF-! can induce
apoptosis, its major role is its involvement in inflammatory processes. Its apoptotic
effect is often masked by the anti-apoptotic effects of NF-"B. In many cell types, TNF
has no apoptotic effect due to its parallel triggering of a signaling pathway that activates
NF-"B (Chen and Goeddel, 2002). TNF-! activates inflammation by inducing a proin-
flammatory cytokine cascade, mediated through expression of IL8 (Vlahopoulos et al.,
1999). It induces a delayed ROS-dependent signaling pathway that is required for NF-
"B transcriptional activation. 
In general, cytokines are downregulated in HEK#shRNA#RelA cells, indicating their
restriction to transcriptional control by NF-"B (RelA).
After treating both cell lines with TNF-!, a clear upregulation of CXC chemokine genes,
including CXCL1, CXCL10, CXCL2 (MIP-2) and CXCL8 (IL8) was observed in HEK-
pNF-"B-d2EGFP/Neo L2 cells, but not in HEK shRNA#RelA cells. CXC chemokines are
one out of four groups within the chemokine family of small cytokines. Chemokines are
secreted by infected cells and induce chemotaxis or migration of cells, especially of
neutrophils, by acting as chemoattractants. Neutrophils act as first responders of inflam-
matory cells to migrate towards site of inflammation. In wound healing, damaged cells
cause an increase of chemokine concentration, leading to movement of cells to site of
damage. In contrast, loss of chemokine induction leads to dysfunctional cell migration
and therefore impaired wound healing. Models of mycobacterial infection have shown
the essential role of TNF in the early induction of chemokines and subsequent recruit-
ment of leukocytes (Roach et al., 2002). Here, in TNF-/- cells induction of chemokines
and cellular recruitment was delayed. CXCL2 (MIP-2), which is upregulated after TNF-
! treatment, was also shown to be activated in vitro by M. tuberculosis (Rhoades et al.,
1995). It was recently published, that NF-"B inhibitor Curcumin inhibits prostate cancer
metastasis by targeting the inflammatory cytokines CXCL1 and CXCL2 (Killian et al.,
2012). Cells lacking RelA#might thus be susceptible to infections, but less prone to
evolve metastatic potential after neoplastic transformation.
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As expected, TNF-! treatment induced high upregulation (13.9) of TNF, as TNF-!, after
being released as a response to immunological stimuli, acts as a positive autocrine
feedback signal to augment NF-"B activation (Coward et al., 2002). In the knockdown
cell line, no upregulation of TNF was observed, as NF-"B is a key transcription factor
involved in the synthesis of TNF-! (May and Ghosh, 1998).
Upregulation of NFKBIA (encoding I"B!) in the original cell line was expected as well,
as in addition to increasing the transcription of cytokines and adhesion proteins, NF-
"B also increases the transcription of the inhibitor I"B, thus leading to its own
inactivation and subsequent termination of the response (Baldwin, 1996).
None of the genes upregulated in HEK-pNF-"B-d2EGFP/Neo L2 cells was induced in
the knockdown cell line. Instead, downregulation of a few NF-"B target genes only
slightly exceeding the threshold of -3 was observed, including CCR5, EXO1, IL10, MT3
and SOD3. CCR5 is a chemokine receptor targeted by NF-"B (Liu et al., 1998). Exonu-
clease 1 (EXO1) is involved in DNA damage signaling (Souto-Carneiro et al., 2008).
The NF-"B target gene interleukin 10 (IL10) is known as immunsuppressive cytokine
and controls the overproduction of inflammatory cytokines (Cao et al., 2006). Its down-
regulation might therefore balance the loss of RelA in HEK shRNA RelA cells, which
would induce proinflammatory genes in case of appropriate stimuli. Methallothionein
(MT3) might function as a negative regulator of NF-"B (Sakurai et al., 1999). Its down-
regulation probably antagonizes the RelA knockdown in HEK shRNA RelA cells. For
superoxide dismutases (e.g. SOD3) it was shown, that RelA controls its transcription
mediated by TNF-! (Maehara et al., 2000).
4.5 The role of RelA in response to radiation of different LET
While the NF-"B pathway has been studied intensively in regard to different aspects
throughout more than two decades, not much is known about its role in response to dif-
ferent radiation qualities, especially to high LET particles. In this project, the HEK
shRNA RelA#cell line had been established to conduct irradiation experiments with cells
lacking the NF-"B subunit RelA.
Due to the limited number of beam time available at particle accelerators, only few, in
maximum four heavy ion experiments were run per year. Most experiments were the-
refore previously established and tested using the X-ray facility at DLR in Cologne. This
additionally provides the opportunity to finally compare biological outcomes after expo-
sure to different LET, and in this context, X-rays serve as a low-LET reference radiation.
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4.5.1 Cell cycle progression after irradiation
Ionizing radiation is known to perturb cell-cycle progression in a dose-dependent man-
ner, thereby causing delay in proliferation (Park et al., 2002; Gerashchenko et al.,
2004). Distribution of cell cycle phases was analyzed at several time points after irra-
diation with X-rays and 48Ti ions (Fig. 38 and Fig. 39). Both cell lines,
HEK-pNF-!B-d2EGFP/Neo L2 and HEK shRNA RelA, exhibit a significant G2 arrest
after ~ 16 to 24 hours, independent of the radiation type, indicating a block in G2 phase,
allowing more time for DNA repair. This was expected for HEK-pNF-!B-d2EGFP/Neo
L2 cells, as they have been characterized by a significant G2 phase arrest in response
to irradiation (Hellweg, 2012). X-ray experiments show that cell cycle arrest depends
on dose, as G2 arrest is more severe after irradiation with 4 Gy compared to 2 Gy. Also,
the time of recovery to the original state of cell cycle distribution was delayed with
increasing doses of X-rays. While cell cycle distribution has come back to the unin-
duced state ~ 32 to 40 hours after irradiation with 2 Gy of X-rays, a reduced number of
cells in G1 phase was still observed 48 hours after X-irradiation with 4 Gy. 
The response to higher LET radiation is shown after 48Ti ion irradiation. Comparing cell
cycle distribution after irradiation with different radiation qualities, 2 Gy of 48Ti ions cause
a more severe cell cycle arrest as well as a prolonged recovery time than 2 Gy of X-
rays, with ~ 40 % of the cell population remaining in G2 compared to 10-15% of the
mock-irradiated cells.
Cell cycle arrest is induced only after several hours, as transcription of cyclin kinase
inhibitors is necessary. The duration of G2 arrest depends on the amount and severity
of DNA"damage. During G2 phase, the DNA repair machinery can use the intact sister
chromatid as a template and induce HR (Shrivastav et al., 2008). With increasing dose
and LET, DNA"damage becomes more severe and complex, which explains its influ-
ence on G2 arrest.
Absence of NF-!B was associated with a delay in cell cycle progression in G1 (Bargou
et al., 1997; Grumont et al., 1998). However, as it was already observed in unirradiated
cells, none of the cell cycle experiments performed in this work showed a difference
between both cell lines. This indicates that cell cycle progression in the G1 phase does
not exclusively depend on RelA controlled expression of cyclin D1 in HEK cells. Instead,
other transcription factors such as AP-1 or other NF-!B subunits could compensate the
missing RelA. Another possible explanation is that cyclin E and cyclin-dependent kinase
2 (CDK2) alone without the CDK4-cyclin D complex could initiate the transition from
the G1 to the S-phase of the cell cycle (Wilson et al., 2004).
Furthermore, induction of a G2 arrest after radiation exposure is not affected by the
absence of RelA and the resulting downregulation of cyclin D1 expression. This is in
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line with the general view that the complex of CDK1 and cyclin B is responsible for the
transition of cells from the G2 phase to mitosis, and that cyclin D1 is not involved in
radiation-induced G2 arrest (Wilson et al., 2004; Metting and Little, 1995).
4.5.2 Survival ability after irradiation 
Cellular survival after exposure of HEK-pNF-!B-d2EGFP/Neo L2 and HEK"shRNA
RelA cells to ionizing radiation was measured by colony forming ability test. Both cell
lines were irradiated with X-rays (Fig. 36), a low LET reference radiation, and high LET
64Ni ions (LET 175 keV/#m; Fig. 37), which is within the range of maximum biological
efficiency (Thacker et al., 1979; Ainsworth et al., 1983; Kraft et al., 1989).
Comparing survival curves of X-ray experiments with HEK-pNF-!B-d2EGFP/Neo L2
cells to those using heavy ions, data in this work confirms the findings, that doses
needed to achieve a clonogenic killing effect decrease with increasing LET. Here, high-
LET radiation exposure of HEK-pNF-!B-d2EGFP/Neo L2 cells results in purely
exponential survival curves. Survival curves of different cell types show no shoulder
formation after heavy ion exposure, depending on LET (Bird and Burki, 1975; Durante
et al., 1995; Hellweg et al., 2011). Absence of the shoulder means that also at low
doses, cells are not able to repair DNA"damage adequately. The same was shown for
HEK"shRNA"RelA cells. Exposure to 64Ni ions results in a much steeper curve than X-
irradiation lacking shoulder formation. After exposure to X-rays, the survival curve of
HEK"shRNA"RelA cells shows a smaller shoulder compared to HEK-pNF-!B-
d2EGFP/Neo L2 cells.
Inhibition of NF-!B activation is associated with a tendency towards apoptosis (Gao et
al., 2004) and therefore, as expected, RelA"knockdown cells showed a significantly
increased radiosensitivity after X-ray exposure compared to HEK-pNF-!B-
d2EGFP/Neo L2 cells. Several studies have shown the impact of NF-!B inhibition on
sensitivity towards low-LET radiation (Pajonk et al., 2000; Raju et al., 1999; Raju et al.,
1997; Yang et al., 2000). It was published that NF-!B activation promoted survival in
mice and primates being irradiated with lethal doses and that radiosensitive tissues can
be protected against radiation damage through Toll-like receptor 5 (TLR5)-dependent
activation of NF-!B using derivatives of bacterial flagellin (Burdelya et al., 2008). 
Upon irradiation, DNA DSB are induced, resulting in ATM activation that then triggers
amongst others NF-!B signaling. At the same time, ATM activates the pro-apoptotic
transcription factor p53, which competes with NF-!B for interaction with transcriptional
co-activators (Ravi et al., 1998; Wadgaonkar et al., 1999). In absence of NF-!B, pro-
apoptotic signaling therefore dominates, as seen here. However, in other cellular
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settings, NF-!B is required for p53 pro-apoptotic signaling (Ryan et al., 2000). A sus-
tained NF-!B activation could permit cells that have accumulated radiation-induced
DNA"damage, to escape elimination by apoptosis (Jung and Dritschilo, 2001).
Surprisingly, the effect of an increased radiosensitivity in absence of RelA was not
observed after exposure to 64Ni ions. Here, survival curves of both cell lines showed
the same progression. Several possible reasons might explain this effect. In contrast
to the X-ray experiment, where cells have been seeded immediately, due to technical
reasons, cells were seeded only 4 hours after irradiation in the heavy ion experiment.
This time frame might have given knockdown cells the possibility to repair DNA
damage. It was shown that HeLa cells repair most strand breaks caused by oxidative
DNA damage within 1 h (Collins et al., 1995). Phosphorylated histone H2AX (#-H2AX)
foci, indicating sites of DSBs, continue to grow in size for about 1 hour after exposure
to X-rays and then disappear slowly over time. #-H2AX is proposed to recruit repair
factors to sites of DNA damage (Celeste et al., 2003). 
Faster recruitment kinetics of repair proteins after high LET irradiation was attributed
not only to a higher number of DSBs, but also to a higher spatial density of the DSB
clusters (Hable et al., 2012). Another group reports in a recent study that foci are for-
med twice as fast after irradiation with 2 Gy of X-rays compared to 0.1 Gy (Neumeier
et al., 2012). According to this data, repair mechanisms are accelerated depending on
the complexity and amount of DNA"damage. Alternatively, the given time frame might
have activated repair mechanisms to compensate for the loss of RelA.
Additionally, the type of DNA"damage differs between high and low LET"radiation and
therefore, repair mechanisms might differ after X-irradiation and heavy ion exposure. 
As it is known, densely ionizing HZE particles cause a higher proportion of direct than
indirect DNA"damage, due to direct ionization, with complex clusters of DNA damages
with distinct protein signaling kinetics compared with low LET radiation like X-rays. Ioni-
zing radiation can also induce DNA damage by generating ROS. It has been suggested
that the radiolytic formation of an oxygenated microenvironment around the tracks of
high-LET heavy ions is an important factor in their enhanced biological efficiency (Mee-
sungnoen and Jay-Gerin, 2009). Probably these different kinds of damage induce
distinct repair mechanisms.
Little is known about the involvement of NF-!B in DSB repair. Recently, it was shown
that NF-!B strongly stimulates the removal of DSB by enhancement of homologous
recombination (HR; Volcic et al., 2012). Further data suggest a link between inhibition
of NF-!B and inhibition of DSB repair that leads to enhancement of X-ray-induced cell
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killing in vitro in non-small-cell lung cancer cells (Estabrook et al., 2011). It is known
that ATM responds to DSBs via the activation of NF-!B. Additionally, ATM can protect
cells from ROS accumulation by promoting NADPH production and the synthesis of
nucleotides required for the repair of DSB. ATM promotes the anti-oxidant response
and DNA repair through regulating the pentose phosphate pathway (PPP; Cosentino
et al., 2011). It might be possible, that"repair of complex DNA damage caused by heavy
ions is not dependent on NF-!B, and therefore no differences are seen after exposure
to 64Ni ions.
Another explanation for the missing effect of RelA knockdown might be the high LET
which is in the range of the highest observed biological efficiency. The cell killing effect
in the LET range of 100-200 keV/#m is already very high, so that disturbed cellular sig-
naling pathways might not be able to further increase cell killing. This was observed for
the pro-apoptotic p53 in some cell systems: apoptosis was independent of the p53 sta-
tus (Mori et al., 2009; Takahashi et al., 2004).
Furthermore, the gene expression profile described below will give more insight in the
differences in the role of NF-!B in cellular survival after exposure to X-rays and heavy
ions, even though these experiments had to be performed with another heavy ion (48Ti
instead of 64Ni ions).
4.5.3 Target gene expression after irradiation 
NF-!B was shown to translocate into the nucleus 15 to 30 minutes after induction. To
find the appropriate time point for investigation of its target gene expression, the expres-
sion kinetics of the NF-!B target genes GADD45$ and NFKBIA was measured after
exposure to 48Ti ions (1000 MeV/n, LET 108 keV/#m). Six hours after irradiation, gene
expression showed its maximum, with the expression level increasing with augmenting
doses. GADD45$, which is regulated by NF-!B, is a cell cycle regulating gene which
is upregulated upon environmental stress like ionizing radiation and regulates cell
growth (Liebermann and Hoffmann, 2008). NFKBIA codes for the NF-!B inhibitor I!B%.
Its upregulation indicates its function of negatively regulating NF-!B in order to prevent
its overexpression. In HEK"shRNA"RelA cells, none of these genes was upregulated.
4.5.3.1 Target gene expression depending on radiation quality and quantity
The target gene array, investigating 162 genes after X- and 48Ti ion irradiation, showed
that NF-!B-dependent gene expression does not only depend on dose, but also on
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LET. Radiation induced gene expression depending on LET!was shown in literature
(Nelson et al., 2002). The extent of gene expression increases with increasing doses.
Further, the degree of regulation is significantly stronger after 4 Gy of 48Ti ion exposure
than after X-irradiation of the same dose. Genes that are regulated more than threefold
and at the same time are controlled by RelA are discussed here.
In HEK-pNF-"B-d2EGFP/Neo L2 cells, the set of genes, that has already been shown
to be upregulated after TNF-# treatment, was likewise upregulated after exposure to
X-rays and heavy ions. It includes CXC chemokines, TNF and the NF-"B inhibitor
I!B". This shows that expression of these genes is activated not only by the classical
NF-"B pathway, but also the genotoxic stress induced pathway, independent of the
radiation quality.
Especially the CXC chemokines are strongly upregulated, in case of CXCL10 up to 21.9
fold after irradiation with 8 Gy X-rays. None of the genes that are upregulated at higher
doses in the original cell line exceeds the threshold of 3 after irradiation with 0.5 Gy of
both, X-rays and 48Ti ions. Though, after 4 Gy of X-rays, CXC chemokines reach
expression values of 3.3 to 5.5 fold. For the same dose, these genes are expressed up
to 9.8 fold after 48Ti ion irradiation. Additionally, exposure to 4 Gy of 48Ti ions results in
the expression of genes that are only expressed after irradiation with 8 Gy of X-rays. 
Apart from the genes expressed after both, TNF-# treatment and irradiation, additional
genes are upregulated only upon X-irradiation, not after heavy ion exposure, proving
the relation between radiation quality or LET and gene expression. These genes
include BIRC3, LTA, NFKB2 and RELB:
BIRC3 (c-IAP2) encodes a member of the IAP family of proteins that inhibit apoptosis
by binding to the tumor necrosis factor receptor-associated factors TRAF1 and TRAF2.
It modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell
proliferation, as well as cell invasion and metastasis (Bertrand et al., 2011). BIRC3
binds to TNF-R2, which is involved in apoptosis, and is activated by NF-"B to inhibit
apoptosis. c-IAP2 expression is upregulated by ionizing radiation through NF-"B bind-
ing sites (Ueda et al., 2001). Unlike what was expected, only one gene involved in
apoptosis was regulated after X-ray exposure.
LTA (TNF-$, TNFSF1) is a member of the TNF superfamily of proteins, having over-
lapping functions with TNF-#. It signals through TNF-R1 and TNF-R2 activating the
classical NF-"B pathway (Wolf et al., 2010).
RELB and NFKB2 code for NF-"B subunits, which are both involved in the non-canon-
ical NF-"B pathway. NFKB2 codes for p100 which is processed to p52. These elements
of the non-canonical pathway seem to be upregulated only by X-rays and not by heavy
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ions. The RelB : p52 dimer was shown to confer radioresistance to prostate cancer cells
by upregulating the expression of the antioxidant enzyme manganese superoxide dis-
mutase (MnSOD) (Josson et al., 2006; Xu et al., 2007; 2008; Holley et al., 2010).
The different gene expression profile after 48Ti ion irradiation indicates distinct
responses, depending on radiation quality, eventually including different repair mecha-
nisms, as indicated in the survival curves in this work. These genes are expressed after
X-irradiation, but not after 48Ti ion exposure. The missing expression of the antiapoptotic
BIRC3 and the protecting RelB genes after heavy ion exposure might be another expla-
nation why RelA knockdown results in higher X-ray sensitivity, but not in higher heavy
ion exposure sensitivity. Their protecting effect ceases to exist in HEK shRNA RelA cells
after X-irradiation, but it is not induced after heavy exposure even in case of normal
RelA levels.
Surprisingly, all genes that are expressed after TNF-! treatment, are also induced after
irradiation with both radiation qualities. Genes that are additionally upregulated upon
X-irradiation are not influenced by TNF-! or 48Ti ions.
The only gene upregulated after both radiation species, but not TNF-!, is CD83. CD83
is one of the central regulatory molecules in immune functions with anti-tumor effects
(Fujimoto and Tedder, 2006). It acts as a co-stimulator during activation of T-cells by
antigen-presenting cells and is therefore essential for the induction of the adaptive
immune response. NF-"B regulates inducible CD83 gene expression in activated T
lymphocytes during an adaptive immune response (McKinsey et al., 2000). Increased
expression of this co-stimulatory molecule indicates that exposure to ionizing radiation
does not only induce inflammation as a prominent innate immune response via pro-
inflammatory cytokines such as TNF-! and via chemokines, but also induces selected
steps towards activation of adaptive immunity.
Expression of JUN#was investigated for 48Ti ions only, as for X-rays, only the RT2 Pro-
filer™ PCR Array for NF-"B signaling targets, which does not involve JUN, was used.
For comparison, increased JUN expression was also observed in human breast epithe-
lial cells after exposure to !-particles (LET 150 keV/$m; Calaf and Hei, 2001).
Differences in gene expression depending on the radiation type are also observed in
absence of RelA, as discussed in the next chapter.
4.5.3.2 Target gene expression depending on RelA
In absence of RelA, none of the genes regulated in HEK-pNF-"B-d2EGFP/Neo L2 cells
are induced. However, as already seen in HEK-pNF-"B-d2EGFP/Neo L2 cells, gene
expression differs between X-ray and heavy ion exposure. Again, different gene expres-
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sion profiles after 48Ti ion irradiation indicate distinct responses depending on radiation
quality, providing an explanation for the differences in survival response of both cell
lines.
Genes expressed after X- but not heavy ion-irradiation in the knockdown cell line are
CCL11, CD80, EGR2 and LTB. 
CCL11 encodes a cytokine called eotaxin, recruiting eosinophils by inducing their che-
motaxis. It seems to play a role in the pathogenesis of asthma and inflammatory bowel
disease (Park et al., 2006; Bischoff and Ulmer, 2008; Waddell et al., 2011). CCL11 was
shown to be slightly upregulated in the spleen of mice irradiated with simulated solar
particle event (SPE) protons, but downregulated after low-dose (0.05 Gy) and low-dose
rate (0.24 mGy/h) !-irradiation (Rizvi et al., 2011).
The protein encoded by CD80 (also known as B7.1) is a costimulatory molecule that is
expressed normally on dendritic cells and induces T-cell proliferation and cytokine pro-
duction during adaptive immune responses. It is an important signal during
antigen-presentation by dendritic cells to T-cells. CD80 was shown to be upregulated
in the spleen of mice irradiated with low-dose (0.05 Gy) and low-dose rate (0.24 mGy/h)
!-rays alone or incombination with simulated SPE protons (Rizvi et al., 2011). Increased
expression of CD80 in antigen-presenting cells might result in a more efficient T helper
response.
EGR2 is a transcription factor involved in the early growth response. Besides its role in
control of inflammation and of antigen-induced B cell proliferation (Li et al., 2012), it
was recently found that it plays a role as transcriptional regulator in T cell anergy
(Zheng et al., 2012). T cells go in this hyporesponsive state when antigen binds to their
T cell receptor in absence of costimulation by CD80 or CD83 for example. Upregulation
of this factor might therefore counteract the effects of increased CD80 expression.
LTB is a membrane protein of the TNF family which anchors lymphotoxin-" to the cell
surface.
Overall, these genes are only slightly exceeding the threshold of 3. While upregulation
of genes upon irradiation in the original cell line seems to be explainable, gene expres-
sion in HEK shRNA RelA cells appears to be rather random. Regulation of these genes
does not seem to have a compensating effect, except maybe CD80 for CD83, for the
loss of RelA and appears to be a consequence of the misregulation of several pathways
which is due to the RelA knockdown.
Genes regulated after both, X- and heavy ion-irradiation, are TNFRSF1B and
TNFSF10. They are of special interest, not only because they are clearly exceeding the
threshold of 3/-3, but also because they are the only genes up-regulated after X-irra-
diation and downregulated after exposure to 48Ti ions.
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TNFRSF1B encodes for the TNF!receptor TNF-R2. It was shown that TNFRSF1B
receptor signaling resulted in the activation of anti-apoptotic survival proteins (Yang et
al., 2012). At the same time, TNFRSF1B promotes TNF-" induced apoptosis (Onizawa
et al., 2009). Baseline plasma TNFRSF1B, a marker of inflammation and a soluble TNF
antagonist, was significantly associated with an increased risk of human colorectal can-
cer (Chan et al., 2011). TNF-" bound to TNFRSF1B recruits intracellular adaptor
proteins to activate multiple signal transduction pathways including NF-#B (Thomme-
sen and Laegreid, 2005). The activation of NF-#B !in intestinal epithelial cells by TNF-"
through TNFRSF1B receptor signaling has been previously linked to carcinogenesis.
Silencing TNFRSF1B increased apoptosis (Yang et al., 2012). However, NF-#B !inter-
feres with apoptotic signals at various levels. The best example is found in the TNF-R1
pathway (Chen and Goeddel, 2002). It is therefore not sure, whether increased apop-
tosis results from pro-apoptotic TNFRSF1A signaling.
BIRC3 and LTA, which have been shown to be upregulated in HEK-pNF-#B-
d2EGFP/Neo L2 cells after X-irradiation, bind to TNFRSF1B. As these genes are not
expressed in the knockdown cell line, upregulation of TNFRSF1B in response to X-rays
might have a compensating effect. Noticeably, TNFRSF1B is expressed inversely pro-
portional to BIRC3 and LTA expression. After 4 Gy of X-rays, BIRC3 and LTA are not
expressed more than threefold. However, in knockdown cells, 4 Gy of X-rays result in
a TNFRSF1B upregulation of 9.7. With increasing X-ray dose (8 Gy), BIRC3 and LTA
expression increases in the original cell line, while TNFRSF1B expression decreases. 
After exposure to 48Ti ions, BIRC3 and LTA are not expressed in HEK-pNF-#B-
d2EGFP/Neo L2 cells. Therefore, no balancing regulatory upregulation of TNFRSF1B
is observed for 48Ti ions in HEK shRNA RelA cells. Instead, expression of this gene is
downregulated, indicating a different molecular mechanism as response to heavy ion
exposure.
The cytokine TNFSF10 is linked to apoptosis in transformed and tumor cells, but not in
normal cells (RefSeq AC007919.18 and AC016938.24, www.ncbi.nlm.nih.gov). It is
upregulated after X-irradiation, but downregulated after exposure to 48Ti ions. This
downregulation possibly indicates the onset of a rescue mechanism in absence of RelA
that prevents increased radiosensitivity after heavy ion exposure in comparison with
the original cell line, but not after X-ray exposure, as observed in survival experiments.
The overlapping gene expression after TNF-" and radiation treatment in HEK-pNF-#B-
d2EGFP/Neo L2 cells cannot be observed in RelA knockdown cells. 
Overall, results revealed the outstanding role of NF-#B in cytokine expression. Surpri-
singly, anti-apoptotic genes were not noticeably influenced by knocking down RelA, and
only one antiapoptotic NF-#B dependent gene, BIRC3, was upregulated after X-ray
exposure.
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4.5.3.3 NF-!B and the bystander effect
Target gene array experiments have revealed a strong correlation between an intact
NF-!B pathway and cytokine and chemokine expression. After treatment of cells with
TNF-" and different radiation qualities, a strong upregulation of genes coding for che-
mokines is observed in HEK-pNF-!B-d2EGFP/Neo L2 cells. In RelA knockdown cells,
this expression profile is completely abolished, indicating the dependence of expression
of these cytokines on NF-!B. 
Cytokines are responsible for cell-cell communication and many aspects of the bystan-
der effect. Chemokines in particular regulate chemotaxis of cells. Impaired cytokine
expression results in the loss of intercellular communication. There is little known about
how inflammatory cytokines mediate the bystander effect. Still, it was shown that the
central inflammatory cytokine TNF-" acts as a diffuse mediator of the bystander effect
(Yang et al., 2012). A radiation induced bystander effect has already been observed
earlier (Gerashchenko and Howell, 2003). Another group has shown a strong upregu-
lation of chemokines in the rat liver after X-irradiation (Moriconi et al., 2008). 
There is direct evidence for the participation of gap junction intercellular communication
(GJIC), allowing the transmission of damage signals resulting from irradiation with from
"-particles to bystander effect (Azzam et al., 2001). It is known that GJIC contributes
to the maintenance of normal cell growth. Further, the rate of cell growth is inversely
correlated with the extent of GJIC and growth inhibition correlates with intercellular com-
munication#(Mehta et al., 1986; Loewenstein and Rose, 1992). Loss of NF-!B leads to
impaired GJIC#and bystander effects. The correlation between NF-!B, cytokines and
GJIC has been shown (Chanson et al., 2001). According to the results shown in this
work, NF-!B is directly involved in cell-cell communication by inducing cytokines, and
insofar the aspects of the bystander effect that represent an inflammatory and immune
response are impaired in absence of NF-!B. 
4.6 Conclusion and Outlook
The overall aim of this work was to improve the understanding of the role of NF-!B in
the cellular response to space relevant radiation, as the NF-!B pathway might be a
potential pharmacological target during space flights.
In cancer therapy, NF-!B has been shown to be a potential pharmacological target, as
its inhibition#would be an approach to potentiate radiation effects in radiotherapy, mainly
by supporting the killing effect (Lee et al., 2007; Baud and Karin, 2009; Madonna et al.,
2012). During space missions, a constant exposure to low doses of radiation, especially
energetic heavy ions, is associated with an increased cancer risk. The absence of
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increased killing by heavy ion exposure in RelA knockdown has to be clarified in expe-
riments with and without repair time and with heavy ions of lower LET than the 64Ni ions
(175 keV/!m) used in this work. If increased cell killing is observed for such heavy ions
for cells with downregulated RelA, this pathway could be an appropriate target to eli-
minate cells with DNA damage. To decrease the long-term risk of late effects like
cancer, inhibition of NF-"B would then be a potential pharmacological target.
Though, inhibition of NF-"B#will not only result in increased apoptosis, but also lower
TNF#production and inflammation (Linard et al., 2004). It has to be considered, that
immunosuppression is one of the major risks to the astronauts$ health during long-term
spaceflights. In space, microgravity (!g) leads to impaired T cell activation and an inef-
fective proinflammatory host defenses by downregulating immediate early genes,
involving TNF#and the Rel/NF-"B pathway (Chang et al., 2012). Astronauts are prone
to infections and show impaired wound healing which might be, among other factors,
due to downregulation of NF-"B in !g. Considering knowledge about the role of NF-"B
in the immune system and results in this work, additional suppression of NF-"B for
radioprotection would probably potentiate the immunosuppressive effect. Therefore,
inhibition of one of the NF-"B target genes that were identified in this work to be upre-
gulated by high-LET radiation might be a better choice to avoid side effects on the
immune system.
However, when astronauts are exposed to high radiation doses during solar particle
events, an increased NF-"B level will be necessary to tolerate or prevent acute effects
such as cell death.
Future work should focus on the role of the NF-"B target genes identified here in the
cellular response to heavy ions. To analyze their function, they could be downregulated
by RNAi as described in this work, or knock-out cell lines could be used. Furthermore,
as these target genes where predominantly involved in cell-cell communication, their
role in the bystander effect which is of eminent importance for single particle effects
should be investigated. Microbeam experiments enable irradiation of single cells and
subcellular compartments by using single particle beams. 
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5 Abstract
Radiation is currently one of the most important limiting factors for manned space flight.
During such missions, there is a constant exposure to low doses of galactic cosmic ra-
diation and in particular high-energy heavy ions. Together this is associated with an in-
creased cancer risk which currently cannot be sufficiently reduced by shielding. As such,
cellular radiation response needs to be further studied in order to improve risk estima-
tion and develop appropriate countermeasures. 
It has been shown that exposure of human cells to accelerated heavy ions, in fluences
that can be reached during long-term missions, leads to activation of the Nuclear Factor
!B (NF-!B) pathway. Heavy ions with a linear energy transfer (LET) of 90 to 300
keV/"m were most effective in activating NF-!B. NF-!B as an important modulating
factor in the cellular radiation response could improve cellular survival after heavy ion
exposure, thereby influencing the cancer risk of astronauts. The NF-!B pathway may
be a potential pharmacological target in the mitigation of radiation response during
space missions; such as the prevention of massive cell death after high dose irradiation
(acute effects), in addition to neoplastic cell transformation during chronic low-dose ex-
posure (late effects). 
The aim of this work was to examine the role of NF-!B in the cellular response to space-
relevant radiation. Firstly, NF-!B activation in human embryonic kidney cells (HEK) after
exposure to different radiation qualities and quantities was investigated. Key elements
of different NF-!B sub-pathways were chemically inhibited to analyze their role in NF-
!B activation induced by low and high LET ionizing radiation. Finally a cell line, stably
transfected with a plasmid coding for a short-hairpin RNA (shRNA) for a knockdown of
the NF-!B subunit RelA, was established to assess the role of RelA in the cellular re-
sponse to space-relevant radiation. The knockdown was verified on several levels and
the cell line was characterized concerning proliferation, cell cycle progression and gene
expression. Additionally, the effects of the RelA knockdown on cell cycle progression,
cellular survival and gene expression after exposure to low and high LET radiation were
investigated.
It was shown that activation of NF-!B depends on radiation quality and quantity. Ex-
periments with chemical inhibitors revealed that NF-!B activation by ionizing radiation
is strictly ATM dependent and degradation of the NF-!B inhibitor I!B by the proteasome
is essential for both the classical and genotoxic stress-induced NF-!B pathway.
Absence of NF-!B dimers containing RelA resulted in a prolonged lag-phase but did
not affect cell cycle progression significantly in untreated cells. After irradiation, a dose
and radiation quality dependent arrest in the G2 phase of the cell cycle occurred and
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also upon downregulation of RelA expression. RelA knockdown resulted in higher sen-
sitivity of HEK cells to the killing effect of X-irradiation. In contrast, RelA knockdown did
not further reduce the cellular survival after heavy ion exposure. 
Further, NF-!B target genes were not inducible in the RelA knockdown cell line. NF-
!B-dependent gene expression rely on radiation dose and LET. Chemokine expression
(e.g. CXCL1, 2, 8 and 10) was induced in a proportional manner to radiation quality
and quantity, emphasizing the role of NF-!B in the bystander effect. These NF-!B reg-
ulated genes are interesting targets for countermeasure development against the ef-
fects of space radiation.
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6 Zusammenfassung
Die Weltraumstrahlung gilt derzeit als einer der wichtigsten limitierenden Faktoren für
die bemannte Raumfahrt. Während solcher Missionen herrscht eine konstante Expo-
sition mit geringen Dosen galaktischer kosmischer Strahlung, insbesondere hoch-
energetischen Schwerionen. Dies wird mit einem erhöhten Krebsrisiko assoziiert,
welches durch Abschirmung nicht ausreichend reduziert werden kann. Deshalb muss
die zelluläre Strahlenantwort untersucht werden, um die Risikoabschätzung zu
verbessern und angemessene Gegenmassnahmen zu entwickeln.
Es wurde gezeigt, dass die Exposition von menschlichen Zellen mit beschleunigten
Schwerionen in Fluenzen, die während Langzeitmissionen erreicht werden können, zur
Aktivierung des Nuclear Factor !B (NF-!B) Signalweges führen. Schwerionen mit
einem linearen Energietransfer (LET) von 90 bis 300 keV/"m hatten den stärksten Ef-
fekt auf die NF-!B Aktivierung. NF-!B als ein wichtiger regulierender Faktor in der zel-
lulären Strahlenantwort könnte das zelluläre Überleben nach Schwerionenbestrahlung
erhöhen und demnach das Krebsrisiko von Astronauten beeinflussen. Der NF-!B Sig-
nalweg könnte ein potentieller pharmakologischer Angriffspunkt für die Abschwächung
der Strahlenantwort während Weltraummissionen sein, um den massiven Zelltod nach
Bestrahlung mit hohen Dosen (akute Effekte) oder neoplastische Zelltransformation
nach chronischer Bestrahlung mit niedrigen Dosen (Spätfolgen) zu verhindern.
Das Ziel dieser Arbeit war der Kenntnisgewinn über die Rolle von NF-!B in der zel-
lulären Antwort auf weltraumrelevante Strahlung. Zuerst wurde die NF-!B Aktivierung
in menschlichen embryonalen Nierenzellen (human embryonic kidney cells, HEK) nach
Exposition mit verschiedenen Strahlenqualitäten und -quantitäten untersucht. Zentrale
Elemente verschiedener NF-!B Signalwege wurden durch Chemikalien inhibiert, um
deren Rolle in der NF-!B Aktivierung, induziert durch ionisierende Strahlung mit
niedrigem und hohem LET, zu analysieren. Zuletzt wurde eine Zellinie mit einem short-
hairpin RNA (shRNA) Plasmid für den Knockdown der NF-!B Untereinheit RelA stabil
transfiziert, um die Rolle von RelA in der zellulären Antwort auf weltraumrelevante
Strahlung abzuschätzen. Der Knockdown wurde auf verschiedenen Ebenen verifiziert
und die Zellinie wurde hinsichtlich Proliferation, Zellzyklus-Progression und Genexpres-
sion untersucht. Zusätzlich wurden die Effekte des RelA Knockdowns auf Zellzyklus-
Progression, zelluläres Überleben und Genexpression nach Exposition mit Strahlung
mit niedrigem und hohem LET untersucht. 
Es wurde gezeigt, dass die Aktivierung von NF-!B von Strahlenqualität und -quantität
abhängig ist. Experimente mit chemischen Inhibitoren zeigten, dass NF-!B Aktivierung
durch ionisierende Strahlung strikt ATM abhängig ist und der Abbau des NF-!B In-
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hibitors I!B durch das Proteasom essentiell ist für beide, den klassischen und den durch
genotoxischen Stress induzierten NF-!B Signalweg.
Abwesenheit von RelA-enthaltenden NF-!B-Dimeren resultierte in einer verlängerten
lag-Phase, hatte aber keinen signifikanten Einfluss auf die Zellzyklus-Progression in
unbehandelten Zellen. Nach Bestrahlung wurde auch in der RelA Knockdown Zellinie
ein von Dosis und Strahlenqualität abhängiger Arrest in der G2 Phase des Zellzyklus
beobachtet. Der RelA Knockdown resultierte in erhöhter Sensitivität von HEK Zellen
für den abtötenden Effekt von Röntgenstrahlung. Im Gegensatz dazu reduziert der RelA
Knockdown das zelluläre Überleben nach Schwerionenbestrahlung nicht stärker. 
Des Weiteren waren Zielgene von NF-!B in der RelA Knockdown-Zellinie nicht induzier-
bar. Die NF-!B-abhängige Genexpression ist abhängig von Strahlendosis und LET. Die
Expression von Chemokinen (z."B. CXCL1, 2, 8 und 10) wurde proportional zu Strahlen-
qualität und -quantität induziert, und unterstreicht somit die Rolle von NF-!B im By-
stander-Effekt. Diese NF-!B regulierten Gene sind interessante Angriffspunkte für die
Entwicklung von Massnahmen gegen die Effekte von Weltraumstrahlung.
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7 Appendix
7.1 Gene expression profiles
Gene Description Gene bank Array
symbol
ACTB Actin, beta NM_001101 Both
ADM Adrenomedullin NM_001124 NF-!B
AGT Angiotensinogen (serpin peptidase inhibitor, clade A,
member 8) NM_000029 NF-!B
AKT1 V-akt murine thymoma viral oncogene homolog 1 NM_005163 NF-!B
ALDH3A2 Aldehyde dehydrogenase 3 family, member A2 NM_000382 NF-!B
ATM Ataxia telangiectasia mutated NM_000051 Customized
ATR Ataxia telangiectasia and Rad3 related NM_001184 Customized
B2M Beta-2-microglobulin NM_004048 Both
BCL2A1 BCL2-related protein A1 NM_004049 NF-!B
BCL2L1 BCL2-like 1 NM_138578 NF-!B
BCL3 B-cell CLL/lymphoma 3 NM_005178 Customized
BIRC2 Baculoviral IAP repeat containing 2 NM_001166 NF-!B
BIRC3 Baculoviral IAP repeat containing 3 NM_001165 NF-!B
BIRC5 Baculoviral IAP repeat-containing 5 (survivin) NM_001168 Customized
BRCA2 Breast cancer 2, early onset NM_000059 Customized
BRCA5 Breast cancer 1, early onset NM_007294 Customized
C3 Complement component 3 NM_000064 NF-!B
CASP3 Caspase 3, apoptosis-related cysteine peptidase NM_004346 Customized
CASP8 Caspase 8, apoptosis-related cysteine peptidase NM_001228 Customized
CASP9 Caspase 9, apoptosis-related cysteine peptidase NM_001229 Customized
CAT Catalase NM_001752 Customized
CCL11 Chemokine (C-C motif) ligand 11 NM_002986 NF-!B
CCL2 Chemokine (C-C motif) ligand 2 NM_002982 NF-!B
CCL22 Chemokine (C-C motif) ligand 22 NM_002990 NF-!B
CCL5 Chemokine (C-C motif) ligand 5 NM_002985 NF-!B
CCND1 Cyclin D1 NM_053056 NF-!B
CCNE1 Cyclin E1 NM_001238 Customized
CCNE2 Cyclin E2 NM_057749 Customized
CCR5 Chemokine (C-C motif) receptor 5 NM_000579 NF-!B
CD40 CD40 molecule, TNF receptor superfamily member 5 NM_001250 NF-!B
CD69 CD69 molecule NM_001781 NF-!B
CD80 CD80 molecule NM_005191 NF-!B
CD83 CD83 molecule NM_004233 NF-!B
CDC2 Cell division cycle 2, G1 to S and G2 to M NM_001786 Customized
CDC25A Cell division cycle 25 homolog A (S. pombe) NM_001789 Customized
CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cip1) NM_000389 Both
CDKN2A Cyclin-dependent kinase inhibitor 2A (melanoma, p16,
inhibits CDk4) NM_000077 Customized
CFB Complement factor B NM_001710 NF-!B
CHEK1 CHK1 checkpoint homolog (S. pombe) NM_001274 Customized
CHEK2 CHK2 checkpoint homolog (S. pombe) NM_007194 Customized
CSF1 Colony stimulating factor 1 (macrophage) NM_000757 NF-!B
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) NM_000758 NF-!B
Table 17: List of all genes included in either the customized RT2 Profiler™ PCR Array or the RT2 Profi-
ler™ PCR Array focussing on Human NF-!B Signaling Targets (SABiosciences). The column "ARRAY#
indicates, in which of both arrays the respective gene occurs.
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CSF2RB Colony stimulating factor 2 receptor, beta, low-affinity 
(granulocyte-macrophage) NM_000395 NF-!B
CSF3 Colony stimulating factor 3 (granulocyte) NM_000759 NF-!B
CUL1 Cullin 1 NM_003592 Customized
CXCL1 Chemokine (C-X-C motif) ligand 1 
(melanoma growth stimulating activity, alpha) NM_001511 NF-!B
CXCL10 Chemokine (C-X-C motif) ligand 10 NM_001565 NF-!B
CXCL2 Chemokine (C-X-C motif) ligand 2 NM_002089 NF-!B
CXCL9 Chemokine (C-X-C motif) ligand 9 NM_002416 NF-!B
DDB1 Damage-specific DNA binding protein 1, 127kDa NM_001923 Customized
DDIT3 DNA-damage-inducible transcript 3 NM_004083 Customized
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 NM_001539 Customized
E2F1 E2F transcription factor 1 NM_005225 Customized
EGFR Epidermal growth factor receptor NM_005228 NF-!B
EGR1 Early growth response 1 NM_001964 Customized
EGR2 Early growth response 2 NM_000399 NF-!B
EIF2AK2 Eukaryotic translation initiation factor 2-alpha kinase 2 NM_002759 Customized
ERCC3 Excision repair cross-complementing rodent repair
deficiency, complementation group 3
(xeroderma pigmentosum group B complementing) NM_000122 Customized
EXO1 Exonuclease 1 NM_130398 Customized
F3 Coagulation factor III (thromboplastin, tissue factor) NM_001993 NF-!B
F8 Coagulation factor VIII, procoagulant component NM_000132 NF-!B
FANCG Fanconi anemia, complementation group G NM_004629 Customized
FAS Fas (TNF receptor superfamily, member 6) NM_000043 NF-!B
FASLG Fas ligand (TNF superfamily, member 6) NM_000639 NF-!B
GADD45A Growth arrest and DNA-damage-inducible, alpha NM_001924 Customized
GADD45B Growth arrest and DNA-damage-inducible, beta NM_015675 NF-!B
GADD45G Growth arrest and DNA-damage-inducible, gamma NM_006705 Customized
GAPDH Glyceraldehyde-3-phosphate dehydrogenase NM_002046 Both
GJA1 Gap junction protein, alpha 1, 43kDa NM_000165 Customized
GPX1 Glutathione peroxidase 1 NM_000581 Customized
GTF2H2 General transcription factor IIH, polypeptide 2, 44kDa NM_001515 Customized
HPRT1 Hypoxanthine phosphoribosyltransferase 1 NM_000194 Both
HRK Harakiri, BCL2 interacting protein
(contains only BH3 domain) NM_003806 Customized
HSF1 Heat shock transcription factor 1 NM_005526 Customized
HSP90AA2 Heat shock protein 90kDa alpha (cytosolic),
class A member 2 NM_001040141 Customized
HSPA1A Heat shock 70kDa protein 1A NM_005345 Customized
ICAM1 Intercellular adhesion molecule 1 NM_000201 NF-!B
IFNB1 Interferon, beta 1, fibroblast NM_002176 NF-!B
IFNG Interferon, gamma NM_000619 NF-!B
IKBKB Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase beta NM_001556 Customized
IKBKE Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase epsilon NM_014002 Customized
IKBKG Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase gamma NM_003639 Customized
IL10 Interleukin 10 NM_000572 Customized
IL12B Interleukin 12B (natural killer cell stimulatory factor 2,
cytotoxic lymphocyte maturation factor 2, p40) NM_002187 NF-!B
IL15 Interleukin 15 NM_000585 NF-!B
IL1A Interleukin 1, alpha NM_000575 Both
IL1B Interleukin 1, beta NM_000576 NF-!B
IL1R2 Interleukin 1 receptor, type II NM_004633 NF-!B
IL1RN Interleukin 1 receptor antagonist NM_000577 NF-!B
IL2 Interleukin 2 NM_000586 NF-!B
IL2RA Interleukin 2 receptor, alpha NM_000417 NF-!B
IL4 Interleukin 4 NM_000589 NF-!B
IL6 Interleukin 6 (interferon, beta 2) NM_000600 Both
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IL8 Interleukin 8 NM_000584 Both
INS Insulin NM_000207 NF-!B
IRF1 Interferon regulatory factor 1 NM_002198 NF-!B
JUN Jun oncogene NM_002228 Customized
KRAS V-ki-ras2 kirsten rat sarcoma viral oncogene homolog NM_004985 Customized
LIG1 Ligase I, DNA, ATP-dependent NM_000234 Customized
LTA Lymphotoxin alpha (TNF superfamily, member 1) NM_000595 NF-!B
LTB Lymphotoxin beta (TNF superfamily, member 3) NM_002341 NF-!B
MAP2K6 Mitogen-activated protein kinase kinase 6 NM_002758 NF-!B
MAPK1 Mitogen-activated protein kinase 1 NM_002745 Customized
MDM2 Mdm2, transformed 3T3 cell double minute 2,p53 binding
protein (mouse) NM_002392 Customized
MMP9 Matrix metallopeptidase 9 (gelatinase B, 92kDa
gelatinase, 92kDa type IV collagenase) NM_004994 NF-!B
MT2A Metallothionein 2A NM_005953 Customized
MT3 Metallothionein 3 NM_005954 Customized
MYC V-myc myelocytomatosis viral oncogene homolog (avian) NM_002467 NF-!B
MYD88 Myeloid differentiation primary response gene (88) NM_002468 NF-!B
NBN Nibrin NM_002485 Customized
NCOA3 Nuclear receptor coactivator 3 NM_181659 NF-!B
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer
in B-cells 1 (p105) NM_003998 Both
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer
in B-cells 2 (p49/p100) NM_002502 Both
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer
in B-cells inhibitor, alpha NM_020529 Both
NOS2 Nitric oxide synthase 2A (inducible, hepatocytes) NM_000625 Customized
NQO1 NAD(P)H dehydrogenase, quinone 1 NM_000903 NF-!B
NR4A2 Nuclear receptor subfamily 4, group A, member 2 NM_006186 NF-!B
OGG1 8-oxoguanine DNA glycosylase NM_002542 Customized
P53AIP1 P53-regulated apoptosis-inducing protein 1 NM_022112 Customized
PCNA Proliferating cell nuclear antigen NM_182649 Customized
PDGFB Platelet-derived growth factor beta polypeptide NM_002608 NF-!B
PIK3Ca Phosphoinositide-3-kinase, catalytic, alpha polypeptide NM_006218 Customized
PLAU Plasminogen activator, urokinase NM_002658 NF-!B
PRKCA Protein kinase C, alpha NM_002737 Customized
PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin
G/H synthase and cyclooxygenase) NM_000963 NF-!B
RAD51 RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) NM_002875 Customized
RAD9A RAD9 homolog A (S. pombe) NM_004584 Customized
RASA1 RAS p21 protein activator (GTPase activating protein) 1 NM_002890 Customized
RB1 Retinoblastoma 1 (including osteosarcoma) NM_000321 Customized
REL V-rel reticuloendotheliosis viral oncogene homolog (avian) NM_002908 Both
RELA V-rel reticuloendotheliosis viral oncogene homolog A,
nuclear factor of kappa light polypeptide gene enhancer
in B-cells 3, p65 (avian) NM_021975 Both
RELB V-rel reticuloendotheliosis viral oncogene homolog B NM_006509 NF-!B
RPL13A Ribosomal protein L13a NM_012423 Customized
RPLP0 Ribosomal protein, large, P0 NM_001002 NF-!B
SELE Selectin E NM_000450 NF-!B
SELP Selectin P (granule membrane protein 140kDa,
antigen CD62) NM_003005 NF-!B
SNAP25 Synaptosomal-associated protein, 25kDa NM_003081 NF-!B
SOD1 Superoxide dismutase 1, soluble (amyotrophic lateral
sclerosis 1 (adult)) NM_000454 Customized
SOD2 Superoxide dismutase 2, mitochondrial NM_000636 Both
SOD3 Superoxide dismutase 3, extracellular NM_003102 Customized
SOS1 Son of sevenless homolog 1 (Drosophila) NM_005633 Customized
STAT1 Signal transducer and activator of transcription 1, 91kDa NM_007315 NF-!B
STAT3 Signal transducer and activator of transcription 3
(acute-phase response factor) NM_003150 NF-!B
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STAT5B Signal transducer and activator of transcription 5B NM_012448 NF-!B
TLR1 Toll-like receptor 1 NM_003263 Customized
TNF Tumor necrosis factor (TNF superfamily, member 2) NM_000594 Both
TNFRSF1B Tumor necrosis factor receptor superfamily, member 1B NM_001066 NF-!B
TNFSF10 Tumor necrosis factor (ligand) superfamily, member 10 NM_003810 NF-!B
TP53 Tumor protein p53 NM_000546 Both
TP53BP2 Tumor protein p53 binding protein, 2 NM_005426 Customized
TP73 Tumor protein p73 NM_005427 Customized
TRADD TNFRSF1A-associated via death domain NM_003789 Customized
TRAF2 TNF receptor-associated factor 2 NM_021138 NF-!B
UNG Uracil-DNA glycosylase NM_003362 Customized
VCAM1 Vascular cell adhesion molecule 1 NM_001078 NF-!B
WT1 Wilms tumor 1 NM_000378 Customized
XIAP X-linked inhibitor of apoptosis NM_001167 NF-!B
XRCC1 X-ray repair complementing defective repair in Chinese
hamster cells 1 NM_006297 Customized
XRCC2 X-ray repair complementing defective repair in Chinese
hamster cells 2 NM_005431 Customized
XRCC3 X-ray repair complementing defective repair in Chinese
hamster cells 3 NM_005432 Customized
XRCC5 X-ray repair complementing defective repair in Chinese
hamster cells 5 (double-strand-break rejoining; ku
autoantigen, 80kDa) NM_021141 Customized
XRCC6BP1 XRCC6 binding protein 1 NM_033276 Customized
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Gene ! SE
ACTB 0.19 0.53
ADM 0.19 1.37
AGT 0.17 0.90
AKT1 -0.57 0.97
ALDH3A2 -1.15 0.00
ATM -1.79 0.06
ATR 1.41 0.19
B2M -0.30 0.59
BCL2A1 -0.32 0.75
BCL2L1 -0.30 0.81
BCL3 -1.31 0.20
BIRC2 -0.41 0.72
BIRC3 0.20 0.95
BIRC5 0.05 1.22
BRCA2 0.06 1.15
BRCA5 -1.25 0.21
C3 -0.29 0.83
CASP3 1.27 0.22
CASP8 -1.62 0.20
CASP9 -1.07 0.03
CAT -0.08 1.23
CCL11 -0.42 0.86
CCL2 1.34 0.18
CCL22 0.32 0.72
CCL5 2.82 1.49
CCND1 -3.69 1.15
CCNE1 0.02 1.09
CCNE2 0.10 1.16
CCR5 0.78 1.13
CD40 -1.15 0.06
CD69 0.32 0.72
CD80 -0.40 0.73
CD83 -1.92 0.72
CDC2 0.05 1.14
CDC25A 1.22 0.17
CDKN1A -0.20 0.53
CDKN2A 0.12 1.17
CFB -0.59 0.80
CHEK1 -0.05 1.09
CHEK2 -1.12 0.05
CSF1 -1.30 0.19
CSF2 -0.44 1.23
CSF2RB 0.32 0.72
CSF3 1.23 0.09
CUL1 0.01 1.12
CXCL1 -2.95 1.66
CXCL10 -1.90 1.96
CXCL2 -0.57 0.93
CXCL9 0.63 0.89
DDB1 0.10 1.29
DDIT3 1.33 0.17
DNAJA1 -0.31 1.33
E2F1 0.04 1.26
EGFR -0.45 0.74
EGR1 2.17 0.67
EGR2 0.38 0.78
EIF2AK2 -1.25 0.03
ERCC3 -0.23 1.26
EXO1 -0.48 1.56
F3 1.12 0.07
F8 0.49 0.79
FANCG -1.49 0.05
FAS -1.48 0.14
FASLG 2.27 0.59
GADD45A -1.31 0.21
GADD45B 2.67 0.53
GADD45G -0.48 1.92
GAPDH 0.34 0.59
GJA1 -1.35 0.27
GPX1 1.50 0.25
GTF2H2 -1.27 0.16
HPRT1 0.39 0.60
HRK -1.34 0.22
HSF1 -0.04 1.37
HSP90AA2 1.78 0.51
HSPA1A 1.94 0.84
ICAM1 0.27 1.31
IFNB1 0.32 0.72
IFNG 0.32 0.72
IKBKB -1.41 0.22
IKBKE -2.42 0.07
IKBKG -0.05 1.42
IL10 1.48 0.26
IL12B -1.20 0.14
IL15 -1.00 1.09
IL1A 0.17 0.62
IL1B 0.40 0.77
IL1R2 -1.34 1.52
IL1RN 0.32 0.72
IL2 0.32 0.72
IL2RA 0.32 0.72
IL4 1.81 0.36
IL6 0.32 0.61
IL8 -8.12 5.20
INS 0.32 0.72
IRF1 -0.50 0.81
JUN 4.25 2.48
KRAS -1.08 0.02
LIG1 -0.49 1.51
LTA 1.30 0.15
LTB -0.51 0.84
MAP2K6 -1.41 0.17
MAPK1 -1.15 0.04
MDM2 -1.29 0.00
MMP9 -0.87 1.05
MT2A 0.00 1.19
MT3 0.32 1.42
MYC 0.33 0.95
MYD88 -1.32 1.40
NBN -2.76 0.89
NCOA3 1.32 0.10
NFKB1 0.14 0.58
NFKB2 -0.08 0.70
NFKBIA -1.92 0.22
NOS2 1.29 0.24
NQO1 -0.10 0.99
NR4A2 2.33 0.30
OGG1 -0.06 1.18
P53AIP1 0.47 1.74
PCNA 1.24 0.08
PDGFB 0.32 0.72
PIK3Ca 1.12 0.02
PLAU -1.86 0.12
PRKCA -0.08 1.19
PTGS2 1.66 0.14
RAD51 0.02 1.06
RAD9A 1.04 0.04
RASA1 -1.25 0.01
RB1 0.00 1.12
REL -1.30 0.07
RELA -6.18 1.47
RELB 0.31 0.77
RPL13A -1.17 0.10
RPLP0 -0.56 0.82
SELE 0.73 0.94
SELP 0.32 0.72
SNAP25 1.48 0.15
SOD1 0.22 1.41
SOD2 -0.71 0.44
SOD3 1.54 0.21
SOS1 -1.15 0.04
STAT1 1.24 0.02
STAT3 -0.45 0.78
STAT5B -1.13 0.04
TLR1 1.14 0.03
TNF -3.37 1.54
TNFRSF1B -1.12 1.39
TNFSF10 -0.69 0.92
TP53 -1.22 0.07
TP53BP2 -0.20 1.38
TP73 0.00 1.05
TRADD -1.47 0.00
TRAF2 -1.13 0.06
UNG 1.69 0.48
VCAM1 0.32 0.72
WT1 0.24 1.37
XIAP -1.20 0.10
XRCC1 0.00 1.15
XRCC2 -1.55 0.09
XRCC3 -0.18 1.26
XRCC5 0.09 1.25
XRCC6BP1 -1.26 0.26
Table 18: Analysis of gene expression in HEK!shRNA!RelA cells compared to the original cell line using
the RT2 Profiler™ PCR array (SABiosciences). Listed are all genes from both, the customized and the
NF-!B signaling array. Mean of fold up- or downregulation and SE are calculated from up to five inde-
pendent experiments. Genes that are more that threefold up- or downregulated are highlighted.
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Gene ! SE
ACTB -0.05 1.07
ADM -1.20
AGT 1.13
AKT1 1.06
ALDH3A2 -1.15
ATM 1.03
ATR -1.36
B2M 1.12 0.01
BCL2A1 1.72
BCL2L1 1.16
BCL3 1.76
BIRC2 1.13
BIRC3 1.50
BIRC5 -1.15
BRCA2 1.11
BRCA5 1.10
C3 1.26
CASP3 1.10
CASP8 -1.08
CASP9 -1.03
CAT -1.05
CCL11 1.39
CCL2 2.75
CCL22 -1.05
CCL5 -1.17
CCND1 -1.14
CCNE1 1.01
CCNE2 -1.07
CCR5 1.58
CD40 1.40
CD69 2.99
CD80 1.46
CD83 2.09
CDC2 -1.07
CDC25A 1.28
CDKN1A 1.14 0.04
CDKN2A -1.25
CFB -1.01
CHEK1 -1.01
CHEK2 1.10
CSF1 1.82
CSF2 1.27
CSF2RB -1.05
CSF3 -1.01
CUL1 -1.16
CXCL1 11.73
CXCL10 5.14
CXCL2 6.51
CXCL9 1.84
DDB1 1.29
DDIT3 -1.01
DNAJA1 1.14
E2F1 1.16
EGFR 1.23
EGR1 1.20
EGR2 1.52
EIF2AK2 -1.02
ERCC3 1.27
EXO1 1.02
F3 1.93
F8 1.09
FANCG 1.14
FAS -1.06
FASLG 1.19
GADD45A 1.59
GADD45B 1.39
GADD45G 1.34
GAPDH 0.03 1.05
GJA1 1.13
GPX1 1.04
GTF2H2 1.46
HPRT1 -1.03 0.01
HRK 1.04
HSF1 -1.02
HSP90AA2 1.40
HSPA1A -1.14
ICAM1 1.23
IFNB1 -1.03
IFNG -1.02
IKBKB 1.00
IKBKE 1.34
IKBKG 1.48
IL10 1.04
IL12B 1.64
IL15 1.29
IL1A 1.19 0.12
IL1B -1.05
IL1R2 -1.04
IL1RN -1.05
IL2 -1.05
IL2RA -1.05
IL4 1.28
IL6 0.00 1.04
IL8 5.35 0.31
INS -1.05
IRF1 2.04
JUN 2.37
KRAS 1.07
LIG1 1.22
LTA 1.44
LTB 1.88
MAP2K6 -1.08
MAPK1 1.07
MDM2 1.17
MMP9 -1.31
MT2A -1.17
MT3 1.04
MYC -1.12
MYD88 -1.03
NBN -1.08
NCOA3 1.00
NFKB1 2.63 0.31
NFKB2 1.60 0.26
NFKBIA 6.31 0.52
NOS2 1.17
NQO1 -1.01
NR4A2 -1.09
OGG1 -1.02
P53AIP1 1.77
PCNA 1.17
PDGFB -1.05
PIK3Ca 1.08
PLAU 2.06
PRKCA 1.24
PTGS2 1.65
RAD51 -1.04
RAD9A 1.13
RASA1 1.02
RB1 1.12
REL 1.83 0.08
RELA 0.02 1.12
RELB 1.51
RPL13A -1.11
RPLP0 -1.01
SELE 1.48
SELP -1.05
SNAP25 1.19
SOD1 -1.03
SOD2 1.17 0.09
SOD3 1.04
SOS1 -1.01
STAT1 -1.01
STAT3 1.10
STAT5B 1.07
TLR1 -1.43
TNF 13.91 0.53
TNFRSF1B 1.50
TNFSF10 1.48
TP53 1.20 0.05
TP53BP2 1.07
TP73 1.29
TRADD 1.17
TRAF2 1.15
UNG -1.02
VCAM1 -1.05
WT1 1.22
XIAP -1.12
XRCC1 1.22
XRCC2 -1.03
XRCC3 1.16
XRCC5 1.02
XRCC6BP1 -1.05
Table 19: Analysis of gene expression in HEK-pNF-!B-d2EGFP/Neo L2 cells 6 hours after treatment
with TNF-" using the RT2 Profiler™ PCR array (SABiosciences). Fold up- or downregulation is shown
for all genes from both, the customized and the NF-!B signaling array.  SE is shown for those genes that
occur in both arrays. Genes that are more that threefold up- or downregulated are highlighted.
Gene ! SE
ACTB -0.04 1.12
ADM -1.34
AGT -1.32
AKT1 -1.11
ALDH3A2 -1.14
ATM 1.29
ATR 1.31
B2M 1.17 0.10
BCL2A1 1.00
BCL2L1 1.03
BCL3 1.00
BIRC2 1.09
BIRC3 1.14
BIRC5 -1.11
BRCA2 1.17
BRCA5 1.00
C3 -1.75
CASP3 1.41
CASP8 1.02
CASP9 -1.10
CAT 1.01
CCL11 -1.29
CCL2 -1.06
CCL22 -1.27
CCL5 -1.16
CCND1 -1.96
CCNE1 -1.03
CCNE2 1.25
CCR5 -4.59
CD40 -1.06
CD69 -1.27
CD80 1.17
CD83 1.60
CDC2 -1.06
CDC25A 1.12
CDKN1A 1.19 0.08
CDKN2A -1.22
CFB -1.05
CHEK1 -1.06
CHEK2 1.02
CSF1 -1.13
CSF2 -1.60
CSF2RB -1.27
CSF3 -1.45
CUL1 -1.20
CXCL1 -1.28
CXCL10 -1.42
CXCL2 -1.01
CXCL9 -1.31
DDB1 -1.12
DDIT3 1.20
DNAJA1 1.10
E2F1 1.04
EGFR -1.01
EGR1 1.18
EGR2 1.01
EIF2AK2 1.04
ERCC3 1.36
EXO1 -4.92
F3 1.28
F8 1.24
FANCG 1.11
FAS 1.10
FASLG -1.79
GADD45A 1.86
GADD45B -1.03
GADD45G -1.19
GAPDH -1.32 0.18
GJA1 -1.08
GPX1 -1.28
GTF2H2 1.43
HPRT1 0.10 1.14
HRK -1.08
HSF1 -1.11
HSP90AA2 -1.05
HSPA1A -1.19
ICAM1 -1.98
IFNB1 -1.27
IFNG -1.27
IKBKB 1.05
IKBKE -1.71
IKBKG -1.52
IL10 -3.11
IL12B 1.28
IL15 1.43
IL1A -1.16 0.16
IL1B -1.02
IL1R2 1.18
IL1RN -1.27
IL2 -1.27
IL2RA -1.27
IL4 -1.76
IL6 -2.10 1.01
IL8 2.77 1.65
INS -1.27
IRF1 1.17
JUN 1.02
KRAS 1.13
LIG1 -1.19
LTA -1.14
LTB 1.07
MAP2K6 -1.16
MAPK1 1.09
MDM2 1.21
MMP9 1.10
MT2A -1.35
MT3 -3.11
MYC 1.06
MYD88 1.01
NBN 1.43
NCOA3 -1.07
NFKB1 1.22 0.08
NFKB2 0.14 1.32
NFKBIA 1.84 0.11
NOS2 1.04
NQO1 -1.01
NR4A2 -1.17
OGG1 1.10
P53AIP1 -1.20
PCNA 1.00
PDGFB -1.27
PIK3Ca 1.10
PLAU 1.22
PRKCA -1.12
PTGS2 1.22
RAD51 -1.10
RAD9A -1.22
RASA1 1.17
RB1 1.01
REL 1.24 0.05
RELA 0.03 1.08
RELB -1.45
RPL13A 1.10
RPLP0 1.03
SELE -1.60
SELP -1.27
SNAP25 1.13
SOD1 -1.26
SOD2 0.04 1.13
SOD3 -3.11
SOS1 -1.13
STAT1 -1.01
STAT3 -1.15
STAT5B -1.08
TLR1 -2.20
TNF 2.49 0.21
TNFRSF1B 1.10
TNFSF10 -1.17
TP53 1.21 0.07
TP53BP2 1.12
TP73 -1.84
TRADD -1.32
TRAF2 1.01
UNG -1.19
VCAM1 -1.27
WT1 -1.26
XIAP -1.02
XRCC1 -1.13
XRCC2 1.26
XRCC3 -1.27
XRCC5 1.04
XRCC6BP1 1.13
Table 20: Analysis of gene expression in HEK shRNA RelA cells 6 hours after treatment with TNF-!
using the RT2 Profiler™ PCR array (SABiosciences). Fold up- or downregulation is shown for all genes
from both, the customized and the NF-!B signaling array.  SE is shown for those genes that occur in
both arrays. Genes that are more that threefold up- or downregulated are highlighted.
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Gene 0.5 Gy 4 Gy 8 Gy
ADM 1.23 1.16 1.08
ACTB 1.02 -1.06 -1.09
AGT 1.03 1.12 1.07
AKT1 1.07 1.10 1.20
ALDH3A2 1.04 1.06 -1.04
B2M 1.04 1.04 1.22
BCL2A1 1.03 1.12 -1.06
BCL2L1 1.32 1.31 1.57
BIRC2 1.04 1.08 1.40
BIRC3 1.10 1.58 3.16
C3 2.79 1.90 1.78
CCL11 1.27 2.14 2.58
CCL2 -1.14 1.70 2.79
CCL22 1.03 1.12 -1.06
CCL5 1.03 1.12 -1.06
CCND1 1.34 1.17 1.30
CCR5 1.67 2.03 2.38
CD40 1.10 1.40 1.44
CD69 1.03 1.12 -1.06
CD80 1.16 1.74 2.39
CD83 -1.11 2.39 3.81
CDKN1A -1.09 1.32 1.39
CFB 1.24 -1.01 1.04
CSF1 1.10 1.49 1.77
CSF2 1.58 1.51 1.69
CSF2RB 1.03 1.12 -1.06
CSF3 1.05 1.03 1.34
CXCL1 1.56 4.22 8.94
CXCL10 1.03 5.53 21.86
CXCL2 1.02 2.55 4.72
CXCL9 1.03 1.47 2.91
EGFR 1.27 1.32 1.39
EGR2 1.21 2.05 2.75
F3 -1.24 1.16 1.33
F8 -1.04 -1.11 1.04
FAS 1.13 1.10 1.29
FASLG 1.39 1.81 2.85
GADD45B 1.12 1.76 2.27
GAPDH 1.02 1.03 -1.08
HPRT1 1.02 -1.04 1.03
ICAM1 1.60 1.67 1.43
IFNB1 1.03 1.12 -1.06
IFNG 1.03 1.12 -1.06
IL12B 1.03 1.12 1.61
IL15 1.47 1.26 1.78
IL1A -1.03 -1.20 1.27
IL1B 1.03 1.12 -1.06
IL1R2 1.08 1.30 1.12
IL1RN 1.03 1.12 -1.06
IL2 1.03 1.12 -1.06
IL2RA 1.03 1.12 -1.06
IL4 1.41 1.40 1.36
IL6 1.03 1.12 -1.06
IL8 1.21 3.27 7.26
INS 1.03 1.12 -1.06
IRF1 1.23 1.66 2.58
LTA 1.99 2.26 3.23
LTB 1.22 1.80 2.55
MAP2K6 -1.04 -1.30 -2.10
MMP9 -1.21 -1.25 -1.31
MYC 1.10 -1.10 -1.24
MYD88 -1.04 -1.06 1.23
NCOA3 1.17 1.06 -1.13
NFKB1 1.11 1.83 2.87
NFKB2 1.22 2.80 3.94
NFKBIA 1.16 2.25 4.23
NQO1 -1.09 -1.02 -1.14
NR4A2 1.13 1.05 1.23
PDGFB 1.03 1.12 -1.06
PLAU 1.20 1.28 1.77
PTGS2 -1.04 1.43 1.85
REL 1.07 1.27 1.62
RELA 1.22 1.23 1.40
RELB 1.22 1.47 3.05
RPLP0 -1.11 1.03 -1.07
SELE 1.39 2.01 2.91
SELP 1.03 1.12 -1.06
SNAP25 -1.30 -1.02 -1.21
SOD2 1.09 1.03 -1.01
STAT1 1.14 -1.03 1.06
STAT3 1.07 1.03 1.05
STAT5B 1.00 -1.09 -1.05
TNF 1.03 2.69 9.32
TNFRSF1B 1.07 1.56 2.22
TNFSF10 1.26 1.70 1.72
TP53 1.17 1.35 1.49
TRAF2 1.05 1.16 1.26
VCAM1 1.03 1.12 1.60
XIAP 1.15 1.21 1.01
Table 21: Analysis of gene expression in HEK-pNF-!B-d2EGFP/Neo L2 cells after treatment with X-rays
(200 kV). RNA!was isolated 6 hours after cells have been irradiated with 0.5, 4 and 8 Gy. Fold up- or
downregulation was investigated with the RT2 Profiler™ PCR Array focussing on Human NF-"B Signaling
Targets (SABiosciences). Listed are all genes from the array. Genes more than threefold up- or downre-
gulated are highlighted. 
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Gene 0.5 Gy 4 Gy 8 Gy
ADM 1.36 1.58 1.53
ACTB 1.03 -1.09 -1.22
AGT -1.01 1.08 -1.09
AKT1 -1.07 -1.00 -1.02
ALDH3A2 -1.04 -1.14 -1.11
B2M -1.07 -1.04 1.10
BCL2A1 1.08 1.60 1.14
BCL2L1 -1.21 1.41 -1.06
BIRC2 -1.13 1.19 1.13
BIRC3 -1.22 1.50 1.26
C3 -1.21 2.04 1.70
CCL11 3.22 3.26 2.11
CCL2 1.33 1.16 1.10
CCL22 1.08 1.16 1.14
CCL5 1.70 2.28 -1.34
CCND1 1.26 1.87 1.85
CCR5 1.53 1.51 -1.02
CD40 1.42 2.06 1.28
CD69 1.08 1.16 1.14
CD80 1.35 4.37 1.34
CD83 1.03 1.53 2.08
CDKN1A 1.05 1.41 1.83
CFB -1.10 -1.16 1.04
CSF1 1.08 1.22 1.24
CSF2 1.22 1.20 -1.24
CSF2RB 1.08 1.16 1.14
CSF3 1.26 1.03 -1.30
CXCL1 1.08 1.54 2.05
CXCL10 1.08 2.29 2.10
CXCL2 1.34 2.15 1.80
CXCL9 1.09 2.15 1.25
EGFR -1.03 1.11 1.01
EGR2 -1.02 3.17 1.59
F3 1.04 1.21 1.55
F8 -1.31 -1.50 -1.44
FAS -1.07 1.03 1.03
FASLG 1.47 1.62 -1.40
GADD45B 1.40 1.27 1.14
GAPDH 1.07 -1.02 -1.12
HPRT1 -1.15 1.03 1.13
ICAM1 -1.29 -1.27 -1.14
IFNB1 1.08 1.16 1.14
IFNG 1.08 1.16 1.14
IL12B 1.08 2.21 1.25
IL15 1.11 1.50 1.59
IL1A -1.42 1.51 -1.03
IL1B 1.08 1.16 1.14
IL1R2 1.12 1.99 1.26
IL1RN 1.08 1.16 1.14
IL2 1.08 1.16 1.14
IL2RA 1.08 1.16 1.14
IL4 1.16 -1.10 -1.51
IL6 1.26 1.16 1.14
IL8 1.21 1.39 1.02
INS 1.08 1.16 1.14
IRF1 -1.03 1.26 1.40
LTA 1.20 2.90 1.56
LTB 1.16 4.78 2.33
MAP2K6 -1.29 -1.22 -1.14
MMP9 -1.19 -1.07 1.01
MYC 1.06 1.02 1.02
MYD88 1.12 1.14 -1.00
NCOA3 -1.02 1.00 -1.19
NFKB1 1.25 1.29 1.39
NFKB2 1.35 1.85 2.01
NFKBIA 1.07 1.79 2.05
NQO1 1.04 1.06 1.31
NR4A2 -1.15 -1.05 1.53
PDGFB 1.08 1.16 1.14
PLAU 1.47 1.52 -1.07
PTGS2 -1.37 -1.02 -1.14
REL -1.18 1.04 1.04
RELA -1.08 1.05 -1.04
RELB 1.20 1.48 1.38
RPLP0 1.12 1.11 1.10
SELE 1.81 1.76 -1.06
SELP 1.08 1.16 1.14
SNAP25 1.12 1.31 1.37
SOD2 -1.10 -1.05 1.08
STAT1 1.02 -1.04 -1.14
STAT3 -1.01 -1.03 -1.04
STAT5B -1.02 -1.10 -1.19
TNF 1.08 1.16 1.14
TNFRSF1B 1.10 9.69 5.65
TNFSF10 1.19 5.37 3.13
TP53 -1.12 1.00 -1.02
TRAF2 1.02 -1.19 -1.11
VCAM1 1.08 1.16 1.14
XIAP 1.08 1.04 -1.04
Table 22: Analysis of gene expression in HEK shRNA RelA cells after treatment with X-rays (200 kV).
RNA!was isolated 6 hours after cells have been irradiated with 0.5, 4 and 8 Gy. Fold up- or downregula-
tion was investigated with the RT2 Profiler™ PCR Array focussing on Human NF-"B Signaling Targets
(SABiosciences). Listed are all genes from the array. Genes more than threefold up- or downregulated
are highlighted. 
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Gene ! SE
ACTB 1.09 0.01
ADM -1.33
AGT -1.05
AKT1 -1.01
ALDH3A2 -1.05
ATM 1.07
ATR -1.28
B2M 0.00 1.05
BCL2A1 -1.11
BCL2L1 -1.17
BCL3 -1.19
BIRC2 -1.09
BIRC3 1.09
BIRC5 -1.20
BRCA2 -1.46
BRCA5 1.09
C3 1.40
CASP3 -1.16
CASP8 -1.43
CASP9 1.20
CAT 1.14
CCL11 -1.42
CCL2 1.01
CCL22 -1.05
CCL5 -1.08
CCND1 -1.28
CCNE1 1.22
CCNE2 1.39
CCR5 -1.06
CD40 1.18
CD69 -1.05
CD80 -1.05
CD83 1.22
CDC2 1.08
CDC25A 1.33
CDKN1A 1.14 0.12
CDKN2A 1.04
CFB -1.36
CHEK1 -1.02
CHEK2 -1.16
CSF1 -1.04
CSF2 -2.09
CSF2RB -1.05
CSF3 1.23
CUL1 1.09
CXCL1 1.23
CXCL10 1.15
CXCL2 1.65
CXCL9 1.00
DDB1 1.15
DDIT3 1.05
DNAJA1 -1.03
E2F1 1.17
EGFR -1.02
EGR1 1.30
EGR2 -1.08
EIF2AK2 -1.17
ERCC3 -1.10
EXO1 1.30
F3 1.21
F8 -1.24
FANCG 1.19
FAS -1.20
FASLG -1.39
GADD45A -1.29
GADD45B -1.47
GADD45G -1.12
GAPDH -0.03 1.05
GJA1 -1.03
GPX1 1.16
GTF2H2 -1.17
HPRT1 -0.02 1.05
HRK -1.06
HSF1 1.18
HSP90AA2 1.08
HSPA1A 1.24
ICAM1 -1.05
IFNB1 -1.05
IFNG -1.05
IKBKB 1.00
IKBKE 1.03
IKBKG 1.02
IL10 1.39
IL12B 1.05
IL15 -1.46
IL1A -1.22 0.03
IL1B -1.05
IL1R2 -1.35
IL1RN -1.05
IL2 -1.05
IL2RA -1.05
IL4 1.08
IL6 0.32 1.37
IL8 1.24 0.10
INS -1.05
IRF1 1.10
JUN 1.28
KRAS -1.16
LIG1 1.01
LTA 1.04
LTB -1.11
MAP2K6 -1.31
MAPK1 1.17
MDM2 1.10
MMP9 1.01
MT2A 1.05
MT3 1.68
MYC -1.15
MYD88 -1.00
NBN -1.11
NCOA3 -1.16
NFKB1 1.15 0.05
NFKB2 -1.02 0.01
NFKBIA 0.08 1.15
NOS2 -1.12
NQO1 -1.28
NR4A2 1.04
OGG1 1.12
P53AIP1 -2.80
PCNA 1.29
PDGFB -1.05
PIK3Ca 1.02
PLAU -1.27
PRKCA 1.02
PTGS2 1.47
RAD51 1.02
RAD9A 1.08
RASA1 -1.01
RB1 -1.14
REL 0.11 1.22
RELA 1.13 0.13
RELB -1.18
RPL13A -1.08
RPLP0 -1.00
SELE -1.19
SELP -1.05
SNAP25 1.05
SOD1 -1.20
SOD2 0.07 1.12
SOD3 1.68
SOS1 1.04
STAT1 -1.05
STAT3 -1.05
STAT5B 1.05
TLR1 -1.21
TNF 1.53 0.15
TNFRSF1B -1.05
TNFSF10 -1.07
TP53 1.06 0.04
TP53BP2 -1.13
TP73 1.15
TRADD -1.35
TRAF2 -1.12
UNG -1.01
VCAM1 -1.05
WT1 1.33
XIAP -1.11
XRCC1 1.17
XRCC2 1.04
XRCC3 1.23
XRCC5 1.07
XRCC6BP1 1.04
Table 23: Gene expression in HEK-pNF-!B-d2EGFP/Neo L2 cells 6 hours after irradiation with 0.5 Gy of
48Ti ions (1000 MeV/n, LET 108 keV/"m) using the RT2 Profiler™ PCR array (SABiosciences). Fold up-
or downregulation is shown for all genes from both, the customized and the NF-!B signaling array. Genes
more than threefold up- or downregulated are highlighted. SE is shown for genes occuring in both arrays. 
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Gene ! SE
ACTB 0.00 1.01
ADM 1.23
AGT 1.21
AKT1 1.11
ALDH3A2 -1.16
ATM 1.19
ATR 1.12
B2M 1.10 0.07
BCL2A1 1.14
BCL2L1 -1.58
BCL3 1.27
BIRC2 -1.11
BIRC3 1.35
BIRC5 -1.71
BRCA2 1.44
BRCA5 1.04
C3 -1.10
CASP3 1.30
CASP8 -1.10
CASP9 1.06
CAT 1.09
CCL11 -2.55
CCL2 2.52
CCL22 1.21
CCL5 1.17
CCND1 1.43
CCNE1 1.85
CCNE2 2.29
CCR5 -2.22
CD40 -1.57
CD69 1.21
CD80 -1.60
CD83 4.26
CDC2 -1.05
CDC25A 1.92
CDKN1A 1.71 0.00
CDKN2A -1.10
CFB -1.20
CHEK1 1.17
CHEK2 -1.01
CSF1 1.88
CSF2 -1.49
CSF2RB 1.21
CSF3 1.22
CUL1 -1.06
CXCL1 9.27
CXCL10 9.79
CXCL2 4.41
CXCL9 -2.20
DDB1 1.21
DDIT3 1.96
DNAJA1 1.06
E2F1 2.01
EGFR 1.17
EGR1 1.84
EGR2 -2.11
EIF2AK2 -1.04
ERCC3 1.37
EXO1 1.88
F3 2.04
F8 -1.07
FANCG 1.38
FAS 1.09
FASLG -1.50
GADD45A 1.64
GADD45B 1.57
GADD45G 1.62
GAPDH -1.12 0.06
GJA1 -1.45
GPX1 1.15
GTF2H2 1.01
HPRT1 1.08 0.01
HRK 1.08
HSF1 1.13
HSP90AA2 1.20
HSPA1A 1.19
ICAM1 -1.10
IFNB1 1.21
IFNG 1.21
IKBKB 1.07
IKBKE 1.06
IKBKG 1.08
IL10 1.37
IL12B -1.05
IL15 -1.03
IL1A -1.42 0.24
IL1B 1.21
IL1R2 -2.08
IL1RN 1.21
IL2 1.21
IL2RA 1.21
IL4 1.04
IL6 1.35 0.14
IL8 5.71 0.64
INS 1.21
IRF1 2.95
JUN 7.93
KRAS 1.03
LIG1 1.18
LTA -2.10
LTB -2.80
MAP2K6 -1.83
MAPK1 1.26
MDM2 1.20
MMP9 -1.27
MT2A -1.02
MT3 1.49
MYC 1.21
MYD88 -1.20
NBN -1.06
NCOA3 1.07
NFKB1 2.72 0.14
NFKB2 2.16 0.90
NFKBIA 3.57 0.12
NOS2 -1.32
NQO1 -1.35
NR4A2 1.05
OGG1 1.34
P53AIP1 -1.41
PCNA 1.67
PDGFB 1.21
PIK3Ca 1.04
PLAU 1.39
PRKCA 1.03
PTGS2 2.24
RAD51 1.20
RAD9A 1.25
RASA1 1.04
RB1 1.03
REL 1.81 0.32
RELA 1.42 0.16
RELB 1.09
RPL13A -1.19
RPLP0 1.09
SELE -1.46
SELP 1.21
SNAP25 -1.30
SOD1 -1.25
SOD2 1.16 0.11
SOD3 2.19
SOS1 1.01
STAT1 1.13
STAT3 -1.07
STAT5B 1.02
TLR1 -1.49
TNF 8.40 0.19
TNFRSF1B -2.28
TNFSF10 -1.88
TP53 1.48 0.07
TP53BP2 -1.02
TP73 1.62
TRADD -1.09
TRAF2 1.33
UNG 1.26
VCAM1 1.53
WT1 1.66
XIAP 1.09
XRCC1 1.03
XRCC2 1.28
XRCC3 1.38
XRCC5 1.09
XRCC6BP1 -1.02
Table 24: Gene expression in HEK-pNF-!B-d2EGFP/Neo L2 cells 6 hours after irradiation with 4 Gy of
48Ti ions (1000 MeV/n, LET 108 keV/"m) using the RT2 Profiler™ PCR array (SABiosciences). Fold up-
or downregulation is shown for all genes from both, the customized and the NF-!B signaling array. Genes
more than threefold up- or downregulated are highlighted. SE is shown for genes occuring in both arrays. 
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Gene ! SE
ACTB -1.07 0.01
ADM 1.37
AGT -1.07
AKT1 1.23
ALDH3A2 1.10
ATM 1.52
ATR 1.32
B2M 1.07 0.05
BCL2A1 1.37
BCL2L1 1.30
BCL3 1.24
BIRC2 1.17
BIRC3 1.17
BIRC5 -1.06
BRCA2 1.71
BRCA5 1.15
C3 -1.13
CASP3 1.04
CASP8 1.36
CASP9 1.05
CAT 1.04
CCL11 1.26
CCL2 1.14
CCL22 -1.14
CCL5 -1.01
CCND1 1.09
CCNE1 1.02
CCNE2 1.24
CCR5 1.44
CD40 1.05
CD69 -1.14
CD80 1.41
CD83 1.22
CDC2 1.05
CDC25A 1.03
CDKN1A 1.14 0.07
CDKN2A -1.14
CFB 1.72
CHEK1 1.00
CHEK2 1.05
CSF1 -1.03
CSF2 -2.61
CSF2RB -1.14
CSF3 1.41
CUL1 -1.15
CXCL1 -1.27
CXCL10 -1.14
CXCL2 1.14
CXCL9 1.14
DDB1 -1.05
DDIT3 1.11
DNAJA1 1.03
E2F1 1.24
EGFR 1.12
EGR1 1.08
EGR2 1.29
EIF2AK2 1.01
ERCC3 1.03
EXO1 1.08
F3 1.30
F8 1.17
FANCG 1.33
FAS 1.37
FASLG 1.17
GADD45A 1.48
GADD45B 1.37
GADD45G 1.51
GAPDH 1.03 0.03
GJA1 -1.18
GPX1 -1.10
GTF2H2 1.21
HPRT1 1.16 0.08
HRK 1.15
HSF1 -1.06
HSP90AA2 1.05
HSPA1A 1.15
ICAM1 1.05
IFNB1 -1.14
IFNG -1.14
IKBKB 1.25
IKBKE 1.48
IKBKG 1.25
IL10 -1.23
IL12B 1.25
IL15 -1.12
IL1A 1.81 0.25
IL1B 1.15
IL1R2 -1.11
IL1RN -1.14
IL2 -1.14
IL2RA -1.14
IL4 1.04
IL6 0.33 1.41
IL8 -0.10 1.16
INS -1.14
IRF1 1.10
JUN 1.11
KRAS 1.05
LIG1 1.36
LTA 1.14
LTB 1.31
MAP2K6 1.09
MAPK1 -1.06
MDM2 1.01
MMP9 1.37
MT2A -1.07
MT3 -1.29
MYC -1.05
MYD88 1.34
NBN 1.15
NCOA3 1.24
NFKB1 1.05 0.02
NFKB2 1.09 0.03
NFKBIA 1.13 0.04
NOS2 -1.16
NQO1 1.17
NR4A2 1.18
OGG1 1.20
P53AIP1 1.12
PCNA 1.03
PDGFB -1.14
PIK3Ca -1.01
PLAU 1.22
PRKCA -1.14
PTGS2 1.34
RAD51 1.14
RAD9A -1.02
RASA1 1.11
RB1 1.16
REL 0.05 1.05
RELA 1.09 0.03
RELB 1.08
RPL13A -1.35
RPLP0 -1.05
SELE 1.07
SELP -1.14
SNAP25 1.33
SOD1 -1.09
SOD2 0.00 1.04
SOD3 -1.02
SOS1 1.11
STAT1 -1.09
STAT3 1.14
STAT5B 1.14
TLR1 -1.15
TNF 0.26 1.40
TNFRSF1B 1.07
TNFSF10 1.06
TP53 -1.05 0.04
TP53BP2 -1.01
TP73 -1.14
TRADD 1.13
TRAF2 1.10
UNG -1.00
VCAM1 -1.14
WT1 -1.16
XIAP 1.04
XRCC1 -1.13
XRCC2 1.55
XRCC3 1.37
XRCC5 1.06
XRCC6BP1 1.05
Table 25: Gene expression in HEK shRNA!RelA cells 6 hours after irradiation with 0.5 Gy of 48Ti ions
(1000 MeV/n, LET 108 keV/"m) using the RT2 Profiler™ PCR array (SABiosciences). Fold up- or
downregulation is shown for all genes from both, the customized and the NF-!B signaling array. Genes
more than threefold up- or downregulated are highlighted. SE is shown for genes occuring in both arrays. 
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Gene ! SE
ACTB -1.09 0.07
ADM 1.39
AGT 1.41
AKT1 1.18
ALDH3A2 -1.13
ATM 1.24
ATR 1.40
B2M 1.11 0.10
BCL2A1 -1.01
BCL2L1 -1.77
BCL3 1.46
BIRC2 -1.26
BIRC3 -1.28
BIRC5 -1.37
BRCA2 1.20
BRCA5 1.32
C3 -1.54
CASP3 1.28
CASP8 -1.21
CASP9 1.12
CAT 1.15
CCL11 1.45
CCL2 1.91
CCL22 -1.01
CCL5 2.29
CCND1 1.08
CCNE1 1.79
CCNE2 2.18
CCR5 1.87
CD40 -1.42
CD69 -1.01
CD80 -2.21
CD83 1.60
CDC2 -1.12
CDC25A 1.50
CDKN1A 1.53 0.01
CDKN2A -1.19
CFB 1.09
CHEK1 1.06
CHEK2 -1.06
CSF1 1.02
CSF2 1.96
CSF2RB -1.01
CSF3 2.02
CUL1 -1.06
CXCL1 1.41
CXCL10 -1.01
CXCL2 1.04
CXCL9 -1.67
DDB1 1.24
DDIT3 1.70
DNAJA1 1.28
E2F1 1.88
EGFR 1.09
EGR1 1.07
EGR2 -1.86
EIF2AK2 1.15
ERCC3 1.18
EXO1 1.49
F3 1.30
F8 -1.03
FANCG 1.64
FAS 1.38
FASLG 1.48
GADD45A 1.92
GADD45B 1.66
GADD45G 1.56
GAPDH -1.11 0.08
GJA1 -1.09
GPX1 -1.01
GTF2H2 1.25
HPRT1 1.11 0.02
HRK 1.29
HSF1 -1.03
HSP90AA2 1.28
HSPA1A 1.25
ICAM1 1.25
IFNB1 -1.01
IFNG -1.01
IKBKB 1.19
IKBKE 1.33
IKBKG 1.68
IL10 1.23
IL12B 1.30
IL15 -1.31
IL1A 0.20 1.27
IL1B -1.01
IL1R2 -2.01
IL1RN -1.01
IL2 -1.01
IL2RA -1.01
IL4 1.33
IL6 1.41 0.13
IL8 1.72 0.20
INS -1.01
IRF1 1.69
JUN 3.30
KRAS 1.18
LIG1 1.57
LTA -1.56
LTB -2.17
MAP2K6 -1.26
MAPK1 1.26
MDM2 1.27
MMP9 1.34
MT2A 1.01
MT3 1.33
MYC 1.13
MYD88 1.64
NBN -1.04
NCOA3 -1.11
NFKB1 1.21 0.16
NFKB2 1.15 0.05
NFKBIA 1.63 0.09
NOS2 1.19
NQO1 -1.11
NR4A2 1.01
OGG1 1.47
P53AIP1 1.23
PCNA 1.57
PDGFB -1.01
PIK3Ca 1.07
PLAU -1.11
PRKCA -1.03
PTGS2 1.27
RAD51 1.48
RAD9A 1.41
RASA1 1.07
RB1 1.02
REL -0.07 1.14
RELA 1.23 0.17
RELB -1.12
RPL13A 1.01
RPLP0 -1.05
SELE 1.14
SELP -1.01
SNAP25 1.04
SOD1 1.12
SOD2 1.11 0.03
SOD3 -1.10
SOS1 1.17
STAT1 -1.11
STAT3 -1.05
STAT5B -1.08
TLR1 -1.25
TNF 0.84 1.86
TNFRSF1B -7.09
TNFSF10 -3.26
TP53 0.17 1.17
TP53BP2 1.10
TP73 1.08
TRADD 1.06
TRAF2 1.28
UNG 1.01
VCAM1 -1.01
WT1 1.21
XIAP -1.24
XRCC1 1.13
XRCC2 1.54
XRCC3 1.77
XRCC5 1.23
XRCC6BP1 1.23
Table 26: Gene expression in HEK shRNA!RelA cells 6 hours after irradiation with 4 Gy of 48Ti ions (1000
MeV/n, LET 108 keV/"m) using the RT2 Profiler™ PCR array (SABiosciences). Fold up- or downregula-
tion is shown for all genes from both, the customized and the NF-!B signaling array. Genes more than
threefold up- or downregulated are highlighted. SE is shown for genes occuring in both arrays. 
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7.2 Abbreviations
aa amino acid
ATM Ataxia telangiectasia-mutated
bp base pairs
BSA bovine serum albumin
Ct threshold cycle
CAPE caffeic acid phenethyl ester
CDK cyclin-dependent kinase
C.I. confidence interval
CKI cyclin-dependent kinase inhibitor
CPT camptothecin
cDNA complementary DNA
CFA colony forming ability
COX2 cyclooxygenase 2
D energy dose
d2EGFP destabilized enhanced green fluorescent protein
DAPI 4',6-diamidino-2-phenylindole
ddH2O double-distilled water
DDR DNA!damage response
dH2O distilled water
DLR Deutsches Zentrum für Luft- und Raumfahrt
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid 
DSB double strand break
DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
dsRNA double-stranded RNA
E. coli Escherichia coli
EDTA ethylenediaminetetraacetic acid
EGFP enhanced green fluorescent protein
ELAM-1 endothelial-leukocyte adhesion molecule-1
ELISA enzyme-linked immunosorbent assay
ELKS glutamine/leucine/lysine/serine
EVA extravehicular activity
FACScan fluorescence-activated cell scanner
FA formaldehyde 
FBS fetal bovine serum
FSC forward scatter
F fluence
Fig. figure
g gram
G1 G1 cell cycle phase
G2/M G2/M cell cycle phase
GADD45 growth arrest and DNA!damage-inducible gene 45
GANIL Grand Accélérateur National d!Ions Lourds 
GCR galactic cosmic rays
GJIC gap junction intercellular communication
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GOI gene of interest
GSI Gesellschaft für Schwerionenforschung
Gy gray 
!g microgravity
!g microgram
H equivalent dose
HEK cells human embryonic kidney cells
HKG housekeeping gene
HR homologous recombination
h hours
HZE high atomic number and high-energy
IF immunofluorescence
IKK I"B kinase
I"B inhibitor of Nuclear factor-"B
iNOS inducible nitric oxide synthase
ISS International Space Station
J joule
kb kilobases
KD knockdown
keV kiloelectronvolt
kg kilogram
l liter
!l microliter
LB Luria Bertani
LEO low Earth orbit
LET linear energy transfer
m slope of the growth curve
MeV megaelectronvolt
mg milligram
min minute(s)
ml milliliter
mRNA messenger RNA
MTT 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide
!m mircometre
n nucleon
NC negative control
NCL nuclear-localization sequences
NEMO NF-"B essential modulator
NF-"B Nuclear factor "B 
ng nanogram
NHEJ non-homologous end-joining
NIK NF-"B inducing kinase
NRE NF-"B-responsive element
nm nanometer
o/n over night
OD optical density
P particles
PBS phosphate buffered saline
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PCR polymerase chain reaction
PE plating efficiency
PI propidium iodide
PIDD p53-inducible death domain-containing protein
PPP pentose phosphate pathway
Q radiation quality factor
QC quality control
RBE relative biological effectiveness
REST© Relative Expression Software Tool
RHD Rel homology domain
RIN RNA Integrity Number
RIP receptor-interacting protein
RISC RNAi induced silencing complex
RNA ribonucleic acid
RNAi RNA interference
RNase ribonuclease
ROS reactive oxygen species
rpm rotations per minute
rRNA ribosomal RNA
RT reverse transcription
S S cell cycle phase
SCR solar cosmic radiation
SD standard deviation
SDS sodium dodecyl sulfate
SE standard error
shRNA short hairpin RNA
siRNA small interfering RNA
SSA single-strand annealing
SSB single strand break
SSC side scatter
s second(s)
SF surviving fraction
SIS heavy ion synchotron (Schwerionen-Synchotron)
S-medium selection medium
Sv sievert
TAE tris base/acetic acid/EDTA
TLR Toll-like receptor
TNF-! tumor necrosis factor !
TNF-R tumor necrosis factor receptor
uPA urokinase plasminogen activator
VEGF vascular endothelial growth factor
WinMDI Windows multiple document interface
"max emission maximum
All gene abbreviations occuring in gene expression analysis are listed and described in Table 17.
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isolated from polyclonal populations transfected with the plasmids RELA-1
or RELA-4. 
Figure 31 Visualisation of RelA after RelA knockdown.
Figure 32 Activation of NF-!B dependent d2EGFP expression in different cell lines by
TNF-" and X-rays. 
Figure 33 Activation of NF-!B dependent d2EGFP expression in different cell lines by
13C ions (75 MeV/n, LET 34 keV/#m). 
Figure 34 Growth kinetics of HEK$shRNA$RelA cells compared to the original cell line. 
Figure 35 Comparison of cell cycle progression within 48 hours in the original and the
knockdown cell line.
Figure 36 Clonogenic survival after exposure of HEK shRNA RelA and HEK-pNF-!B-
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Figure 37 Clonogenic survival after exposure of HEK shRNA RelA and HEK-pNF-!B-
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7.5 Screen for Mycoplasma contamination
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Fig. 41: Certificate of Mycoplasma test. Cell culture samples were sent to the Leibnitz-Institut DSMZ-
Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH to ensure that cells are free from
Mycoplasma contamination. Here, the knockdown cell line HEK!shRNA RelA is named HEK-shRNA 4
#9 P9.
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